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ABSTRACT
The increase in multidrug resistance (MDR) among bacterial pathogens is an
ongoing threat to public health, with the CDC estimating more than 2.8 million MDR
infections in the United States each year, and greater than 35,000 deaths annually. Gramnegative bacteria possess intrinsic mechanisms to resist available therapeutics and are
frequently responsible for difficult-to-treat nosocomial, blood stream, and soft tissue
infections. In addition to biophysical and genetic MDR mechanisms, Gram negatives are
metabolically versatile, enabling them to utilize host-derived nutrients to promote
proliferation and colonization within the host. The metabolic versatility of Gram-negative
bacteria is due, in part, to the transcription of a diverse array of compound-specific
transcriptional regulators, which facilitate the integration of extracellular signals into
transcriptional changes. This ability to adjust to a changing extracellular environment
contributes to the success of a bacterium as an opportunistic pathogen. Many
opportunistic pathogens are found in environmental reservoirs and evolve or acquire
mechanisms within these competitive niches that are also effective during host-infection.
Some of these multipurpose systems pertain to the utilization of host-derived compounds.
While the title ‘host-derived’ suggests that these compounds are exclusively encountered
as integral parts of the host, bacteria also encounter host-derived compounds in other
contexts, such as within soils or aquatic ecosystems. The compounds focused on in this
dissertation can be derived from within the host, but are also found within environmental
niches. Here we investigate, through genetic, transcriptomic, and biochemical
approaches, how three Gram-negative bacteria of varying degrees of virulence,
Pseudomonas putida, Stenotrophomonas maltophilia, and Pseudomonas aeruginosa,
interact with several host-derived compounds, including creatine, sphingosine, and
mucin. It is important to gain a deeper understanding of how bacteria utilize these hostderived compounds, and how this utilization effects the transition to and exploitation of
the host during infection, with the ultimate goal of identifying new avenues for
therapeutic intervention.
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CHAPTER 1: Introduction

1.1 Bacterial metabolic versatility
Bacteria are instrumental in the recycling of earth’s essential elements. Through
processes such as respiration, nitrification/denitrification, and carbon and nitrogen
fixation, bacteria incorporate elements from organic or inorganic sources, such as dead
biotic material or the atmosphere, into themselves or into compounds that can be utilized
by other living organisms. Bacteria participate in nutrient recycling in various niches,
including soils and water systems, with each environment possessing a distinctive
assortment of available nutrients. In soils, bacteria are important players in the carbon
and nitrogen cycles, fixing atmospheric CO2 or N2 for assimilation into other
organisms[1]. Conversely, bacteria return carbon and nitrogen to the environment through
decomposition of organic matter, respiration, and mineralization[1]. In aquatic niches,
bacteria participate in the oxidation of organic matter, mineralizing elements such as
sulfur, iron, and phosphorous [2], [3], [4]. Pseudomonas and Stenotrophomonas species,
which will be the focus of this dissertation, participate in many important biogeochemical
cycling processes in environmental niches but are also able to transition successfully
from water and soil to the human infection niche, which is abundant in organic nutrients
[5], [6], [7], [8]

. The growth and survival of bacteria in a variety of niches whether nutrient

poor, nutrient rich, anoxic or aerobic, is influenced by the level of bacterial metabolic
diversity.

1

1.2 Metabolic strategies for bacterial nutrient acquisition
Several elements are required for all life, especially the macronutrients carbon,
hydrogen, nitrogen, phosphate, sulfur, and oxygen. In order to satisfy elemental
requirements bacteria employ a variety of strategies focused on nutrient acquisition. Here
we will focus on strategies used by Pseudomonas and Stenotrophomonas species to
acquire essential carbon and nitrogen from the environment. These Gram-negative
bacteria are characterized as chemoheterotrophic, gaining carbon and nitrogen from other
organisms (decaying organic matter, host-derived compounds) and the environment
(fixation of CO2) and copiotrophic, responding quickly to and successfully exploiting
nutrients that are abundant in the environment [9], [10], [11], [12].
Nutrient availability is the limiting factor for bacterial growth in any given
environment [13]. In a diverse microbial niche competitive interactions are complex, with
species of bacteria out-competing each other for limiting nutrients in non-transitive
fashions (Figure 1.1) [13], [14]. Depending on the environment, bacterial growth strategies
can be divided into two categories, exploitative competition and competition by
interference [13], [15], [16], [17].

1.2.1 Exploitative Competition
Exploitative competition is a passive process where a certain bacterial species
dominates a niche by efficiently utilizing the available nutrients, resulting in depletion of
resources and growth inhibition of competing organisms [13], [17]. Success in the
exploitative field of competition is aided by constant and/or fast growth kinetics [18]. In a
nutrient rich but competitive environment, fast growth, or a copiotrophic growth strategy,
2

ensures niche domination, while in nutrient limited environments slower but constant
growth and an oligotrophic or generalist metabolic strategy is favorable [19], [20], [21], [22].
The impact of bacterial diversity and increased competition in a given environment on
bacterial growth rate is demonstrated by the evolution of a bacterial species after it
changes its niche. The transition of P. aeruginosa from environmental reservoirs into the
human lung demonstrates how adaptation to a specific niche can impact bacterial growth
strategy. During the beginning stages of infection, P. aeruginosa enters the lung as a
generalist with high metabolic versatility and is able, through the use of its diverse
compound-specific metabolic systems, to rapidly exploit host-derived compounds to
promote fast growth and colonization [23]. As P. aeruginosa transitions into a chronic
lung infection, it begins to adapt to the lung environment, acquiring mutations resulting
in loss of motility, a decrease in transcription of virulence associated genes, development
of auxotrophy, and slower growth [24], [25], [26]. Reciprocal to the correlation between
development of auxotrophy and decreased growth rate in P. aeruginosa, a positive
correlation between growth rate and metabolic versatility has been observed in
Escherichia coli and many other Gram-negative bacteria [27], [28], [29], [30].
Given that constant efficient growth is always a safe bet for niche domination,
having a genome large enough to house various metabolic pathways, as well as a large
proportion of regulatory genes for precise control, provides a significant competitive
advantage when there is a fluctuating and diverse array of nutrients available [31].
Increased metabolic flexibility allows a bacterium to efficiently adjust its metabolic
strategy in order to dominate a given niche, while tight control of genes by transcriptional
regulators maintains a favorable balance between energy expenditure and yield [32]. This
3

is especially important when there is extensive metabolic overlap between competing
species, a situation where a small decreases in growth efficiency can have a large impact
on competition and therefore survival [13], [33], [34], [35], [36], [37], [8], [38].
Pseudomonas species are generalist Gram-negative bacteria with large,
metabolically versatile genomes and a high ‘environmental scope index’ or ESI, which
means that they are capable of growing in a diverse array of environments [31], [39]. This
high ESI as well as their competitiveness in diverse microbial environments is due in part
to their metabolic versatility. When Pseudomonas flourescenes is grown in competition
with other soil-dwelling bacteria, ~45% of the characterized induced genes are involved
in transport and metabolism of specific compounds [40]. Pseudomonas aeruginosa, a
bacterium characterized as an opportunistic pathogen – a pathogen that can cause
infection under certain circumstances such as when the immune system of the host is
compromised – also alters transcriptional levels of metabolic genes in response to the
selective pressures of its niche. When P. aeruginosa transitions from a diverse reservoir,
such as the soil or water, into a chronic lung infection of an individual with cystic
fibrosis, persistence becomes more important than fast growth for niche domination, and
slow growing, auto-aggregative, exopolysacchride-producing small colony variants
(SCVs) arise , [29], [30], [41]. These SCVs are clones of P. aeruginosa that have reversibly
inverted large areas of their genome, resulting in transcriptional repression of a majority
of metabolic genes [28]. Transcription of siderophores – transport molecules that have a
high affinity for certain compounds – is another way that bacteria compete for essential
nutrients that are under heavy demand. Pyoverdines are the iron scavenging siderophores
secreted by P. aeruginosa to sequester iron from co-infecting cystic fibrosis (CF)
4

pathogen Staphylococcus aureus [42], [43]. Sequestration of free iron in the lung inhibits the
activity of S. aureus’s electron transport chain, forcing a shift to fermentative metabolism
and reducing S. aureus’s fitness in the CF lung [44].

1.2.2 Competition by interference
When extensive metabolic overlap between species in a given niche causes
growth rate to be insufficient for niche domination, bacteria must resort to more active
forms of competition, including competition by interference. Antagonistic behavior
towards competing bacteria manifests in the secretion of secondary metabolites such as
anti-bacterial compounds, contact-dependent inhibition involving the injection of
competing neighbors with toxins, and secretion of enzymes to inhibit intra-species
communication [13], [17]. Competing bacteria can ablate communication between members
of a different species, called ‘quorum-signaling’, by using quorum-sensing inhibitors to
physically block communicatory molecules called ‘auto-inducers’, or by degradation of
auto-inducers via secreted lytic enzymes [45]. While secreted enzymes aimed at
degradation of auto-inducers are generally harmful to targeted bacterial populations,
other secreted secondary metabolites help to liberate nutrients for the community at large,
an example of cooperative ecological strategy.

1.2.3 Cooperation
Cooperation via synergistic metabolic networks or intra/inter-species crossfeeding is an effective metabolic strategy when co-existing microbes don’t have much
metabolic overlap or when the majority of nutrients in a niche are sequestered within
5

highly complex substrates [19], [20], [21], [46], [47], [48]. Cooperation between species has been
studied in various environments ranging from the gut and soil to the cystic fibrosis lung
during infection, where pathogens in the lung coexist by stratifying into different regions
depending on oxygen and nutrient requirements [49], [50], [51], [52].
Co-existing microbes tend towards synergistic, or syntrophic, metabolism when
the primary available nutrient source is too complex for any one member of the niche to
rapidly or efficiently metabolize alone. The co-evolution of Pseudomonas putida sp.
KT2440 and Acinetobacter sp. C6 grown on benzyl alcohol as the sole source of carbon
is an example of this. The growth rate of both bacteria is much higher when they are able
to synergistically metabolize benzyl alcohol, with Acinetobacter participating in the first
step of metabolism to supply benzoate as a carbon source for P. putida [53], [54].
Lignocellulose is another substrate that requires bacterial cooperation for metabolism,
due to its highly complex and recalcitrant structure. When supplied as the sole source of
carbon, bacterial communities form consortia to synergistically degrade lignocellulose,
but when a more accessible nutrient is added to the mix, the once cooperative groups fall
back into competition [46]. Many bacterial synergistic processes that take place in the soil
also aid in the growth of more complex organisms such as plants. An example of this is
the process of nitrification, which relies on the interplay between ammonia-oxidizing and
nitrite-oxidizing species of bacteria [55].
Cooperative metabolic strategies are also useful during bacterial pathogenesis. In
silico modeling has been used to predict the capacity for cross-feeding between
opportunistic pathogens that commonly co-infect the lungs of individuals with cystic
fibrosis. Some of the predictions made via in silico modeling have been supported
6

experimentally, such as the ability of mucin degradation by Streptococcus species to
supplement growth of Burkholderia species by supplying acetate for consumption [49], [50],
[51]

.
The metabolic strategies outlined above are focused on interspecies cooperation,

but intraspecies cooperation is also a common bacterial metabolic strategy when the
primary nutrient source is homogeneous or when nutrients are limited [33], [48], [56], [57], [58],
[59]

. When a single nutrient source is supplied in continuous culture, subpopulations with

substrate preferences for metabolic intermediates of the primary substrate arise within a
monoculture bacterial population. This phenomenon has been observed in populations of
Escherichia coli, where after ~800 generations of growth on glucose, polymorphic
populations with preferences for secondary metabolic intermediates, acetate and glycerol,
were isolated from culture [33], [48], [58], [59]. This cooperative intraspecies cross-feeding
strategy, made possible by genetic and physiological diversification over time within a
single population, can transform a previously homogeneous nutrient landscape into a
dynamic one, supporting the growth of multiple polymorphic populations at different
rates [33], [48], [58], [59].
Other cooperative strategies that can function in either an intra- or inter-species
capacity are the formation of protective multicellular architectures called biofilms, and
the production of siderophores, which can be used for acquisition and dissemination of
public goods to members of a given population [57], [60], [61], [62], [63], [64], [65], [66].
While the afore-mentioned cooperative strategies are useful in certain situations,
in niches where more metabolic overlap occurs between species, such as in fresh,
brackish, and tap water environments, competition for nutrients increases, driving
7

bacterial away from altruism [38], [67]. It is the evolutionary pressures exerted by these
highly competitive environments that create bacteria with the metabolic flexibility and
competitive strategies essential to becoming effective opportunistic pathogens, and it is
from these environments that most opportunistic pathogens emerge [8], [38], [68], [69], [70], [71].

1.3 Gram-negative bacteria with varying degrees of virulence interact with hostderived compounds
The metabolic strategy of a given bacteria plays a large role in determining its
ability to establish an infection within a host. Specifically, the ability to access and utilize
host-derived compounds is an absolute requirement for opportunistic pathogens during
infection, an idea that is not new[72]. Many host-derived compounds, or compounds
similar to those found in the host, are also found in environmental niches [73], [74].
Therefore, systems for utilization of host-derived nutrients are not limited to professional
and opportunistic pathogens but are also found in many non-pathogenic bacterial species.
Three Gram-negative bacteria of varying virulence are the focus of this dissertation: the
primarily non-pathogenic Pseudomonas putida, the emerging opportunistic pathogen
Stenotrophomonas maltophilia, and the common opportunistic pathogen Pseudomonas
aeruginosa. The characteristics of these bacteria, and their degree of interaction with the
host and host-derived compounds, are explained in detail below.

8

1.3.1 Pseudomonas putida
Pseudomonas putida is a Gram-negative bacterium found primarily in soils and
water systems [74], [75]. Extensive research has been conducted using P. putida strain
KT2440 focusing on its capabilities for biotechnology and bioremediation, as well as its
natural activities within the rhizobiome, specifically highlighting how characteristics such
as stress-tolerance and versatile metabolic and physiological strategies contribute to its
success [74], [75].

1.3.1.1 Roles in biotechnology and the rhizobiome
P. putida’s physiological flexibility and stress-tolerance mechanisms, combined
with its metabolic versatility, contribute to its ability to degrade biosurfactants and soil
contaminants such as the aromatic compound toluene [74], [76], [77], [78], [79]. P. putida is able
to successfully degrade toluene even at high concentrations ranging from 50%-90% (v/v)
in the culture, demonstrating its high resistance to solvents [76], [77]. This solvent resistance
can be attributed to the involvement of over 100 solvent-tolerance related genes,
including those specifically involved in membrane-stress tolerance, which are controlled
by the ColR/ColS two-component regulatory system [74], [80], [81], [82]. The many metabolic
pathways under the control of transcriptional regulatory systems like ColR/ColS
endogenously transcribed by P. putida make its genome a valuable source of metabolic
modules that can be pieced together and transferred to other species of bacteria, enabling
the formation of synthetic metabolic pathways to create novel compounds [74], [75], [78], [79],
[83]

.
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P. putida is also very tolerant of orthologous metabolic pathways, defined as
pathways derived from other species of bacteria, and trans-metabolic systems, defined as
artificially designed metabolic systems, together making P. putida a valuable organism
for the building of and execution of biotechnical projects like the production of
biosurfactants [75], [78], [83], [84], [85], [86], [87]. P. putida has already been utilized as an agent of
bioremediation which involves the introduction of high-stress tolerant and metabolically
versatile organisms into a polluted environment to degrade toxic substances like oil [88].
In addition to its vast biotechnical applications, P. putida is a valuable member of the
rhizosphere, promoting crop growth through plant protection from disease via
antagonism towards plant pathogens [89], [90], [91]. It is within soils that P. putida may
encounter mammalian host-derived compounds, which are frequently deposited during
waste excretion and tissue decay, providing the opportunity for interaction between hostderived compounds and the generally non-pathogenic bacterium. Plants and other
protozoan and invertebrate members of the soil community also produce compounds that
are generally thought of in a mammalian context [92], [93], [94]. Some of the methods P.
putida uses for plant protection and growth promotion could be manipulated for host
infection, including the production of biofilms and secondary metabolites like
antimicrobials and siderophores [89], [95], [96], [97], [98].

1.3.1.2 Incidence of infection
Although the incidence of P. putida infection in humans is low, there are several
reported cases [99], [100], [101], [102], [103], [104], [105], [106], [107]. Due to the bacterium’s low
pathogenicity, the majority of P. putida infections occur in immune-compromised
10

individuals, manifesting as skin and soft tissue infections, systemic infections
(bacteremia), and nosocomial infections [107]. One of the main concerns when considering
the presence of P. putida in the hospital setting is the potential to transfer multi-drug
resistance (MDR) genes to pathogenic bacteria [108]. Like other soil-dwelling bacteria, P.
putida is constantly acquiring and evolving mechanisms to resistance antibacterial
compounds produced by competing microbes in the environmental niche. Analysis of P.
putida KT2440’s genome reveals the presence of many resistance-associated genes
(Figure 1.2)[109]. These resistance-associated genes run the risk of being transferred to
pathogens and making therapeutic strategies less effective [108]. It is also possible for P.
putida strains to pick up genes that increase their ability to infect a host, such as genes
needed for successful tissue colonization and nutrient acquisition from host tissues [110].
Chapter 2 of this dissertation characterizes a specific set of genes in P. putida strain
KT2440 associated with the detection and degradation of creatine, a host-derived
compound that is present in many host tissues [111]. Creatine degrading genes homologous
to those found in P. putida strain KT2440 are present in several strains of P. putida
including two pathogenic strains, HB4184 and H8234, potentially indicating that creatine
degradation may be linked to pathogenicity of the generally non-pathogenic bacterium
[110]

.

1.3.2 Stenotrophomonas maltophilia
The Gram-negative bacterium Stenotrophomonas maltophilia is a predominantly
soil and water-dwelling microbe with potential to be a successful opportunistic pathogen
due in part to its ubiquity and intrinsic multidrug resistance. S. maltophilia is commonly
11

associated with the rhizobiome, where it participates in nitrogen and sulfur cycles and has
been observed to improve plant growth [112], [113], [6], [114]. The success of S. maltophilia in
its environmental niches is due to many factors including its metabolic versatility,
secondary metabolite production, and intrinsic stress tolerance, qualities which also make
S. maltophilia a functional opportunistic pathogen.

1.3.2.1 Emerging opportunistic pathogen
The majority of Stenotrophomonas maltophilia is isolated from soils and water
systems and it is within these niches where robust responses to antimicrobials and other
abiotic stressors were most likely evolved or acquired, transforming S. maltophilia into a
MDR and highly stress tolerant microbe [37], [115], [116]. The distribution of S. maltophilia
within the environment is wide spread, and it has been recovered from plant roots, soils,
animals and invertebrates, and environmental and potable water sources [37]. Due to the
presence of S. maltophilia in water systems, it is not surprising that the microbe is also
found on the surfaces of medical and dental supplies, surfaces that can be in frequent
contact with humans [117], [118], [119], [120], [121].
While Stenotrophomonas maltophilia is not highly virulent, it has many qualities
that enable survival of opportunistic pathogens. S. maltophilia is intrinsically resistant to
several antimicrobial classes including β-lactams and aminoglycosides [122]. S.
maltophilia’s resistance to these antibiotics is due to a high number of multidrug efflux
pumps, transcription of lytic enzymes, and a relatively low membrane permeability [122].
In addition to antibiotic resistance, S. maltophilia forms robust biofilms on a variety of
surfaces, including the materials used to make equipment such as intravenous cannulae,
12

prothestics and nebulizers[37], [117], [118], [119], [120], [121], [123]. Adherence to surfaces is one
potential way that S. maltophilia gains access to the human body. Once inside the host,
the weakly pathogenic bacterium is able to utilize its repertoire of extracellular and cellassociated virulence factors to establish an infection [122].
Among S. maltophilia’s extracellular virulence factors are serine proteases, such
as the Xps Type II secretion system (T2SS) protease StmPr1 involved in degradation of
connective tissue and host immune system components, and clinical isolate-associated
lipases, phospholipases, and haemolysins [122]. Cell-associated factors include
lipopolysaccharide (LPS), which affords protection against host complement, and pili and
fimbrial structures that aid in adherence to host epithelial cells and biofilm formation.
Clinical isolates of S. maltophilia use flagella for initiation of infection and adhesion to
epithelial cells with aid from Stenotrophomonas maltophilia specific fimbriae called
SMF-1 fimbriae [122], [124]. SMF-1 fimbriae have been implicated in haemagglutination,
biofilm formation, and adherence to mammalian cells [124]. The participation of flagella in
adhesion has been observed in the cystic fibrosis (CF) lung, where loss of flagella during
chronic infection leads to lower adherence of S. maltophilia to host cells. Other types of
pili are also likely involved in biofilm formation and maintenance including Type IV
pilus machinery and TadE-like machinery [125], [126], [127], [128]. There are several other
genes observed to be required for biofilm formation in high-stress environments like the
CF lung, including rmlA (glucose-1-phosphate thymidylyltransferase), which is involved
in the LPS/EPS biosynthetic pathways [129]. Phylogenetic studies of multiple strains of S.
maltophilia, both clinical and environmental, show marked distinctions between those
strains primarily isolated from environmental niches versus those recovered from host
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infection. One study analyzing 171 publically available S. maltophilia genomes identified
that the strains separated into 23 monophyletic lineages, 2 of which were comprised
strictly of environmental isolates while the other 21 were a mix of environment and
human-derived strains, demonstrating the slow adaption of environmental S. maltophilia
strains to the human niche [130]. The human-derived strains in this study were most similar
to strains isolated from hospitals, suggesting transmission in the hospital setting [130].

1.3.2.2 Incidence of infection
Over the past decade Stenotrophomonas maltophilia has become more prevalent
in infection niches typically dominated by opportunistic pathogens such as Pseudomonas
aeruginosa, driven by more effective antibiotic treatment of the other pathogens and the
relative antibiotic resistance of S. maltophilia. Infections involving S. maltophilia are
generally associated with poor outcomes, especially in cases of CF lung infections. These
lung infections frequently involve multiple opportunistic pathogens. P. aeruginosa is one
of the most prevalent Gram-negative bacteria to infect the CF lung and co-infection with
S. maltophilia is a common occurrence leading to patient decline. The synergy between
P. aeruginosa and S. maltophilia during infection can result in higher incidence of
morbidity and higher mortality rates among patients, with one study measuring a coinfection mortality rate of 64%, which is a higher rate than that observed in cases of
singular infection with either pathogen [131]. While P. aeruginosa is commonly the
dominant pathogen in the CF lung, there are also cases in which S. maltophilia is the
primary opportunistic pathogen present. In a survey of 104 individuals with CF, S.
maltophilia was cultured out of 7.7% of patients, and in several of these patients S.
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maltophilia dominated the niche [132]. This survey identified S. maltophilia infection as an
independent risk factor in severe pulmonary exacerbations [132]. Although the scientific
community has yet to definitively determine whether S. maltophilia infection is the
causative agent of lung decline, or whether advanced lung decline allows for S.
maltophilia infection, it holds true that CF patients infected with S. maltophilia have a
three-fold higher risk of death or lung transplant [133].
S. maltophilia infects not only individuals with cystic fibrosis, but also occurs in
oral, tracheal, and blood infections in immune compromised individuals [134], [135], [136],
[137]

. While the health of the patient and strain of S. maltophilia affect the outcomes of

these infections, they can be severe; for example, bacteremia caused by S. maltophilia
carries a mortality rate of 65-69% [135], [136]. The high mortality rates associated with S.
maltophilia infections are concerning as cases have been increasing over the past decade
[138]

. A ten-year retrospective study identified S. maltophilia in 47.3% of children’s

tracheal secretions after undergoing tracheotomy, making it one of the 6 most common
opportunistic pathogens present in these post-operative airway infections [137].
Vancomycin resistant S. maltophilia has also been associated with mucosal injury
infection in chemotherapy patients [139]. The increased prevalence of S. maltophilia
infections is especially concerning given its intrinsic antibiotic resistance and stress
tolerance. S. maltophilia’s ability to utilize complex nutrient sources found in the host is
another characteristic that promotes bacterial growth during infection. Chapter 4 of this
dissertation characterizes S. maltophilia’s response to and utilization of mucin, a rich
host-derived nutrient source that is not readily metabolized by the majority of
opportunistic pathogens.
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1.3.3 Pseudomonas aeruginosa
There are several Pseudomonad species capable of causing infections in plants,
invertebrates, and animals, but the majority of Pseudomonas species including P. putida,
P. flourescenes, P. stutzeri, and P. chlororaphis act primarily as saprophytic members of
soil and water communities. Pseudomonas aeruginosa is the most-well studied
Pseudomonad due to its ability to cause severe infection in humans. The vast metabolic
versatility encoded by P. aeruginosa’s 5-7 Mb genome contributes to its ability to survive
in various environments and to effectively transition into a human host [140], [141], [142].
Analysis of P. aeruginosa’s genome reveals a large percentage of genes encoding
biological sensors and transcriptional regulators involved in complex transcriptional
responses to the ever-changing extracellular environment [140], [143]. Although P.
aeruginosa is the most well studied of the Pseudomonads, there are many genes present
in its large genome that have yet to be characterized and share little to no similarity with
previously characterized genes [140], [143]. Due to the severity and/or chronic nature of P.
aeruginosa infections in immune-compromised humans and the high incidence of P.
aeruginosa infection, further investigation into the identities and potential functions of P.
aeruginosa’s uncharacterized genes remains a high priority.

1.3.3.1 Transition from environment to the lung
The majority of the species belonging to the genus Pseudomonas are nonpathogenic soil and water dwelling bacteria, but several are pathogenic to plants, animals,
and invertebrates [144], [140], [145], [146], [147]. Several of the pathogenic species of
Pseudomonas, including P. putida and P. stutzeri, are occasionally implicated in human
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disease, but P. aeruginosa is by far the most pathogenic towards humans [105], [141], [148],
[149]

. Although P. aeruginosa is able to cause severe infections in humans, it is commonly

isolated from environmental niches like the other members of its genus. There is evidence
to suggest that evolutionary pressures exerted by environmental factors such as phage
interactions, osmotic and pH stress, and inter-microbial competition, can lead to the
emergence of P. aeruginosa epidemic strains by triggering frequent recombination and
gene acquisition through horizontal gene transfer (HGT) within P. aeruginosa’s genome
[150], [151]

. For example, one of the clones of P. aeruginosa most frequently isolated from

individuals with cystic fibrosis is also frequently isolated from aquatic sources [152]. A
separate study found that isolates collected from soils polluted with gasoline were
extremely similar to clones isolated from clinical settings [153]. Although it is plausible to
believe that the similarities between environmental and epidemic P. aeruginosa isolates
is the result of environment to host transition, an extensive sampling study observed that
P. aeruginosa was only abundant in environmental niches impacted by humans and was
rarely found in pristine environmental niches [154]. The uneven environmental distribution
of P. aeruginosa, biased towards man-impacted environments, suggests that P.
aeruginosa’s primary niche may be the host and that it is deposited into soils and water
systems via host-environment interactions.
There is evidence that the host environment selects for P. aeruginosa strains
possessing virulence gene-encoding pathogenicity islands, as they are present in the
majority of characterized clinical isolates [155]. P. aeruginosa isolates that have adapted to
chronic infection in the lung invert large regions of their genome, resulting in a lack of
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flagella and excessive EPS production. These SCVs are generally less immunogenic
allowing P. aeruginosa to persist within the niche [28], [156], [157].
Although the most common infections caused by P. aeruginosa are folliculitis and
otitis, P. aeruginosa lung infections have much more severe impacts on patient health. P.
aeruginosa lung infections occur in individuals who are immunocompromised or
incapacitated to some degree, such as individuals on assisted ventilation, those with
chronic obstructive pulmonary disorder (COPD), or those with cystic fibrosis (CF). In
these cases, it is easier for P. aeruginosa to bypass initial host immune mechanisms
including muco-cillary clearance responses, which are severely impaired in CF lungs.
Once past these barriers, P. aeruginosa can implement several virulence strategies to
establish infection. Metabolic flexibility is an important factor when establishing
infection, as nutrients must be derived from the host environment. P. aeruginosa’s
metabolic diversity allows it to grow well within the host lung and utilize the many
proteinaceous and lipid components available. The liberation of nutrients from cells
through cytotoxic methods is also a virulence strategy of P. aeruginosa involving
virulence factors encoded in pathogenicity islands. Several pathogenicity islandassociated virulence factors secreted by P. aeruginosa’s type III secretion system
machinery (T3SS) are involved in host cell toxicity and host tissue invasion, and are
strongly correlated with worse clinical outcomes [155], [158], [159]. These T3SS effectors,
including ExoU, ExoT, ExoS, and ExoY, are instrumental in host cell lysis and tissue
invasion, although a single P. aeruginosa isolate generally does not possess all of these
effectors. The tradeoff between effectors usually occurs between ExoU and ExoS. These
two effectors do not coexist in the P. aeruginosa genome, but are indicative of whether a
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certain strain of Pseudomonas will be cytotoxic or invasive. ExoU is associated with a
cytotoxic phenotype while ExoS along with ExoT are associated with host tissue
invasion, via disruption of tight junctions between epithelial cells and dampening of
phagocytic activity and lysosome signaling in macrophages [160], [161], [162], [159], [163]. Other
secreted factors such as pyocyanin and Exotoxin A also participate in the acute phase of
infection, facilitating oxidative damage to host tissues and inhibiting host protein
biosynthesis, respectively [155]. Another strategy that P. aeruginosa uses to establish itself
in the host niche is colonization via flagellar attachment to host cells. While adherence to
host cells via pili and flagella is important to prevent clearance of the pathogen, flagellar
structures are very immunogenic and are selected against as the infection transitions from
acute to chronic [164], [165], [166].
Isolates of P. aeruginosa collected from chronic CF lung infections are
phenotypically unique to environmental or acute phase isolates. In order to maintain a
chronic infection, Pseudomonas must dampen its immunogenicity to protect itself from
host immune responses. Strategies to evade immune detection include down-regulation of
flagella and up-regulation of alginate and EPS production to create protective biofilm
structures [159], [166], [167]. P. aeruginosa strains that have adapted to the host lung almost
never express ExoU because of its ability to induce inflammation [163]. Host-adapted
strains are also commonly deficient in proteases, non-motile, display a loss of the LPS Oside chains that are usually present in environmental isolates, and have different LPA
acylation patterns [155], [168], [169], [170], [171]. All of these factors render P. aeruginosa more
resistant to therapeutics, less immunogenic, and more likely to persist in the lung [159].
Chapter 3 of this dissertation investigates one facet of P. aeruginosa’s ability to resist
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innate immune mechanisms; specifically how P. aeruginosa detects and metabolizes the
host-derived antimicrobial sphingosine.

1.3.3.2 Incidence of infection
Pseudomonas aeruginosa infection carries a high healthcare cost burden,
estimated by the CDC in 2017 to be approximately $767 million. These costs were
accrued over the span of 32,600 cases, 2,700 of these resulting in death as reported by the
CDC. A majority of these infections are complicated by high frequencies of MDR and
involve individuals who are critically ill and immunocompromised. Of a survey of 740
patient isolates, 226 were MDR and strongly correlated with higher mortality in the
hospital setting [172]. In a similar study that identified bacteria present in infected burn
wounds, 58.6% of recovered P. aeruginosa samples were found to be MDR [173]. Severe
P. aeruginosa infections manifest in patients in a variety of ways, including bacteremia,
urinary tract infections (UTI), ventilator associated pneumonia (VAP), hospital and
community acquired pneumonia (HAP/CAP), and skin and soft tissue infections [173], [174],
[175], [176], [177], [178], [179], [180], [181], [182], [183], [184]

. In many of these types of infections, P.

aeruginosa is one of the most prevalent Gram negatives observed [174], [176], [177], [181], [182],
[183], [184]

.
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1.4 Systems for detection of and transcriptional response to specific compounds:
AraC/XylS transcriptional regulators
The ability to detect and respond to the extracellular environment is essential to
bacterial survival in any niche. A large genome may afford the high metabolic flexibility
needed to survive in a diverse array of environments, but in order to efficiently utilize
available resources, transcription of certain pathways must be prioritized over others.
Transcriptional regulators (TRs) participate in this prioritization process, activating or
repressing transcription of certain genes in response to specific compounds or
environmental conditions [185], [186]. Gram-negative bacteria utilize many different families
of transcriptional regulators, but in this dissertation we will focus on a diverse family of
regulators, the AraC/XylS family [187], [188]. This family of TRs is characterized most
broadly by the presence of two DNA binding helix-turn-helix (HTH) motifs in the Cterminal domain, which are responsible for binding to specific DNA sequences within the
promoter region of the target gene termed ‘half sites’. The HTH domain is highly
conserved throughout members of the family [186], [188]. The N-terminal domain of
AraC/XylS family proteins is not well conserved and is usually involved in ligand
binding and/or dimerization. Due to the weak conservation and low sequence similarity
of the N-terminal domains between members of the family, it is very difficult to predict
the cognate ligands for specific regulators [186], [188]. Due to the unreliability of
bioinformatic predictions there are many AraC/XylS TR family members whose ligands
remain unidentified.
The canonical members of the AraC/XylS family are the arabinose-specific TR
AraC from Escherichia coli, and the toluene-specific TR from P. putida, XylS. While
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these two transcriptional regulators share ligand-specific activitation and dimerization
ability, there are several differences in how they function. AraC exists as a dimer bound
to DNA at two half-sites denoted I1 and I2, changing conformation from looped to linear
after it binds its ligand arabinose, allowing the transcription of arabinose metabolic
machinery to occur (Figure 1.3A) [189]. XylS is constitutively expressed at low levels but
is also under the control of a xylene-responsive promoter [190], [191], [192]. XylS exists in an
unbound monomeric state until the concentration of monomers increases to the saturation
point where dimers begin to form [190]. XylS monomers increase in concentration when
there is higher basal transcription of xylS due to plasmid-borne expression, or when
inducing compounds such as 3-methylbenzoate (3-mBz) are present [190], [191], [192]. Once
sufficient dimers are formed, they bind to their respective half-sites in the distal and
proximal regions to the Pm promoter, which is responsible for the transcription of an
operon involved in the lower (meta) pathway of degradation of aromatic compounds
(Figure 1.3B). While the specific inducing compounds, half-site sequences, and
responsive genes vary between TRs that belong to the AraC/XylS TR family, most
members align with either the AraC or XylS mechanism of transcriptional activation.

1.4.1 GATRs: A subset of AraCs that detect amine-containing compounds
Although the N-terminal domains of AraC/XylS TR family members are not well
conserved, there are several subfamilies characterized by the presence of specific Nterminal motifs. One of these subfamilies is comprised of AraC-type TRs that contain a
glutamine amindotransferase-1 (GATase-1) type domain in the N-terminus. These
GATase-1-containing AraC-like TRs, or GATRs, are involved in recognizing amine22

containing compounds, particularly N-methylated amines, but do not show the amidegroup transferase activity characteristic of the GATase-family of enzymes. Several
members of this subfamily and their cognate ligands have been characterized in P.
aeruginosa and Burkholderia thailandensis. Among these are arginine-responsive ArgR,
choline-responsive CdhR, glycine-betaine responsive GbdR, and sarcosine-responsive
SouR. [193], [194], [195], [196], [197], [198].

1.5 Biomedical importance
The steady increase in multi-drug resistance observed in Gram-negative
opportunistic pathogens is an on-going healthcare concern worldwide. Current reports
from the CDC attribute greater than 2.8 million infections and greater than 35,000 deaths
to MDR microbes. MDR Pseudomonas aeruginosa is among the microbes deemed a
‘serious threat’ by the CDC. Treatment and management of MDR Gram negatives is
especially difficult due to how easily drug resistance cassettes are transferred between
bacteria in the hospital setting. Evidence of independent acquisition of drug resistance
genes after exposure to antibiotics has been seen in Gram-negative bacteria including, but
not limited to, Klebsiella pneumonia, Escherichia coli, and Salmonella typhimurium [199],
[200], [201]

. In all of these cases, plasmid borne antibiotic resistance cassettes can be easily

transferred between bacteria within the host or within the hospital setting, making it
difficult for therapeutic treatments to keep up with the dynamic resistance profiles of
bacterial pathogens. Apart from class-specific antibiotic resistance genes, such as
carbapenemases that are frequently transferred between bacteria and make certain classes
of antibiotics less effective, the acquisition of broad-spectrum efflux pumps is also
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concerning [202], [203], [204], [205]. Efflux-pump machinery allows bacteria to pump out
antibiotics at an alarming rate, conferring resistance to a wide range of antibiotics.
Because of the constant evolutionary pressure exerted on bacterial pathogens by
antibiotic therapies, we are seeing a rise in antibiotic resistance and a decline in the
effectiveness of available therapeutics [206]. The growing threat of multidrug resistance
worldwide highlights the urgent need to identify alternative targets for therapeutic
intervention. Investigation into the processes involved in the host-pathogen interaction,
including how microbes detect and utilize host-derived nutrients, is an integral step in
developing new strategies for prevention and control of opportunistic bacterial infections.
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1.6 Chapter 1 Figures
Figure 1.1 A simplified example of non-transitive competition for resources shows
the three different outcomes of three species competition for nutrients. The general
scheme is that the Species A (solid red) outcompetes Species B (solid white) for
nutrients, but Species B is able to outcompete Species C (stripped). By impeding the
growth of Species B, Species A allows for growth of Species C, but Species C depletes
nutrients required by Species A, meaning that by inhibiting Species B, Species A inhibits
its own growth. Scenarios 1, 2, and 3 depict how the absence of any one species impacts
the balance of species within the niche. This non-transitive competition occurs within the
environment and during poly-microbial host infections.
Figure 1.2 The environmental bacterium Pseudomonas putida transcribes many
resistance-associated genes within its genome. This circular map of P. putida
KT2440’s genome highlights the presence of putative resistance-associated genes via the
presence of a pink dot. Resistance genes appear to exist in clusters throughout the
genome. The internal jagged grey line is a representation of differences in sequence
composition, including GC content and codon bias, as compared to the genome as a
whole. Genomic regions where the grey line dips below the blue inner circle have a
higher probability of having originated from a different bacterial species and may have
been acquired through horizontal gene transfer.
Figure 1.3 The majority of members of the AraC/XylS family of transcriptional
regulators (TRs) operate in one of two canonical fashions (A) The arabinoseresponsive TR of Escherichia coli operates in the light-switch fashion where the AraC
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dimer exists bound to operator (O2) and initiator (I2) regions upstream of the araBAD
promoter region. Regulator unbound to its ligand arabinose fixes the DNA in a curved
confirmation making the promoter region of araBAD inaccessible to RNA polymerase.
Upon binding ligand (arabinose), AraC dimers switch confirmation and bind to the two
initiator regions (I1 and I2) upstream of the promoter and switch the DNA confirmation to
linear allowing transcription by RNA polymerase. (B) The canonical XylS TR of
Pseudomonas putida is constitutively expressed at low basal levels as unbound
monomers. Once the concentration of monomers reaches a saturation point, or the
presence of an inducing ligand like 3-mBz induces a conformational change in XylS
monomers, dimers form and bind to distal and proximal regions to the Pm promoter,
which controls the meta pathway of aromatic compound cleavage.
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Figure 1.1 A simplified example of non-transitive competition for resources shows the
three different outcomes of three species competition for nutrients.
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Figure 1.2 The environmental bacterium Pseudomonas putida transcribes many
resistance-associated genes within its genome.
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Figure 1.3 The majority of members of the AraC/XylS family of transcriptional
regulators (TRs) operate in one of two canonical fashions.
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CHAPTER 2: Pseudomonas putida KT2440’s utilization of creatine as a sole
nitrogen source is transcriptionally regulated by PP_3665

2.1 Abstract
Pseudomonas putida is a soil-dwelling Gram-negative bacterium that rarely
causes infection in humans. The majority of P. putida research focuses on its use in
biotechnology and bioremediation due to its high stress tolerance and metabolic
versatility. Although not as virulent towards humans as other Pseudomonads like
Pseudomonas aeruginosa, P. putida occasionally infects severely immunocompromised
individuals, causing blood stream and soft tissue infections. Here we characterize P.
putida’s interaction with the host-derived polyamine compound creatine, which is found
in eukaryotic tissues and acts as a buffer for the charging of high-energy compounds like
adenosine tri- and di-phosphate (ATP/ADP). Through genetic and biochemical
approaches, we identify a glutamine amidotransferase-1 domain-containing AraC-family
transcriptional regulator (GATR), PP_3665, which is necessary for the transcription of a
creatine amidohydrolase-encoding gene (PP_3667) in the presence of creatine, and
evaluate the role of PP_3665 in P. putida’s ability to utilize creatine as a sole source of
nitrogen. This study identifies a previously uncharacterized GATR and contributes
important information to the fields of bacterial transcriptional regulation and polyamine
metabolism.
2.2 Introduction
Like many primarily soil dwelling microbes, the Gram-negative bacterium
Pseudomonas putida has evolved a vast and diverse array of transport and metabolic
43

machinery to fuel its organoheterotrophic lifestyle [1]. Within the rhizosphere, fast and
efficient adjustment to the surrounding environment ensures successful acquisition of
essential nutrients and activation of stress responses that are crucial to P. putida’s
survival [2]. Effective response to the extracellular environment is partly afforded by the
large number of transcription regulatory proteins encoded by the Pseudomonas genome.
About 2% of the predicted genes in the 6.15 Mbp P. putida KT2440 genome contain a
conserved AraC-type DNA-binding Helix-Turn-Helix motif, characteristic of many
catabolism-related transcription regulators [3]. These AraC-like transcription regulators
control a large number of metabolic processes within P. putida, although for many, the
cognate inducing ligands and target regulons have not been identified.
P. putida PP_3665 encodes an AraC-type transcription regulator upstream of a
creatinase gene (PP_3667). Among characterized Pseudomonas genomes, only P. putida
and P. resinovorans maintain close predicted orthologs of both the creatinase gene and
the associated AraC-family transcription regulator in this syntenic arrangement [3]. Both
of these species of Pseudomonas are present primarily in soils and are active participants
in the rhizobiome, i.e. bacteria within the rhizosphere. It is within the rhizosphere that P.
putida most likely encounters creatine, as creatine and its anhydrous form, creatinine, are
present in soils, deposited via animal urine or feces as well as through animal tissue
degradation [4], [5], [6], [7].
Creatine is a polyamine compound found in many eukaryotic tissues where it
serves to buffer charging of high-energy carriers like adenosine triphosphate (ATP) and
adenosine diphosphate (ADP). It is particularly abundant in tissues that require large
pools of ATP and ADP for periods of intense energy expenditure, such as fast twitch
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muscles [8]. Metabolism of creatine in eukaryotes occurs via partial metabolism and
modification by gut-residing bacteria creating 1-methylhydantoin, a metabolite that is not
easily metabolized by the body and can lead to tissue inflammation. Given this toxic
metabolite, the major avenue of creatine homeostasis in eukaryotes is the excretion of
creatine and creatinine in the urine. Pseudomonas species have been observed to
metabolize creatine and creatinine, as well as the breakdown product, 1-methylhydantoin
[8], [9], [10], [11], [12], [13], [14], [15], [16]

. The final products of creatine and creatinine metabolism

by Pseudomonas can vary depending on the specific degradation pathway. For creatinine,
the process begins with breakdown of creatinine to creatine by a creatininase (creatinine
amidohydrolase). Creatine is then further degraded to sarcosine and urea by creatinase
(creatine amidinohydrolase), and sarcosine is then converted to glycine and formaldehyde
by the tetrameric sarcosine oxidase (SoxBDAG), or to methylamine by sarcosine
reductase and/or glycine reductase (Fig. 1A) [8], [9], [17], [18].
Production of creatinase is inducible in P. putida when the bacterium is supplied
with creatine as the sole carbon or nitrogen source, but the induction mechanism is
currently unknown [12]. In this study we identify the regulator required for transcriptional
induction of creatinase in P. putida and demonstrate its role for P. putida growth on
creatine as a sole nitrogen source.

2.3 Materials and Methods
2.3.1 Strains and Growth Conditions
Pseudomonas putida strain KT2440 and mutants made from this parent strain
were grown at 30°C shaking (170 rpm) in morpholinopropanesulfonic acid (MOPS)
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media supplemented with 25 mM pyruvate, 5 mM arginine, and 20 µg/ml gentamicin
when needed for plasmid maintenance [19]. Escherichia coli strains DH5α and S17λpir,
used for cloning and mating with P. putida, and E. coli strain T7 used for recombinant
protein expression, were maintained in lysogeny broth (LB), Lennox formulation,
supplemented with 7 µg/ml gentamicin or 150 µg/ml carbenicillin as appropriate. E. coli
strains were grown at 37°C with shaking (170 rpm). Strains and plasmids used in this
study can be found in Table 2.1.

2.3.2 Construction of P. putida PP_3665 deletion strain and complementation
construct
A 980 base pair (bp) upstream of the coding reading of PP_3665 were amplified
with primers engineered to include a HindIII restriction digest site and an overlap region
for splicing by overlap extension (SOE) (primers can be found in the PP_3665 deletion
construct section of Table 2). A 1 kb fragment downstream of the coding region of
PP_3665 was amplified with primers engineered with EcoRI restriction site and overlap
region. The two fragments flanking the PP_3665 coding region were spliced together via
SOE PCR using the outside restriction-site containing primers, digested with HindIII and
EcoRI, and ligated into similarly cut plasmid pMQ30 containing a gentamicin resistance
cassette for initial selection and the sacB gene for counter selection. pMQ30 containing
the flanking regions of PP_3665 (pMQ30:PP_3665KO) participated in homologous
recombination with P. putida. A clean deletion of gene PP_3665 in P. putida strain
KT2440 was achieved via homologous recombination as previously described, described
in detail below [20], [21].
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Plasmid pMQ30:PP_3665KO was cloned and propagated in E. coli strain DH5α,
then transferred into conjugative strain E. coli S17λpir. The S17λpir strain carrying
plasmid pMQ30:PP_3665KO was then mixed in 1:1 and 1:10 ratios with Pseudomonas
putida strain KT2440, spot-plated on LB agar plates, and incubated at 30°C for 18 hours
to allow for conjugation to take place. Half of each spot was then scraped and plated on
LB agar plates amended with 50 µg/ml gentamicin to select for colonies that underwent
the first crossover event. Several single crossover clones were then grown for 5 hours in
LB broth at 30°C with shaking to allow for the second crossover event to occur. After
this incubation, 100 µl of culture was plated onto LB agar with no salt and amended with
10% sucrose to screen for those colonies that underwent the second crossover event. The
resulting colonies were screened for a clean deletion of the PP_3665 gene or a reversion
to the wild type chromosome with primers #1601 and #1602 (Figure 2.1B). The clone
LAH111 with genotype ∆PP_3665 was stocked for use in future experiments.
PP_3665 complementation in the ∆PP_3665 strain was achieved by expression of
PP_3665 from a plasmid. Briefly, the coding region of PP_3665 and divergently
transcribed gene pssA (to ensure the full coding region of PP_3665 was included) were
amplified using primers engineered with HindIII and BamHI cut sites (#1158 and #2350).
The ~2.5 kb fragment was digested with the aforementioned enzymes and ligated into the
similarly cut pMQ80 plasmid. The resulting pMQ80:pssA/PP_3665 complement plasmid
was then electroporated into P. putida KT2440 ∆PP_3665 as previously described with
the voltage set at 2.2 kV [20]. Sequences of primers used to construct plasmids can be
found in Table 2.2.
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2.3.3 Nitrogen source growth assays
P. putida KT2440 wild type and ∆PP_3665 strains carrying the pMQ80 empty
vector, and P .putida KT2440 ∆PP_3665 complemented with pMQ80:pssA/PP_3665
were grown overnight at 30°C shaking in 1x MOPS buffer amended with 25 mM
pyruvate, 5 mM arginine, and 20 µg/ml gentamicin. Cells from overnight culture were
collected by centrifugation, washed with 1x MOPS media lacking nitrogen, and adjusted
in 1x MOPS no nitrogen to an optical density at 600 nm (OD600) of 0.5. These normalized
cell suspensions were added to pre-warmed 1x MOPS no nitrogen media amended with
20 mM pyruvate, 20 µg/ml gentamicin, and 2 mM of one of the following nitrogen
sources: choline, creatine, creatinine, sarcosine, or arginine. A control for growth in
media lacking nitrogen was also included. Cells were added to each condition to a final
optical density at 600 nm (OD600) of 0.05 in a 48-well plate. Cultures were incubated at
30°C shaking at 170 rpm for 18 hours. The optical densities of cultures were measured at
times 0 hours and 18 hours using a Synergy H1 plate reader (BioTek, Winooksi, VT).
Growth was reported as the fold growth of each strain amended with a nitrogen source
over the growth in the 0 mM nitrogen condition.
Fold Growth = (OD6002mM N-source/OD6000mM nitrogen)

2.3.4 PP_3665-dependent transcriptional induction assays and PP_3667 promoter
mapping
A transcriptional reporter fusion of the PP_3667 promoter to the coding region of
green fluorescent protein (PP_3667-gfp) was constructed for use in compound-specific
transcriptional induction assays. The promoter region of PP_3667 was amplified with
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primers that contain 3’ extensions that anneal to the pMQ80 vector backbone upstream of
the region encoding the GFP protein. The full PP_3667 promoter (-228 bp from the
translational start) as well as a -193 bp promoter truncation was spliced into the pMQ80
vector by splice overlap extension (SOE) PCR upstream of the coding region of GFP
following the previously described protocol [22]. Further truncations of the PP_3667
promoter, -104 bp and -80 bp from the translational start, were spliced to gfp by splice
overlap extension PCR (SOE) and the PP_3667-gfp fusion fragment was then digested
with restriction enzymes EcoRI and HindIII and ligated into the similarly cut pMQ80
backbone.
Each plasmid encoding the PP_3667 promoter-gfp fusion, full or truncated, was
electroporated into P. putida KT2440 wild type or ∆PP_3665 for transcriptional
induction assays. To test metabolite-specific induction using the full PP_3667 promoter
gfp reporter construct, P. putida KT2440 wild type and ∆PP_3665 carrying the
pMQ80:PP_3667-228gfp plasmid were grown overnight in 1x MOPS media amended with
25 mM pyruvate, 5 mM arginine, and 20 µg/ml gentamicin. Overnight cultures were
adjusted to a uniform OD600 and added to 1xMOPS media amended with 20 mM
pyruvate, 20 µg/ml gentamicin, and +/- 2 mM of each experimental small molecule to a
final OD600 of 0.5 in a 48-well plate. The compounds creatine, creatinine, sarcosine, and
glycine betaine were tested for their PP_3665-dependent induction via the PP_3667
promoter. Plates were incubated at 30°C with periodic shaking for 18 hours with readings
of the OD600 and GFP fluorescence (Excitation: 425 nm/Emission: 535 nm) taken every
hour.
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To determine the region of the PP_3667 promoter essential for creatineresponsive PP_3665-dependent induction, induction assays using PP_3667-gfp
transcriptional reporters engineered with truncated regions of the PP_3667 promoter
upstream of gfp were conducted. The assays were conducted as described above with the
following adjustments; P. putida KT2440 wild type strains carrying the
pMQ80:PP_3667-228-gfp, pMQ80:PP_3667-193-gfp, pMQ80:PP_3667-104-gfp, or
pMQ80:PP_3667-80-gfp plasmids were induced in 1xMOPS media amended with 20 mM
pyruvate, 20 µg/ml gentamicin, and +/- 2 mM creatine. The full (-228) and -193 PP_3667
promoters were tested for PP_3665-dependence by measuring the transcriptional
induction of gfp carried on the respective reporter plasmid in the P. putida KT2440
∆PP_3665 background. Fold induction was reported using the equation: Fold Induction =
(Fluorescence Units2mM N-source/Fluorescence Units0mM nitrogen)

2.3.5 MBP-PP_3665 fusion construct and protein purification
A maltose binding protein-PP_3665 (MBP-PP_3665) fusion was engineered in
the pMALc2x vector as previously described [17], [23], [24]. Briefly, the coding region of
PP_3665 was amplified with primers engineered to include EcoRI and HindIII restriction
sites (#2596 and #2597). The ~1 kb fragment was then digested with restriction enzymes
EcoRI and HindIII (New England Biolabs, Ipswitch MA), purified using Fisher’s
GeneJET Gel Extraction and DNA Clean Up Kit (ThermoFisher Scientific, Waltham,
MA), and ligated into the similarly cut pMALc2x vector downstream of the MBP coding
region present in the vector. Cloning and propagation of the pMALc2x:MBP-PP_3665
vector was carried out in E. coli DH5α cells grown in LB broth supplemented with 150
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µg/ml carbenicillin for plasmid maintenance. The pMALc2x:MBP-PP_3665 vector was
then transformed into E. coli T7 cells which are engineered to support protein expression.
Expression of purification of MBP-PP_3665 was conducted as previously
described [17], [23], [24]. Briefly, E. coli T7 cells carrying the pMALc2x:MBP-PP_3665
plasmid were grown in a 50 ml volume of LB broth supplemented with 150 µg/ml
carbenicillin, shaking at 170 rpm at 37°C for 3 hours. Protein expression was induced by
addition of isopropyl-β-D- thiogalactopyranose (IPTG) to 1 mM followed by an
additional 2.5 hours of growth. Cells were then collected by centrifugation, frozen at 20°C overnight, thawed, and brought up in 4 ml lysis buffer per 1 gram cells (lysis
buffer: 20mM Tris HCl, pH=7.4, 1 mM EDTA, 200 mM NaCl, 1x Halt protease
inhibitor, 3 mg/ml lysozyme). After a 20-minute incubation to allow for lysis to occur, an
additional 5 volumes of lysis buffer was added to further dilute the lysate. Cell lysates
were then clarified by a 20-minute centrifugation (21,000 x g at 4°C) and run through an
amylose resin column. After running the lysate through the column, the column was
washed with 10x the resin bed volume (wash buffer: 20 mM Tris-HCl, 150 mM NaCl, 1
mM EDTA pH 7.4) and the protein was eluted using one resin bed volume of elution
buffer containing 10 mM maltose (elution buffer: 20 mM Tris-HCl, 150 mM NaCl, 1 mM
EDTA, 10 mM maltose, pH 7.4). Expression and purification of MBP-PP_3665 fusion
protein was visualized via Coomassie staining and concentration was measured via
nanodrop. Aliquots of protein were stored at -80°C in 20% glycerol for future use in
electrophoretic mobility shift assays (EMSAs).
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2.3.6 Electrophoretic Mobility Shift Assays (EMSA)
Electrophoretic mobility shift assays (EMSAs) using MBP-PP_3665 protein and a
biotinylated PP_3667 promoter probe were conducted as previously described [23].
Briefly, the promoter region of the PP_3665-dependent gene PP_3667 was amplified
using primers #1160 and #2615 to create the 5’-biotinylated probe and primers #1159 and
#1160 for amplification of the cold probe. The promoter region of the dhcA gene was
used as a competitive target to test the specificity of PP_3665 promoter binding. All
probes were gel purified using Fisher’s GeneJET Gel Extraction and DNA Clean Up Kit
(ThermoFisher Scientific, Waltham, MA). EMSA binding reactions were conducted with
the changes previously described and the replacement of poly(dI-dC) with salmon sperm
DNA to a final concentration of 500 µg/ml [23]. Binding reactions were incubated for 40
minutes at 37°C then run through a 5% acrylamide gel for 1 hour at 100V. After transfer
to Biodyne B Pre-Cut Modified Nylon Membrane (ThermoFisher), biotinylated probe
was visualized as per manufacturers instructions with changes as previously described
with the Pierce Lightshift Chemiluminescent EMSA kit (ThermoFisher Scientific) [23].
Primers used for amplification of probes can be found in Table 2.2.

2.3.7 Growth conditions and RNA preparation for semi-quantitative RT-PCR
P. putida KT2440 wild type and ∆PP_3665 overnight cultures were grown in
1xMOPS amended with 25 mM pyruvate and 5 mM arginine at 30°C with shaking at 170
rpm. Overnight cultures were washed in 1xMOPS and adjusted to OD600 = 1.0 in
1xMOPS with 20 mM pyruvate, and 600 µl of adjusted culture was added to 600 µl prewarmed 1xMOPS with 20 mM pyruvate +/- 2 mM creatine in a 24-well plate. Each P.
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putida strain was grown in the +/- creatine condition in technical duplicate and biological
triplicate. Cultures were incubated at 30°C with shaking with sample collection at 1 hour
via centrifugation and preservation of RNA in 600 µl of hot RNAzol RT® (SigmaAldrich). Analysis of creatinase gene (PP_3667) expression at 1 hour was conducted by
semi-quantitative RT-PCR.

2.3.8 RNA Extraction, Purification, and Semi-Quantitative RT-PCR
RNA was extracted and purified from samples frozen at -80°C in RNAzol buffer
(SigmaAldrich) using the RNeasy Mini Extraction Kit (Qiagen) as per the manufacturers
instructions with the following adjustments. After the initial RNA extraction, the RNA
samples underwent a DNaseI treatment and a subsequent RNeasy purification. cDNAs
were then created from the purified RNA samples via reverse transcription using
Superscript RT II (Thermofisher) and random hexamer primers. cDNA samples were
treated with RNaseH after reverse transcription to eliminate remaining RNA. Semiquantitative RT-PCR was conducted by adding equal amounts of cDNA substrate to PCR
reactions containing primers specific to the experimental gene-of-interest, encoding a
creatinase enzyme PP_3667, or the control gene, encoding a peptidylprolyl-isomerase D
enzyme ppiD/PP_2304. Gene-specific DNA abundance in each reaction, as visualized by
running PCR samples on 1% agarose gels, was used as an indicator of the relative
abundance of gene transcripts for each gene at the 1 hour time point in the presence or
absence of creatine. Primers used for semi-quantitative RT-PCR can be found in Table
2.2.
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2.3.9 Phylogenetic Tree Building
The protein FASTA sequences of homologs of the PP_3667 gene that possess an
associated AraC (PP_3665 homologs) were compiled via the STRING protein database
and downloaded from the National Centers for Biotechnology Information database [25],
[26], [27], [28], [29], [30], [31], [32], [33], [34], [35, 36]

. Sequences were entered into a phylogenetic tree-

building pipeline available on Phylogeny.fr [37], [38]. This pipeline strings together
alignment of multiple protein sequences via MUSCL, determination of phylogeny using
maximum likelihood via PhyML, and tree rendering by TreeDyn. The sequence of a
creatine amidinohydrolase from Candidatus thioglobus sp. NP1 that has no associated
AraC transcriptional regulator was used as the out-group for tree rooting. A list of the
accession numbers for protein sequences used in tree building is included in Table 2.3.

2.4 Results
2.4.1 PP_3665 is essential for P. putida KT2440 growth on creatine, and its
precursor creatinine, as sole nitrogen sources
To test whether the transcriptional regulator PP_3665 is necessary for creatine
metabolism in P. putida, we evaluated wild type and deletion strain ∆PP_3665’s ability
to grow on various nitrogen sources related to creatine metabolism. After 18 hours of
incubation both the P. putida wild type and P. putida ∆PP_3665 complement strains
grew most efficiently on choline and arginine as sole nitrogen sources (Figure 2.2A).
When P. putida WT was supplied with creatine as the sole nitrogen source, its growth
was comparable to growth on choline (Figure 2.2B). Growth of P. putida ∆PP_3665 on
creatine was significantly lower when compared to WT and complemented strains
54

(****p-value<0.0001) (Figure 2.2A). When supplied with the anhydrous form of
creatine, creatinine, as the sole source of nitrogen, P. putida WT growth was significantly
lower when compared to both choline and creatine growth (***p-value=0.0001, *pvalue=0.0111, respectively) (Figure 2.2B), but growth of P. putida ∆PP_3665 strain did
not display a further growth deficiency on creatinine as compared to growth on creatine
(Figure 2.2A).

2.4.2 PP_3665 binds the promoter region of PP_3667 and induces transcription of
PP_3667 in the presence of creatine
Compounds related to the creatine metabolic pathway were tested for their ability
to induce transcription of the PP_3667 promoter in a PP_3665-dependent manner
(Figure 2.3A). Significant transcriptional induction was observed in the presence of
creatine, averaging 13.2 fold over the no-inducing-compound condition (pvalue<0.0001). The induction of the PP_3667 promoter in the presence of creatine was
also significantly higher in wild type as compared to the ∆PP_3665 deletion strain (pvalue<0.0001), indicating that PP_3667 promoter induction in the presence of creatine is
a PP_3665-dependent process. We also demonstrated that the transcriptional regulator
PP_3665, tagged with a maltose-binding protein (MBP) tag for purification (MBPPP_3665), binds to the promoter region of PP_3667, causing altered shift of the PP_3667
promoter probe in the presence of MBP-PP_3665 due to PP_3665-probe binding (Figure
2.3B). Altered PP_3667 promoter migration in the presence of MBP-PP_3665 is
demonstrated in Lanes 2, 3, and 4 of the gel in Figure 2.3B. PP_3667 probe migration in
the absence of MBP-PP_3665 is shown is Lane 6. The PP_3667 promoter-specific
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binding of PP_3665 is supported by the lack of altered probe migration when a creatineunrelated probe, dhcA, was mixed with purified MBP-PP_3665, which is shown in Lane
1 (Figure 2.3B).

2.4.3 Identification of the PP_3665 binding site in the PP_3667 promoter
PP_3665-dependent transcriptional induction of the PP_3667 promoter is highest
when the full promoter region (-228 bp from the translational start site) is present. When
the promoter is truncated to include only 193 bps upstream of the translational start site,
transcriptional induction drops to approximately half of the induction observed when 228
bp upstream are included (Figure 2.4A). Truncations of the PP_3667 promoter beyond
104 bp upstream of the translational start eliminate all creatine-dependent transcriptional
induction of the reporter gene. The creatine-dependent induction of the -228 bp and -193
bp reporters is also PP_3665-dependent, with a significant difference in fold induction
observed between the reporters in the P. putida wild type and P. putida ∆PP_3665 strains
(-228bp p-value<0.0001, -193bp p-value=0.001) (Figure 2.4B).

2.4.4 PP_3665 transcriptionally regulates the creatine-amidohydrolase gene
PP_3667 in the presence of creatine
Relative transcript abundance of the creatine-amidohydrolase gene PP_3667 is greatly
increased in wild type P. putida KT2440 in the presence of creatine. P. putida ∆PP_3665
shows no change in PP_3667 transcripts in the presence of creatine. There are also no
marked changes in transcript abundance of the control gene ppiD/PP_2304 +/- creatine in
either the wild type or ∆PP_3665 strains of P. putida. Transcript abundance in wild type
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P. putida quickly increases in the presence creatine, with noticeable changes in as little as
1-hour post-creatine exposure (Figure 2.5).

2.4.5 Orthologs of PP_3667 with an associated glutamine amidotransferase-1
containing transcriptional regulator are maintained in nonpathogenic and
pathogenic bacteria
Orthologs of the PP_3667 creatinase cluster into two clades; Clade 2 includes exclusively
environmental species while Clade 1 includes a majority of pathogenic bacteria (Figure
2.6). The pathogenic Acinetobacter species within Clade 1 maintain a genomic region
that is orthologous to P. putida’s PP_3665-PP_3668 region on a plasmid-borne
transposon (Figure 2.7). The presence of creatine-metabolic genes on a transposon
maintained in pathogenic bacteria supports the hypothesis that creatine metabolism is
beneficial during pathogenesis. PP_3665-PP_3668 orthologs are also present on a
plasmid in the non-pathogenic bacterium Shinella, demonstrating a potential
environmental source of mobile creatine-metabolic genes.

2.5 Discussion
Creatine is a polyamine compound present in many of the ecological niches
occupied by Pseudomonas species. A large creatine pool is found within vertebrates,
where it participates in the cycling of phosphate between high-energy ATP and ADP
molecules. The body is constantly recycling its creatine stores leaving spent creatine to be
excreted into the surrounding environment through urine and feces [4], [5], [6], [7]. Most of
the creatine in the body is non-enzymatically converted into creatinine before excretion,
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making this cyclic form of creatine abundantly present in the colon, where gut-resident
microbes degrade it, and the rhizosphere where it can be utilized by soil-dwelling
microorganisms [7], [39], [40], [41]. Because of the conversion of creatine to creatinine within
veterbrates before excretion, many bacterial pathways for creatine metabolism begin with
lysis of creatinine via creatinine amidohydrolase enzymes [41]. [42], [43], [[44] . The ability to
metabolize the naturally occurring forms of creatine (cyclic and/or noncyclic) allows
bacteria to access a rich nitrogen source and in some cases a sufficient source of carbon
[14], [45]

. This manuscript identifies a creatine-responsive transcription regulator, PP_3665,

in P. putida that is critical for utilization of creatine as the sole nitrogen source.

2.5.1 Functional PP_3665 is essential for activation of P. putida’s predominant
pathway for utilization of creatine as a sole nitrogen source.
The AraC/XylS-family of transcriptional regulators is a diverse family generally
characterized by a helix-turn-helix (HTH) DNA binding C-terminal domain and a Nterminal domain dedicated to dimerization and/or ligand binding [46]. The creatineresponsive transcriptional regulator of P. putida, PP_3665, belongs to a subset of
AraC/XylS-family regulators that contain a glutamine amidotransferase-1 (GATase)
domain in the N-terminal region with structural similarity to the DJ-1/ThiJ/PfpI
superfamily of proteins. Members of this superfamily include the human DJ-1 protein,
which while its functions in humans is unknown, has high similarity to bacterial ThiJ
proteins that are involved in bacterial thiamine biosynthesis. Bacterial AraC-family
transcriptional regulators in the GATase subfamily have a likely non-catalytic ThiJ-like
domain in the N-terminus, which includes a conserved cysteine residue that is present in
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the catalytic domain of active bacterial GATase proteins such as Klebsiella pneumoniae’s
ThiJ [47], [48], [49]. Members of the GATase 1-containing AraC transcriptional regulator
(GATR) family have been identified in multiple Gram-negative and Gram-positive
bacteria, including Pseudomonas species, although their functions remain predominately
unknown. Several of the characterized GATRs in P. aeruginosa participate in pathways
involving metabolism of amine-containing compounds like arginine, glycine betaine,
sarcosine, and carnitine [17], [23], [50], [51]. The P. putida GATR identified in this manuscript,
PP_3665, controls the metabolism of the amine-containing compound creatine via
transcriptional induction of creatinase PP_3667.
The participation and necessity of PP_3665 in creatine metabolism is
demonstrated in Figure 2.2, where a loss of PP_3665 results in the inability of P. putida
to grow on creatine as the sole nitrogen source. As shown in Figure 2.3, PP_3665 binds
with specificity to the promoter region of PP_3667, subsequently inducing transcription
of PP_3667, which encodes a functional creatinase with the ability to efficiently lyse
creatine into sarcosine and urea [9], [10], [11], [12], [13], [52], [53], [54]. Transcription of the
creatinase-encoding gene PP_3667 occurs relatively quickly in wild type P. putida,
within 1 hour after exposure to creatine. This suggests that lysis of creatine by creatinase
PP_3667 is the preferential pathway of P. putida creatine metabolism and that quick
metabolism of creatine when it is available in the environment is likely a beneficial
metabolic strategy for P. putida. It is interesting to note that while there is significantly
less P. putida WT growth on creatine, creatinine, and sarcosine as sole nitrogen sources
as compared to choline, P. putida WT utilizes creatine and sarcosine significantly more
efficiently then creatinine (Figure 2.2B). Creatinine is generally a precursor to creatine in
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the context of bacterial metabolism (Figure 2.1A) but creatinine metabolism via Nmethylhydantoin and N-carbamoylsarcosine has also been observed in P. putida strains
[42]

. Depending on which pathway of creatinine metabolism is favored by the particular P.

putida strain, creatine may or may not be an intermediate of metabolism. The lack of P.
putida KT2440 growth on creatinine as a sole nitrogen source, independent of whether
creatinase PP_3667 is being produced, may be due to inefficient lysis of creatinine
resulting in an intermediate that is not creatine [42], [55]. The hypothesis that creatinine is
lysed by P. putida KT2440 into an intermediate that is not creatine, such as Nmethylhydantion, is supported by the negligible induction of creatinase PP_3667 in the
presence of creatinine.
The genome of P. putida KT2440 does not appear to transcribe a putative
creatinine amidohydrolase protein, while several other strains of P. putida, including
strain S16, W619, and RS56, possess one transcribed divergently or in the vicinity of
creatinase PP_3667 homologs. The evidence for creatininase function was demonstrated
using the cloned and purified enzyme from P. putida strain RS56, GenBank Accession:
AF164677 [56]. In all cases, these creatininase genes are either transcribed divergently
(strains S16 and RS65) or located in close proximity (strain W619) to a creatinase gene
orthologous to P. putida’s PP_3667 creatinase encoding gene (60% coverage and 83%
identity with P. putida RS65 creatinase). P. putida strain KT2440 possesses the
creatinase (PP_3667) but not the cognate creatininase present in other creatinasecontaining strains. The absence of the creatininase could explain the lack of PP_3665dependent induction of PP_3667 when creatinine is the starting substrate. Other
enzymes, such as one of the multiple creatinase domain-containing paralogs of PP_3667
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present in the P. putida KT2440 genome, may be capable of creatinine lysis but at an
inefficient rate, resulting in a slower rate of creatine or N-methylhydantoin production
and lower PP_3665-dependent PP_3667 induction.
If you eliminate the primary inducer, creatine, from the analysis of the PP_3665dependent transcriptional induction assays, a small yet significant difference in PP_3665dependent PP_3667 induction is observed in the presence of creatinine between the WT
and ∆PP_3665 strains (**p-value=0.0021)(Figure S2.1). This modest PP_3665dependent increase in PP_3667 transcriptional induction of the creatinase in the presence
of creatinine may be indicative of weak recognition of an alternative intermediate like Nmethylhydantoin by transcriptional reporter PP_3665, or that creatinine is spontaneously
converted into creatine slowly over time. It is also interesting to note that glycine betaine
significantly inhibits basal transcription of creatinase PP_3667 independently of
PP_3665. This may be indiciative of an inhibitory feedback mechanism perpetuated by
downstream products of creatine metabolism or the direct or tangential involvement of
other compound-specific regalutors in creatine metabolism.

2.5.2 Conservation of creatinase PP_3667 and amidotransferase 1-containing AraC
family transcriptional regulator PP_3665 illustrate the utility of the inducible
system in creatine rich environments
Pathways for creatinine and creatine metabolism are conserved among many
bacterial species. When looking at sequence similarity and genomic organization between
bacteria, the presence of a creatine-responsive inducible metabolic system appears to be
conserved among several species. The evidence of this rests in the presence of homologs
61

of P. putida’s creatinase, PP_3667, along with a cognate amidotransferase 1-containing
AraC family transcriptional regulator, PP_3665, transcribed in the same general
organization as P. putida, in multiple bacteria (genomic organization in P. putida
KT244o shown in Figure 2.1B). The phylogenetic tree in Figure 2.6A shows which,
likely inducible, creatinase enzymes are most closely related to each other and to
PP_3667 of P. putida. The creatinase enzymes appear to cluster into a predominantly
pathogenic clade (Clade 1) and an exclusively nonpathogenic clade (Clade 2), indicating
potential divergent evolution of creatinase genes in bacterial populations interacting
within the rhizosphere versus the hospital/human host. It is interesting to note that for
each sub-clade within Clade 1 there appears to be a nonpathogenic bacterial species to
represent the origin of the creatinase enzyme in the rhizosphere. For example, soil
resident Paraburkholderia is a closely related species to Burkholderia cenocepaciea, an
opportunistic pathogen involved in cystic fibrosis infections and Burkholderia
pseudomalli, the causative agent of the musculoskeletal infection meliodosis [57], [58], [59].
All of the bacterial species noted in Figure 2.6A are primarily soil or water
dwelling species while some can cause opportunistic infections. The retention of the
bacterial creatinase enzyme in opportunistic pathogens such as Burkholderia sp. supports
the hypothesis that creatine metabolism can be a beneficial metabolic strategy during
infection. The benefit of the creatine-inducible system during opportunistic infection is
further supported by the retention of creatinase and AraC transcriptional regulator in
Acinetobacter strains. In each of the three pathogenic Acinetobacter strains (A.
baumannii, A. nosocomialis, and A. pitti), homologs of the creatinase and associated
regulator are present in transposons present on plasmids, potentially derived from soil
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resident microbe Moraxella osloensis, which possesses the most closely related enzyme
(Figure 2.7).
P. putida’s PP_3667 and PP_3665 proteins cluster with the soil-dwelling
nonpathogenic bacterial strains in Clade 2, most of which are notable for their ability to
fix nitrogen or participate in denitrification in soils, but orthologs are also found in
pathogenic P. aeruginosa strains isolated from Shanghai fever patients [60]. The
distribution of creatinase and creatinase-inducing transcription regulators among soildwelling bacteria, as well as the maintenance of these proteins in opportunistic
pathogens, illustrates the importance of being able to transition efficiently to creatine
utilization pathways when creatine is present as a high-yield source of nitrogen in the
environment.
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2.6 Chapter 2 Figures

Figure 2.1 Pathway of bacterial creatine metabolism. (A) Pseudomonas putida
KT2440 does not transcribe a putative creatinine amidohydrolase, but other enzymes of
similar function may act on creatinine to form creatine. Creatine is then lysed by creatine
amidinohydrolase (CreA) to sarcosine and urea. Oxidation of sarcosine by SoxBDAG, as
characterized in Pseudomonas aeruginosa, creates glycine and formaldehyde as end
products of creatine metabolism. (B) Organization of the creatine-responsive
transcriptional regulator and creatinase genes in P. putida strain KT2440. A clean
deletion of transcriptional regulator PP_3665 was made in P. putida to determine the role
of PP_3665 in transcription of creatinase CreA (PP_3667).

Figure 2.2 PP_3665 contributes to P. putida KT2440’s growth on creatine and
creatinine when supplied as the sole nitrogen source. After 18 hours of growth (A)
with choline, creatine, creatinine, sarcosine, or arginine supplied as the sole nitrogen
source to P. putida wild type, ∆PP_3665 and complemented strains, the OD600 of cultures
was measured. Growth of each strain on 2mM nitrogen source was reported as the fold
growth over the 0mM nitrogen (no nitrogen) condition; Fold Growth = (OD6002mM Nsource/OD6000mM nitrogen).

Statistical significance was determined via 2-way ANOVA with

Tukey’s multiple comparison’s test. P. putida wild type and complement strains grew to
a significantly higher density as compared to ∆PP_3665 in the presence of creatine
(****p-value<0.0001). (B) Growth of P. putida WT on creatinine as a sole nitrogen
source was significantly lower as compared to growth on choline (***p-value= 0.0001).
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Growth of P. putida WT on creatinine is statistically lower then growth on creatine (*pvalue= 0.0111). Statistical significance was determined via One-way ANOVA with
Tukey’s multiple comparison’s test. The data shown are averages of three independent
experiments; error bars represent standard deviation from the mean.

Figure 2.3 PP_3665 induces expression of PP_3667 in the presence of creatine and
binds preferentially to the PP_3667 promoter region. A transcriptional reporter fusion
of the promoter region of PP_3667 to the coding region of gfp was used to measure
PP_3667 gene expression in the presence of several nitrogen sources. (A) After a 5-hour
incubation with 2 mM creatine significant fold induction of the PP_3667-gfp reporter
was observed in P. putida wild type (****p-value<0.0001) as compared to the negligible
induction detected in ∆PP_3665. All other nitrogen sources, including creatinine,
sarcosine, and glycine betaine, demonstrated negligible inducing power in P. putida wild
type as compared to ∆PP_3665. Fold Induction was calculated by the equation Fold
Induction = (Fluorescence Units2mM N-source/Fluorescence Units0mM N-source) Statistical
significance was calculated using 2way ANOVA with Sidak’s multiple comparisons test.
The data shown are averages of three independent experiments; error bars represent the
standard deviation from the mean. (B) MBP-PP_3665 preferentially binds the promoter
region of PP_3667 causing probe shift (Lanes 2-4). The promoter region of the dhcA
gene was not bound by MBP-PP_3665, demonstrating the specificity of PP_3665 for the
PP_3667 promoter (Lane 1). The migration of unbound PP_3667 probe is shown in Lane
6.
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Figure 2.4 The region between positions -228 and -104 from the translational start
site of PP_3667 is essential for PP_3665-dependent gene induction. Promoter
truncations were measured as base pairs upstream from the translational start of
PP_3667. (A) Maximum induction of the PP_3667-gfp reporter was achieved when 228
bps upstream of the PP_3667 translational start site (-228) were provided, while the -193
truncated promoter reduced transcriptional induction by half. Removal of base pairs
beyond -104 completely ablated transcriptional induction of the PP_3667-gfp reporter.
Statistical significance was calculated by Ordinary one-way ANOVA using Tukey’s
multiple comparisons test. ****p-value<0.0001, **p-value=0.0023. (B) Transcriptional
induction of the -228 and -193 PP_3667-gfp reporters remained PP_3665-dependent. The
data shown are averages of three independent experiments; error bars represent the
standard deviation from the mean. Statistical significance of differences between
promoter truncation inductions was calculated via 2way ANOVA using Sidak’s test for
multiple comparisons. ****p-value<0.0001, **p-value=0.0010.
Fold Induction = (Fluorescence Units2mM N-source/Fluorescence Units0mM N-source)

Figure 2.5 PP_3665 controls the transcription of the creatine-amidohydrolase
encoding gene PP_3667 in the presence of creatine Transcription of creatinase gene
PP_3667 at 1 hour post-creatine exposure, as measured by semi-quantitative qRT PCR, is
increased in response to creatine in wild type P. putida but not in ∆PP_3665. There is no
change between transcriptional levels of a control gene PP_2304, encoding a
peptidylptolyl isomerase D, in the presence or absence of creatine in either wild type or
∆PP_3665 P. putida.
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Figure 2.6 Homologs of creatinase PP_3667 and the associated AraC transcriptional
regulator PP_3665 are found in both pathogenic and nonpathogenic bacterial
strains. The PP_3667 and PP_3665 genes of P. putida KT2440 are closely
phylogenetically related to homologs found in other soil-resident bacteria. Homologs are
also found both on the chromosome and plasmid-borne in bacteria that cause infection in
humans (highlighted in red), demonstrating the potential utility of the creatine-responsive
metabolic system in bacterial pathogenesis.

Figure 2.7 Putative creatine-responsive creatine metabolic genes are maintained on
a transposon in several Acinetobacter sp. Orthologs of P. putida’s creatine-responsive
transcriptional regulator, creatinase gene, and MFS transporter are present on a plasmidborne transposon, as outlined above, in pathogenic Acinetobacter species.

Figure S2.1 PP_3665-dependent induction of PP_3667 in the presence of creatinine.
Transcription of PP_3667 is significantly lower in the ∆PP_3665 mutant in the presence
of creatinine, the usual precursor to creatine in bacterial metabolism (**p-value=0.0096).
Glycine betaine significantly suppresses the transcription of PP_3667 independent of the
presence of PP_3665 to approximately half of the 0mM nitrogen transcriptional
induction (****p-value<0.0001). Fold induction was calculated using the following
equation:
Fold Induction = (Fluorescence Units2mM N-source/Fluorescence Units0mM N-source)
Significance determined by 2Way ANOVA with Tukey’s test for multiple comparisons.
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Figure 2.1 Pathway of bacterial creatine metabolism.
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Figure 2.2 PP_3665 contributes to P. putida KT2440’s growth on creatine and creatinine
when supplied as the sole nitrogen source.
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Figure 2.3 PP_3665 induces expression of PP_3667 in the presence of creatine and binds
preferentially to the PP_3667 promoter region.
72

A

4

P. putida WT

Fold Induction
Fold Induction

4
3

P. putida ΔPP_3665

****

3

2

2

**
1

n. s.

1

0

0

-216

-193

Truncation
-228Promoter
-193 -104
-80

Promoter Truncation
B

4

P. putida WT

Fold Induction

****

P. putida ΔPP_3665

3

**

2
1
0
-228

-193

Promoter Truncation
Figure 2.4 The region between positions -228 and -104 from the translational start site of
PP_3667 is essential for PP_3665-dependent gene induction.
73

Figure 2.5 PP_3665 controls the transcription of the creatine-amidohydrolase encoding
gene PP_3667 in the presence of creatine.
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Figure 2.6 Homologs of creatinase PP_3667 and the associated AraC transcriptional
regulator PP_3665 are found in both pathogenic and nonpathogenic bacterial strains.
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Figure 2.7 Putative creatine-responsive creatine metabolic genes are maintained on a
transposon in several Acinetobacter sp.
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Table 2.1 Strains and plasmids used in this study.
Designation
LAH237
LAH258
LAH295
LAH249
LAH284
LAH297
LAH298
LAH254
LAH265
LAH293
LAH256
LAH111

Strains and Plasmids
Genotype or Description
Plasmid
P. putida KT2440 WT
pMQ80
P. putida KT2440 ∆PP_3665 pMQ80
P. putida KT2440 ∆PP_3665 pMQ80:pssA/PP_3665
P. putida KT2440 WT
pMQ80:PP_3667Prom-228gfp
P. putida KT2440 WT
pMQ80:PP_3667Prom-193gfp
P. putida KT2440 WT
pMQ80:PP_3667Prom-104gfp
P. putida KT2440 WT
pMQ80:PP_3667Prom-80gfp
P. putida KT2440 ∆PP_3665 pMQ80:PP_3667Prom-216gfp
P. putida KT2440 ∆PP_3665 pMQ80:PP_3667Prom-193gfp
E. coli T7
pMALc2x:MBP-PP_3665
P. putida KT2440 WT
none
P. putida KT2440 ∆PP_3665 none

Primers Used in Condition
none
none
2613-2614
2590-2591
2592-2591
2602-2591
2605, 2604, 2603, 2591
2590-2591
2592-2591
2596-2597
none
none

Table 2.2 Sequences of primers used in this study.
pssA/PP_3665 complement construct
Primer Number Primer Name
Primer Sequence
2613 PP_3665-EXP-F_EcoRI
ATAGAATTCGACATCAATGCGCGGTGC
2614 PP_3665-EXP-R-HindIII
AAAAAGCTTCTGCACTGGCTTCTTCTCAC
PP_3665 Deletion Construct
Primer Number Primer Name
Primer Sequence
N/A PP3665KO_F1_HindIII
AAGCTTCGGGATCGTTCCAGATGCGT
N/A PP3665KO_R1
GATCCAGGTGCTGCCCGATGCCA
N/A PP3665KO_F2
GTTGGGTCAGGTATTGGCATTG
N/A PP3665KO_R2_EcoRI
GAATTCCCGAGGCGGAAAACCCCTGT
MBP-PP_3665 Expression Construct
Primer Number Primer Name
Primer Sequence
2597 PP_3665Exp2ndMet
AAAGAATTCGTCCACCCCGCTTCTGCAAAC
2596 PP_3665ExpR_HindIII
AAACAAGCTTAATGCCAATACCTGACCCAA
PP_3667 Transcriptional Reporter Construct
Primer Number Primer Name
Primer Sequence
2590 PP_3667PromFSOEpMQ80
CGGGTACCGAGCTCGTTCAGGCCGGCCGC
2591 PP_3667PromRSOEpMQ80
TAAGATTAGCGGATCAGACTTTGTGGC
2592 PP3667Prom164FSOEpMQ80 CGGGTACCGAGCTCGTCATGGAGCTGGACC
2602 PP3667-75_1_NheI
AATGCTAGCATTCCAGGTCGGATAGATACAAAAGTGTCCTCGTCGGT
2605 PP3667-51_1
CTTCTCAGGCGGCCGGCCTGAACCGAGCTCGGTACCCG
2604 PP3667-51_2
GTCGGTTCTGTTGCAATGCTTCTCAGGCGGCCGGCC
2603 PP3667-51_3_BamHI
AATGGATCCGTGTCCTCGTCGGTTCTG
PP_3665 Deletion Screening
Primer Number Primer Name
Primer Sequence
1601 PP3665 KO screen F
ATT TCA CCA CCA TCG GCC TT
1602 PP3665 KO screen R
AGC GGT AGC CTT TGA GCA AT
EMSA Probe
Primer Number Primer Name
Primer Sequence
2615 CreatinaseProm_F_biotin
5'/Biosg/TGT GGA TCC GTT TGT CCG AGA CTT TGT GGC
1160 CreatinaseProm_R
AAG CCA TGG CAC GCT GTT CAG GCC GGC CGC
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Table 2.3 Protein sequences of PP_3667 orthologs used in phylogenic tree building.
Organism
Pseudomonas putida KT2440
Azoarcus DN11
Burkholderia cenocepacia DDS 22E-1 (chromosome 2)
Burkholderia pseudomultivorans SUB-INT 23 BP2 (chromosome 1)
Pseudogulbenkiania NH8B
Acinetobacter pittii AP43 (plasmid pAP43-2)
Acinetobacter nosocomialis 6411 (plasmid p6411)
Acinetobacter baumannii AYE (plasmid p3ABAYE)
Paraburkholderia hospita mHSR1 (chromosome HSR1B)
Paraburkholderia caribensis MBA4 (chromosome 2)
Marinobacterium aestuarii ST58-10
Castellaniella defragrans 65Phen
Kushneria konosiri x49
Moraxella osloensis MOXF1
Shinella HZN7 (plasmid pShiri 02)
Mesorhizobium M7D.F.US.005.01.1.1
Candidatus thioglobus NP1 (no associated AraC)
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Accession Numbers
Protein
Genome/Plasmid
WP_010954506.1 PP_RS19040
WP_121428226.1 CDA09_RS08520
WP_038454959.1 DM39_RS01105
WP_009692155.1 WS57_RS17285
WP_014086563.1 NH8B_RS06510
WP_016802527.1 FXO17_RS20445
WP_151859504.1 RR32_RS18280
WP_001094923.1 ABAYE_RS00225
WP_094297778.1 CUJ88_RS28440
WP_035989123.1 K788_RS15830
WP_067381805.1 A8C75_RS10610
CDM24031.1
NZ_HG916765.1
WP_086623322.1 NZ_CP021323
WP_138019426.1 NZ_CP040257
WP_064333646.1 NZ_CP015738
WP_126071010.1 NZ_CP034453
WP_114114565.1 NZ_CP023860
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CHAPTER 3: The role of metabolic operon sphBCD in Pseudomonas aeruginosa’s
response to the host-derived antimicrobial sphingosine
3.1 Abstract
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that causes
difficult to treat nosocomial infections in individuals with chronic obstructive pulmonary
disorder (COPD) or cystic fibrosis (CF). Multidrug resistant P. aeruginosa is a serious
threat to public health and novel approaches to treatment and control of these infections
are needed. P. aeruginosa is not only resistant to exogenous antibacterial compounds, but
it is also highly resistant to many innate-immune mechanisms. Here we characterize,
through genetic and biochemical approaches, the interaction between the host-derived
antimicrobial sphingosine and P. aeruginosa. We identify a putative metabolic operon,
sphBCD, which encodes a putative cytochrome c (SphB), oxidoreductase enzyme
(SphC), and aldolase enzyme (SphD), that act on sphingosine and evaluate the role of
sphBCD in P. aeruginosa’s ability to resistant high levels of sphingosine. This study
expands on our knowledge of how P. aeruginosa evades a component of host innateimmunity and provides a foundation for further work in identifying ways to disrupt this
sphingosine-resistance machinery, with the goal of rendering P. aeruginosa more
susceptible to host innate-immune defenses.
3.2 Introduction
Sphingolipids are key players in the human innate immune system’s defense
against bacterial pathogens, with high activity against both Gram positives and Gram
negatives [1], [2], [3], [4], [5], [6]. A variety of sphingolipids are found at sites throughout the
body that are prone to bacterial infection, including mucosal barriers, the lungs, the skin,
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and concentrated in hair follicles [4],

[7], [8], [9], [10]

. Imbalances or deficiencies in certain

skin and mucosal barrier-associated sphingolipids have been shown to increase chances
of bacterial infection, illustrating the importance of these antimicrobial lipids in defense
against pathogens [11].
Sphingolipids’ mechanism of action against bacterial pathogens is predicted to be
similar to that of cationic peptides, beginning with bacterial membrane disruption that
can be caused by charged functional groups such as the primary amine present in the
majority of sphingolipid structures. Increased permeability of the inner and outer
membranes allows for increased diffusion of sphingolipids into the cytosol of bacterial
cells where the formation of large inclusion bodies can cause further structural damage.
The negative effects of sphingolipids on different species of bacteria are illustrated in a
study by Fischer et al that depicts, through scanning electron micrographs, how
accumulation of sphingoid bases sphingosine, phytosphingosine, and dihydrosphingosine
cause ultra-structural damage and ultimately lead to cell death in both Gram negatives
Escherichia coli and Porphyromonas gingivalis and Gram positive Staphylococcus
aureus [4], [5]. The most substantial structural cell damage that occurs in gram-negative
bacteria when treated with sphingolipids is the separation of the outer and cytoplasmic
membranes, which is similar to the type of damage caused by cationic peptides like
cathelicidins [4]. The concentrations of sphingoid bases needed to cause this severe and
cytotoxic membrane disruption in E. coli and P. gingivalis are relatively low compared to
other Gram-negative bacteria that can withstand higher levels of sphingolipids. The
minimum bactericidal concentration (MBC) for P. aeruginosa was measured at greater
than 1.67 mM, approximately 380x higher than the MBC of the often co-infecting Gram85

positive microbe Staphylococcus aureus [1]. Although there are many factors that
influence antimicrobial-bacterial interactions, the extremely high sphingolipid resistance
profile of P. aeruginosa suggests that it possesses specific mechanisms for resistance to
or detoxification of sphingolipids.
Many of P. aeruginosa’s infection niches contain abundant sphingosine,
sphingosine analogs, and sphingosine precursors, sphingomyelin and ceramide [2], [12], [13],
[14], [15]

. Therefore, it is not surprising that P. aeruginosa may possess mechanisms to

detoxify or utilize sphingolipids. P. aeruginosa is most commonly associated with
hospital-acquired and ventilator associated pneumonias and bacteremia [16], [17], [18], [19].
Incidence of infection in individuals with chronic pulmonary conditions, such as cystic
fibrosis (CF) and chronic obstructive pulmonary disorder (COPD), is associated with
high morbidity, rapid decline of lung function, and increased levels of immune-signaling
molecule sphingosine-1-phosphate [20], [21], [22], [23], [24]. Within the context of pulmonary
infections, P. aeruginosa’s ability to resist the antimicrobial affects of sphingosine is
correlated with a significant survival advantage, likely due to the presence of sphingoid
bases within the lung epithelium [21].
During exposure to pulmonary surfactant, the lipid-rich mixture secreted by TypeII alveolar epithelial cells located in the lower airways, a small set of sphingosineresponsive genes is induced in P. aeruginosa, including an outer membrane β-barrel
protein SphA, a neutral ceramidase CerN, and a predicted metabolic cassette sphBCD,
encoding a putative cytochrome c (sphB), putative oxidoreductase enzyme (sphC), and
putative PLP-dependent aldolase enzyme (sphD) [21], [25], [26]. Transcription of these genes
is induced in the presence of sphingosine via the sphingosine-responsive transcriptional
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regulator SphR, leading to increased survival of P. aeruginosa in the presence of
sphingosine [21]. It has been determined that putative oxidase SphC, along with regulator
SphR and β-barrel protein SphA, contributes to the ability of P. aeruginosa to resist
killing by sphingosine but the mechanism by which SphC, in coordination with coexpressed proteins SphB and SphD, protects against sphingosine is unknown [21]. Further
investigation into whether the enzymes encoded by metabolic cassette sphBCD
participate in catabolism of sphingosine is needed in order to gain a broader
understanding of how P. aeruginosa manipulates innate immune mechanisms to establish
and maintain successful infections. Here we describe the inducer specificity driving
sphBCD induction, establish the role of sphBCD in sphingosine metabolism, and
demonstrate the importance of sphBCD during P. aeruginosa growth in the presence of
sphingosine.
3.3 Materials and Methods
3.3.1 Strains and Growth Conditions
Pseudomonas aeruginosa PAO1 and mutants made from the PAO1 parent strain
were grown on morpholinopropanesulfonic acid (MOPS) media[27] supplemented with 25
mM pyruvate, 5 mM glucose and 20 µg/ml gentamicin, when needed for plasmid
maintenance, for all reporter and sphingosine modification assays. Pyruvate was supplied
at 20 mM as the sole carbon source with 20µg/ml gentamicin for P. aeruginosa growth
assays in the presence of sphingosine. Escherichia coli strains DH5α and S17λpir, used
for cloning and mating with P. aeruginosa, and E. coli strain T7, used for recombinant
protein expression, were maintained in lysogeny broth (LB), Lennox formulation,
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supplemented with 7 µg/ml gentamicin or 150 µg/ml carbenicillin as appropriate. Strains
and plasmids can be found in Table 3.1.
3.3.2 Sphingolipids and related analogs
All sphingosine analogs were purchased from Avanti Polar Lipids with the
exception of analog FTY720 and palmitate, which were purchased from MilliporeSigma.
Stock solutions of 50 mM and 5 mM sphingosine, phytosphingosine, FTY720, and
FTY720 O-Methyl were dissolved in 100% molecular grade ethanol. Stock solutions of 5
mM 1-deoxysphingosine and 3-deoxysphingosine were dissolved in 3:1 chloroform:
methanol. Palmitate was dissolved in methanol at 5mM. All sphingosine analog stocks
were stored in glass vials at -20°C.
3.3.3 Construction of sphBCD triple gene deletion in P. aeruginosa strains PAO1
and PA14
A 550 bp region upstream of the sphBCD metabolic cassette was amplified from
PAO1 genomic DNA with primers engineered with KpnI and SmaI restriction sites
(#2080 and #2083). A 560 bp fragment downstream of sphBCD was amplified from
PAO1 genomic DNA using primers engineered with HindIII and SmaI restriction sites
(#2081 and #2082). After gel purification of each fragment via Thermo Fisher’s GeneJET
DNA Gel Extraction and Clean Up Kit (Waltham, MA), the upstream and downstream
sphBCD flanking fragments were mixed in an equal molar ratio and spliced together by
amplification with the outside primers (#2080 and #2082) resulting in a ~1.1 kb fragment
flanked with KpnI and HindIII restriction enzyme sites and internal SmaI sites. The 1.1
kb fragment was digested using enzymes KpnI and HindIII (New England Biolabs,
Ipswitch MA) and ligated into the similarly cut suicide vector pMQ30, containing the
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counter-selective sacB gene, to create the plasmid pMQ30:∆sphBCD to be used in
homologous recombination with P. aeruginosa. Cloning and propagation of the plasmid
was carried out in competent E. coli DH5α cells.
After isolation of the plasmid from the E. coli DH5α cells via Thermo Fisher’s
GeneJET Plasmid Extraction Kit (Waltham, MA), pMQ30:∆sphBCD was transformed
into the chemically competent conjugative E. coli strain S17λpir. Donor S17λpir cells
containing pMQ30:∆sphBCD were mixed with the recipient strain P. aeruginosa PAO1
or strain PA14 and single crossover colonies that partially integrated the deletion
construct were selected by plating on LB agar plates amended with 50 µg/ml gentamicin.
Gentamicin resistant colonies were then grown in LB broth overnight at 37°C in order for
the second recombination event to occur. These cultures were then plated onto LB plates
with no salt and 5% sucrose, and LB plates containing gentamicin. Those colonies that
were able to grow on sucrose but were no longer resistant to gentamicin were screened by
polymerase chain reaction using primers flanking the potentially deleted region (#2080
and #2082) to determine whether the second recombination event resulted in a reversion
to the wild type (WT) chromosomal region or successful triple-gene deletion [28], [29].
Strains LAH82, a revertant to the WT PAO1 genotype (PAO1 ∆sphBCD WTR), and
LAH83, a triple gene deletion of sphBCD (PAO1 ∆sphBCD) were grown up in LB broth
and frozen at -80°C in 20% glycerol. Sequences of primers used to construct the
∆sphBCD suicide plasmid (∆sphBCD triple deletion) can be found in Table 3.2.
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3.3.4 Cloning of sphBCD complement constructs
The plasmid pMQ80 was used as the backbone for all complement constructs.
Constructs for complementation of the whole or partial sphBCD operon were constructed
via PCR amplification, restriction enzyme digestion, and ligation into similarly cut
pMQ80 using the primers outlined in the sphBCD operon complement constructs section
of Table 3.2. All plasmids were transformed via heat shock into chemically competent E.
coli DH5α following ligation. Once propagated in and purified from E. coli, plasmids
were introduced into the appropriated P. aeruginosa strain via electroshock
transformation.
3.3.5 Construction of a chromosomally integrated sphB-lacZYA transcriptional
reporter promoter fusion in P. aeruginosa strain PA14
A 1 kilobase (kb) region upstream of the sphBCD metabolic cassette in P.
aeruginosa strain PAO1 was amplified from PAO1 genomic DNA using primers
engineered with HindIII and KpnI restriction sites (#2082 and #2286). This region
includes the promoter region of sphB for construction of the transcriptional reporter
promoter fusion. This 1 kb fragment was digested with restriction enzymes HindIII and
KpnI (New England Biolabs, Ipswitch MA) and ligated into the similarly cut plasmid
pGW78, a plasmid that contains the β-galactosidase encoding operon lacZYA flanked
with two multiple cloning sites. This resulted in a plasmid containing the lacZYA operon
under the control of the sphB promoter region. A 500 base pair (bp) region downstream
of the sphBCD cassette was amplified with primers engineered with NheI and SphI
restriction sites (#2287 and #2288) and digested with enzymes NheI and SphI (New
England Biolabs, Ipswitch MA). This fragment was ligated into similarly cut pGW78 at
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the 3’ end of lacZYA to provide the second region for homologous recombination with
the P. aeruginosa chromosome. lacZYA flanked by the sphB promoter region and the end
of the sphBCD operon was cut from pGW78 with HindIII and SphI and ligated into
similarly cut suicide vector pMQ30.
After homologous recombination, carried out as described previously, the
sphBCD metabolic cassette was replaced in P. aeruginosa strain PA14 with the lacZYA
operon under the control of the sphB promoter, creating strain LAH118. This
chromosomally reporter was also integrated into an sphR deletion background (∆sphR) of
P. aeruginosa PA14 to create strain LAH122. Sequences of primers used to construct this
chromosomally integrated reporter (sphB-lacZYA promoter fusion transcriptional
chromosomal reporter) can be found in Table 3.2.
3.3.6 Testing the specificity of SphR-dependent activation of the sphB-driven
metabolic cassette via sphingosine analogs
Transcriptional induction assays were carried out via β-galactosidase assay as
described previously[30], [31] with the following modifications. Several sphingosine
analogs were tested for their ability to induce transcription of the sphBCD metabolic
cassette in an SphR-dependent manner. The chromosomally integrated sphB-lacZYA
transcriptional reporter was used as the reporter strain for these assays to give a
biologically relevant measure of transcriptional activity at sphBCD’s native locus.
Transcriptional induction was measured in the presence and absence of SphR by using
reporter strain LAH118 and reporter strain LAH122 possessing the ∆sphR background.
The sphingosine analogs tested included sphingosine, 1-deoxysphingosine, 3deoxysphingosine, FTY720, FTY720 O-Methyl, phytosphingosine, and the potential
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metabolic product of sphingosine breakdown, palmitic acid. All analogs were tested at 20
µM in 1X MOPS media amended with 25 mM pyruvate and 5 mM glucose. Sphingosine
analogs were added to glass tubes and solvent was evaporated under nitrogen gas before
addition of culture and induction for 18 hours, shaking, at 37°C. Levels of growth
(optical density at 600nm) and β-galactosidase activity (absorbance at 420 nm) were
measured using the Synergy II plate reader (BioTek). Transcriptional activity was
calculated via Miller’s protocol[32] reported as a percentage of the induction observed in
the presence of the primary inducer, sphingosine.
3.3.7 Protein expression and purification
A maltose binding protein (MBP) N-terminal fusion of the full-length SphR
transcriptional regulator protein was expressed and purified as previously described by
LaBauve and Wargo, 2014. Briefly, the coding sequence of sphR was inserted
downstream of the MBP coding sequence in vector pMALc2 and expressed in E. coli T7
cells. Cultures were grown in LB amended with 150 µg/ml carbenicillin at 37°C for 3
hours and protein expression induced with 1 mM isopropyl-β-D- thiogalactopyranose
(IPTG) for 2.5 hours. Cells were then harvested by centrifugation and frozen at -20°C
overnight. Frozen pellets were lysed the following day in 4 ml lysis buffer per 1 g cells
(lysis buffer: 20 mM Tris HCl, pH=7.4, 1 mM EDTA, 200 mM NaCl, 1x Halt protease
inhibitor, 3 mg/ml lysozyme) and diluted 5-fold in lysis buffer. Cell lysates were then
clarified by centrifugation and cleared lysates were run through an amylose resin column.
After washing the column with 10x the resin bed volume (wash buffer: 20 mM Tris-HCl,
150 mM NaCl, 1 mM EDTA pH 7.4), MBP-tagged SphR was eluted from the column via
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wash buffer amended with 10 mM maltose. Protein concentration was measured by
Bradford Assay and aliquots were flash frozen in liquid nitrogen for storage at -80°C[33].
3.3.8 Electrophoretic mobility shift assays (EMSA)
Electrophoretic mobility shift assays testing the specificity of SphR’s
sphingosine-mediated promoter binding ability were performed as previously described
with some modifications [31]. As previously demonstrated, SphR binds the promoter
region of sphA in a sphingosine-dependent manner [21]. Therefore, an sphA probe was
amplified with 5’-biotinylation using primers #874 and #988 and purified via GeneJET
Gel Extraction and DNA Purification Kit (ThermoFisher Scientific) for use as the probe
for evaluation of SphR binding.
The following modifications were made to the EMSA binding reaction
conditions; sodium chloride was removed from the binding buffer, no magnesium
chloride was added, and Poly(dI-dC) was substituted with 100 ngs of salmon sperm DNA
(Invitrogen). Sphingosine analogs were added first to each binding reaction to a final
concentration of 5 µM and solvent was evaporated off before addition of the binding
reaction mixture, DNA probe, and protein. 5’-biotinylated sphA probe was used at a final
concentration of 1 femtamole per microliter (fmol/µl) and MBP-SphR protein was added
to a final concentration of 0.5 µM. Reactions were incubated at 37°C for 40 minutes, ran
on a prerun 5% acrylaminde gel at 100V for 1 hour and transferred to a Biodyne B PreCut Modified Nylon Membrane (ThermoFisher) then visualized as per the manufacturers
instructions with modifications as previously described using the Pierce Lightshift
Chemiluminescent EMSA kit (ThermoFisher Scientific)[31]. Sequences of primers used to
amplify EMSA probes can be found in Table 3.2.
93

3.3.9 P. aeruginosa sphingosine and phytosphingosine modification assays
P. aeruginosa PAO1 WT strain or sphBCD deletion mutant (PAO1 ∆sphBCD)
carrying either the empty vector control, pMQ80, or complement vectors expressing one
or more of the genes belonging to the sphBCD metabolic cassette were grown overnight
on the roller wheel at 37°C in 1X MOPS media supplemented with 25 mM pyruvate, 5
mM glucose, and 20 µg/ml gentamicin. Overnight cultures were collected by
centrifugation at 13,000 rpm for 1 minute, washed with 1X MOPS buffer and adjusted to
uniform optical density read at 600nm (OD600) and added to 1XMOPS, 25 mM
pyruvate, 5 mM glucose, 20 µg/ml gentamicin and 20 µM sphingosine or
phytosphingosine for a final OD600 of 0.05. Media alone +/- 20µM sphingosine or
phytosphingosine were also incubated as controls. Cultures were incubated on the roller
wheel for 18 hours at 37°C. After incubation the cells were collected via centrifugation
and cell pellets were separated from supernatant. The cell pellets were then re-suspended
in 1x MOPS media for equal volume supernatant and pellet samples.
Lipids remaining in the culture supernatant and cell pellets were extracted by the
following method; chloroform: methanol was added at a 1:2 (volume/volume) ratio,
samples were then vortexed for ten seconds and one volume of water was added. After an
additional 10 seconds of vortexing, samples were spun for 10 minutes at 14,000 rcf to
fully separate the organic and aqueous phases. 200 microliters (µl) of the organic lipidcontaining phase was dried under nitrogen gas in glass tubes and used to induce the
reporter strain LAH118 overnight. 200µl of the aqueous phase was also tested for
inducing capability using reporter strain LAH118. The level of sphingosine or
phytosphingosine remaining in each culture was determined by observation of the level
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of SphR-dependent, sphingosine specific, induction measured via Miller’s protocol[32].
Levels of induction were reported as a percentage of the induction measured in
sphingosine controls.
3.3.10 P. aeruginosa PAO1 growth and respiration assays
P. aeruginosa PAO1 WT and PAO1 ∆sphBCD carrying either empty vector
pMQ80 or complement plasmids containing one or more genes belonging to the sphBCD
cassette were adjusted from 1XMOPS, 25 mM pyruvate, 5 mM glucose, 20 µg/ml
gentamicin overnight cultures to an OD600 of 0.5. The adjusted cells were then added to
a 96 well culture plate to a final OD600 of 0.05 in 150 µl of 1XMOPS amended with 20
mM pyruvate, 20 µg/ml gentamicin, 10µg/ml tetrazolium violet, and either 200 µM or 0
µM sphingosine or phytosphingosine per well. The OD600 and absorbance at 550 nm
was measured per well, to determine cell growth and respiration (via tetrazolium violet
reduction), respectively, every hour for 18 hours. The growth ability of each strain was
reported as a ratio of sphBCD mutant growth over WT growth in each condition.
3.3.11 Thin layer chromatography for detection of sphingosine
Overnight culture was added to a final OD600 of 0.05 in 1 ml of 1xMOPS
supplemented with 20mM pyruvate, 20µg/ml gentamicin, and 30µg of sphingosine and
incubated for 18 hours on the roller wheel at 37°C. The full volume of culture was
separated into organic and aqueous fractions via chloroform: methanol phase separation
and the organic fractions were dried under nitrogen gas. The dried organic fractions were
solubilized in 20µl of ethanol and 5µl of each sample was spotted at the base of a pre-run
TLC Silica Gel 60 F254 plate (EMD Millipore Sigma). The spotted plate was then placed
in a saturated chamber and run in a mobile phase of chloroform: methanol: water
95

(65:25:4). The dried plate was sprayed with ninhydrin solution (Sigma Aldrich) and
placed in a heated chamber for 30 minutes or until purple coloration appeared indicating
the presence of sphingosine via it’s amine group.
3.3.12 Phylogenetic tree building
A maximum likelihood phylogenetic tree was constructed using a pipeline
consisting of MUSCLE protein sequence multiple alignment, PhyML to determine
phylogeny using maximum likelihood, and tree rendering by TreeDyn, provided by
Phylogeny.fr [34], [35]. Homologs of putative oxidoreductase enzyme SphC were identified
in other bacterial species using the National Center for Biotechnology’s BLAST tool.
Only homologs belonging to a similar operon structure were included. A similar FADlinked oxidoreductase enzyme from S. cerevisiae was included as an out-group. A list of
the accession numbers of protein sequences used in tree building are included in Table
3.3.
3.4 Results and Discussion
3.4.1 Transcriptional regulator SphR interacts with sphingosine and
phytosphingosine to bind target promoter regions and induce transcription of the
sphingosine-responsive operon sphBCD
Sphingosine is one of many antimicrobial sphingolipids present throughout the
body. In order to determine whether the sphingosine-responsive metabolic operon
sphBCD is transcribed as part of P. aeruginosa’s response to other sphingolipids and/or
related compounds, a panel of sphingosine analogs was tested for the ability to induce a
sphB’-lacZYA-‘sphD chromosomal reporter in P. aeruginosa strain PA14 (LAH118).
Analogs were chosen based on biological relevance and structural factors, such as the
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presence or absence of functional groups and the geometry of the hydrocarbon tail, to test
the effects of these factors on ligand recognition by the sphingosine-responsive
transcriptional regulator SphR and consecutive induction of the metabolic operon (Figure
3.1A). Of the analogs tested, phytosphingosine was the only compound able to
significantly induce transcription of the sphBCD operon in an SphR-dependent manner
(****p-value<0.0001).
Phytosphingosine is the only analog that retains sphingosine’s structure at carbons
C1 through C3 and is the only structure to achieve SphR-dependent transcription. This
suggests that the most important structural features needed for detection by SphR and
subsequent gene induction are the two hydroxyl groups and one primary amine group
present at C1 through C3. Alteration of these groups significantly decreases SphRdependent induction of sphBCD (Figure 3.1B). The lack of either hydroxyl group, as
demonstrated in the 1-deoxy and 3-deoxysphingosine analogs causes a lack of sphBCD
induction. The same ablation of sphBCD induction is observed in the presence of
palmitate, a structurally similar fatty acid lacking an amine group. The presence of the
hydroxyl groups and primary amine are not the only factors influencing SphR-dependent
sphBCD induction. Drastic alternation of the hydrocarbon tail, demonstrated by FTY720,
also reduces induction.
While these observations support the importance of the hydroxyl and amine
functional groups present in sphingosine’s structure for SphR-ligand recognition and
consecutive sphBCD transcriptional induction, it does not rule out issues with transport
across cell membranes as the limiting factor. It is known that SphR is able to bind
sphingosine via the N-terminal domain (Figure S3.1) and binds to the promoters of
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sphingosine-responsive genes in the presence of sphingosine [21]. In order to confirm the
binding of SphR to promoter in the presence of analogs that induce transcription, and to
ensure that SphR was coming into contact with the tested ligands, electrophoretic
mobility shift assays (ESMAs) were conducted, using the promoter region of the
sphingosine-responsive gene sphA as the target probe, in the presence of the sphingosine
analogs. In support of our transcriptional induction observations and previously
conducted assays [21], only compounds that induce transcription of sphingosineresponsive genes, including sphingosine, phytosphingosine, and a C16 tail-length variant
of sphingosine, are able to promote SphR-dependent probe shift (Figure 3.1C).
3.4.2 The presence of a functional sphBCD operon results in the modification of
sphingosine to a form undetectable by SphR
Given the predicted functions of the enzymes encoded by the sphBCD operon,
Figure 3.2A outlines a putative sequential mechanism for sphingosine metabolism,
involving oxidation by oxidoreducatase SphC at the C1 position followed by cleavage of
the resulting aldol by aldolase SphD. In order to determine whether the predicted
metabolic operon sphBCD is responsible for modification of sphingosine, sphingosine
levels in cultures of WT and ∆sphBCD P. aeruginosa PAO1 were measured after
incubation of 20 µM sphingosine for 18 hours with each strain. The sphingosineresponsive transcriptional reporter strain LAH118 was used as a biological sensor to
detect un-modified sphingosine present in the cultures, as structure-function assays
(Figure 3.1) indicate that modification of the hydroxyl or amine groups of sphingosine
result in a lack of SphR detection.
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After incubation with WT P. aeruginosa, the sphingosine signal remaining in
culture was significantly reduced in the supernatant of cultures as compared to the
sphingosine control sample (**p-value=0.0199). WT cell lysate contained a decreased
level of sphingosine that approached significance when compared to the sphingosine
control (*p-value=0.1936), suggesting that sphingosine enters the cell and accumulates in
cytoplasm where it is subsequently modified by WT P. aeruginosa (Figure 3.2B).
Although variability in samples caused the decrease in sphingosine signal in WT cell
lysate cultures to be a less-than significant change (over our significance threshold of
0.05), only 10.5% of the sphingosine-responsive transcription remained in WT cell lysate
cultures as compared to sphingosine controls. In WT supernatant cultures there was no
detectable sphingosine-responsive transcription remaining. This reduction in detectable
sphingosine in total culture is not a result of increased sequestration of sphingosine into
bacterial cells, as both the supernatant and bacterial pellets were tested for inducing
power and found to elicit a greatly decreased level of sphingosine-responsive
transcription. In P. aeruginosa ∆sphBCD cultures, levels of sphingosine-dependent
induction remained comparable to sphingosine controls. Complementation of the
∆sphBCD phenotype, via the pMQ80:sphBCD complement plasmid, recovered the ability
of ∆sphBCD P. aeruginosa to decrease the sphingosine signal to a value that was at, or
approaching, significance in comparison to sphingosine controls (supernatant: **pvalue=0.0193, pellet; *p-value=0.165) (Figure 3.2B). This suggests that the sphBCD
operon is essential for modification of sphingosine into a form undetectable by SphR.
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3.4.3 The sphBCD operon is necessary for maximal growth and respiration in the
presence of sphingosine
P. aeruginosa is intrinsically resistant to high levels of sphingosine. To
investigate whether sphingosine modification by the encoded products of the sphBCD
operon aid P. aeruginosa growth in the presence of sphingosine, P. aeruginosa PAO1
wild type, ∆sphBCD, and complemented strains were grown in the presence of 200 µM
sphingosine and growth was compared. After 16 hours of growth P. aeruginosa WT and
complement strains grew to comparable optical densities in the presence of 0 µM and 200
µM sphingosine (Figure 3.3A). P. aeruginosa ∆sphBCD did not display a growth defect
in the 0 µm sphingosine condition but only achieved on average 34.1% of WT growth
when grown in the presence of 200 µM sphingosine. The WT strain grew to a
comparable level as compared to the ∆sphBCD:sphBCD complemented strain, while the
∆sphBCD uncomplemented strain grew to a significantly lower OD600 as compared to
the complemented strain (*p-value= 0.0252)(Figure 3.3A). The lower cell density
achieved after 16 hours is due to the decrease in growth rate of P. aeruginosa ∆sphBCD
compared to WT and complement strains. There is a significant increase in the doubling
time of the ∆sphBCD strain during log phase (between 4 and 11 hours) in the presence of
200µM sphingosine as compared to WT and complement strains (**p-value=0.0030)
(Figure 3.3B).
It has been demonstrated that sphingosine accumulates within bacterial cells
causing flocculation and/or formation of inclusion bodies of cellular contents, which may
impact measures of OD600 [5]. To support the OD600 readings, measures of cellular
respiration were also measured via reduction of tetrazolium violet (TV). In keeping with
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the growth results measured by OD600, the maximum level of respiration as measured by
TV reduction was not significant different between the 0 µM and 200 µM sphingosine
conditions in WT and complement strains, while the ∆sphBCD 0 µM and 200 µM
sphingosine cultures showed visible difference in respiration levels (Figure 3.3C). This
difference in respiration can be directly correlated to the differences in cell density, as the
respiration per cell (Abs550/OD600) is consistent between all strains in all conditions
(Figure 3.3C).
Total levels of respiration were expected to be lower in ∆sphBCD cultures in the
presence of sphingosine due to the decreased amount of cells measured through OD600.
In order to determine whether the respiration per cell varied between strains in the
presence of sphingosine, cellular respiration, reported as the amount of TV reduction
(Abs550 unit) per cell (OD600 unit), was measured over a time course of 18 hours. A
significant spike in P. aeruginosa WT cellular respiration in the presence of 200 µM
sphingosine occurs at the entry to log phase (T= 4 hours) (**p-value=0.0014). This
transient increase in WT cellular respiration is not observed in the 0 µM sphingosine
condition or in any other strain in the 200 µM sphingosine condition. This burst of
respiratory activity may indicate a spike in transcription of essential sphingosineresponsive metabolic machinery that does not occur in ∆sphBCD and constitutive
complementation strains (Figure 3.3D).
3.4.4 Maximum growth of P. aeruginosa in the presence of the SphR-detectable
sphingosine analogs phytosphingosine and sphinganine is dependent on sphBCD
As evidenced by the transcriptional induction assays shown in Figure 3.1,
phytosphingosine is a sphingosine analog that causes promoter binding by SphR and
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consecutive sphingosine-responsive gene transcription, including induction of the
sphBCD operon. Phytosphingosine is another antimicrobial sphingolipid that P.
aeruginosa is resistant to. To determine whether sphBCD enhances the growth of P.
aeruginosa in the presence this sphingosine analog, growth assays involving WT,
∆sphBCD, and complement strains of PAO1 were conducted in the presence of the
phytosphingosine. After 16 hours, the growth of P. aeruginosa WT and complement
strains did not significantly differ in the presence of 0 µM or 200 µM phytosphingosine,
while 200µM phytosphingosine significantly decreased the growth of the ∆sphBCD
strain to 34.3% that of WT in the same condition (**p-value=0.0093) (Figure 3.4A).
Another sphingosine analog with the ability to induce SphR-dependent transcription,
sphinganine, also inhibits P. aeruginosa growth in a sphBCD-dependent manner. P.
aeruginosa ∆sphBCD grown in the presence of 200µM sphinganine resulted in a
significant decrease in its maximum growth as compared to P. aeruginosa WT and
sphBCD complement strains (Figure 3.4B) (*p-value= 0.0398). The significant
contribution of the sphBCD operon to P. aeruginosa growth in the presence of two
biologically revelent sphingolipids, phytosphingosine and sphinganine, along with
phytosphingosine and sphinganine’s ability to induce transcription of the sphBCD
operon, suggests that the sphingolipid-responsive system is essential to maximal growth
of P. aeruginosa in the presence of multiple host-derived sphingolipids.
3.4.5 Functions of the individual members of the sphBCD operon in modification of
sphingosine and growth in the presence of sphingosine
The identities and functions of each member of the sphBCD operon can be
predicted using NCBI’s sequence alignment and conserved domain databases. The
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putative metabolic operon includes cytochrome c SphB, oxidoreductase enzyme SphC,
and aldolase enzyme SphD. Given the functions of these predicted products, a potential
pathway for sequential metabolism of sphingosine, shown in Figure 3.2A, was
developed. To investigate whether each individual member of the sphBCD operon acts on
sphingosine and to determine the biological importance of each member, sphingosine
modification and growth assays were conducted in strains lacking sphB, sphC, or sphD.
According to the predicted pathway of sphingosine metabolism, oxidation of
sphingosine by the oxidoreductase enzyme SphC is the essential first step to create an
aldol substrate for cleavage by aldolase SphD. To test whether action by SphC is the ratelimiting step in sphingosine modification, singular deletions of sphingosine-responsive
genes were tested for their effect on sphingosine modification. The putative enzymes
encoded by the sphBCD operon, sphC and sphD, were tested for their sphingosinemodifying abilities along with another non-enzymatic SphR-dependent sphingosineresponsive gene, sphA. Deletion of sphC resulted in the inability of P. aeruginosa to
modify sphingosine, while strains with deletions of the sphingosine-responsive genes
sphA and sphD behaved similar to WT (Figure 3.5A) The ∆sphC phenotype was
successfully complemented, showing a recovery of the P. aeruginosa WT’s ability to
modify sphingosine, resulting in a decrease in sphingosine signal that reached or
approached significance in both the supernatant and cell pellets of ∆sphC cultures
complemented by plasmid-borne sphC (pMQ80:sphC) (Figure 3.5B).
These data indicate that the first modification step achieved by SphC is
responsible for altering sphingosine into a species undetectable by SphR (Figure 3.5B).
This supports the hypothesis that SphC modifies one or more of the functional groups of
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sphingosine, as sphingosine analogs with altered hydroxyl or amine groups at carbons
C1, C2, or C3 are undetectable by SphR (Figure 3.1).
The putative aldolase SphD is predicted to participate in the second crucial
sphingosine cleavage step. This cleavage has the potential to improve Pseudomonas
growth in the presence of sphingosine as it cleaves the sphingolipid into less toxic and
metabolically useful compounds. To assess the importance of SphD to P. aeruginosa
growth in the presence of sphingosine, ∆sphBCD complemented with sphBC but lacking
sphD was evaluated for its growth in the presence of sphingosine. The importance of
sphC and sphB to P. aeruginosa growth in the presence of sphingosine was also
evaluated by complementing the ∆sphBCD strain with sphC and sphCD respectively.
A comparison of growth in the presence of sphingosine between strains lacking
one or more of the members of sphBCD gave a complete picture of those members
essential to sphingosine detoxification and/or metabolism. Surprisingly, it is not only
SphC, but also cytochrome c SphB that is essential for maximum growth of P.
aeruginosa in the presence of sphingosine (Figure 3.5C).
In the presence of 200µM sphingosine, the full sphBCD operon complemented
strain (PAO1 ∆sphBCD : sphBCD) grows to 100% of its growth in 0µM sphingosine,
indicating that the presence of a functional sphBCD operon prevents growth attenuation
in the presence of 200µM sphingosine. The full complement strain and WT strains do not
show a significant difference in % growth. Complementation with sphC or sphCD alone
did not increase growth in the presence of sphingosine, and these strains along with the
un-complemented (EV) strain, have significantly attenuated growth as compared to the
sphBCD complemented strain (sphC *p-value=0.0179, sphCD *p-value=0.0129, EV **p104

value=0.0078) (Figure 3.5C). The sphBC-complemented strain grew to ~76% of its
maximal growth, and does not show a significant decrease in growth in the presence of
sphingosine as compared to the full sphBCD complement. This indicates that cytochrome
c sphB is essential for oxidoreductase sphC activity and that both genes are necessary for
maximal P. aeruginosa in the presence of 200µM sphingosine.
The lack of sphD does not significantly impact growth of P. aeruginosa in the
presence of sphingosine, indicating that there may be redundant cleavage mechanisms
transcribed by P. aeruginosa. The possibility that the oxidized intermediate of
sphingosine produced by SphC is not further metabolize but rather detoxified from
bacterial cells by excretion is unlikely as no species possessing properties consistent with
oxidized sphingosine are detected in P. aeruginosa WT cultures (whole culture including
supernatant and cells) via thin layer chromatography (Figure 3.6). After incubation of
100µM sphingosine with cultures of wild type, ∆sphC, ∆sphC:sphC, ∆sphD, and
∆sphD:sphD, lipid fractions were collected and amine-containing species were detected
through thin layer chromatography using ninhydrin reagent (Figure 3.6). Aminecontaining lipids whose Rf are similar to the sphingosine control (°), including a potential
oxidized sphingosine intermediate (*) are present in the ∆sphC culture and control only,
indicating that SphC is necessary for further metabolism of sphingosine. No aminecontaining lipids are found to migrate at the Rf of sphingosine or a potentially oxidized
sphingosine-like compound or sphingosine intermediate in the WT, ∆sphD, or
complemented samples, suggesting that metabolism of sphingosine is accomplished in
these cultures. The approximate Rf of sphingosine in a chloroform: methanol: solvent
system is 0.28, but sample overloading may be responsible for slightly altered migration.
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A potentially oxidized form of sphingosine is present in the sphingosine control and
∆sphC samples, migrating at a slightly higher Rf (denoted by *) as compared to
sphingosine (denoted by °). The presence of this species may due to spontaneous
oxidation of the sphingosine stock. No unique amine-containing lipid was found in
∆sphD cultures, supporting the hypothesis that deletion of sphD does not halt sphingosine
metabolism after oxidation by SphC.
3.5 Conclusions
Sphingosine and other host-derived sphingolipids are an important part of innateimmune defenses against bacterial pathogens. The ability to detect and metabolize
antimicrobial sphingolipids plays an important role in P. aeruginosa’s interactions with
the host [21], [38], [39], [40]. The mechanism by which P. aeruginosa resists high levels of
sphingosine and phytosphingosine was previously unknown. The data presented in this
manuscript describes a predicted metabolic operon, sphBCD, whose members act on
sphingosine as substrate. Specifically, the cytochrome c SphB and oxidoreductase
enzyme SphC are essential for sphingosine modification and maximal P. aeruginosa
growth in the presence of sphingosine and analog phytosphingosine, while the putative
aldolase SphD displays no essential function. The growth advantage afforded by sphBC
may be important in biological niches where sphingosine and phytosphingosine are
abundant, such as in the lung and on the skin. The phytosphingosine-dependent activation
of the sphingolipid-responsive system is not surprising, as this species of sphingolipid is
concentrated in hair follicles and comprises ~37% of hair shaft-associated lipids[8]. P.
aeruginosa is commonly associated with hair follicle infection, termed ‘hot-tub’

106

folliculitis [36], [37]. The ability to metabolize antimicrobial phytosphingosine at the follicle
may contribute to P. aeruginosa’s ability to infect.
Homologs of SphC belonging to a similar operon structure as sphBCD are found
in a wide range of bacteria including Gram negatives and Gram positives of a pathogenic
and nonpathogenic nature (Figure 3.7). P. aeruginosa’s SphC clusters with the rest of the
Gram-negative homologs, most closely related to other Pseudomonas species but not far
removed from homologs in Acinetobacter haemolyticus and Mycobacterium tuberculosis.
The conservation of members of the sphBCD operon in several professional and
opportunistic pathogens demonstrates the importance of the sphingosine-responsive
operon to the survival of bacteria in the sphingosine-rich environments of the host.
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3.6 Chapter 3 Figures
Figure 3.1 SphR-dependent transcriptional induction of the sphBCD operon by
sphingosine analogs. (A) Structures of sphingosine analogs tested for their ability to
induce transcription of sphBCD. (B) Sphingosine and phytosphingosine induce
significant transcription of sphBCD in an SphR-dependent manner (****pvalue<0.0001). (C) SphR binds the promoter region of sphingosine-responsive gene sphA
in the presence of sphingosine, phytosphingosine, and tail-length variant C15 sphingosine
(lanes with probe shift denoted with *). Alteration of either hydroxyl group or the
primary amine of sphingosine impairs detection by SphR and subsequent induction of
sphBCD. All values represent the averages of three independent experiments; error bars
represent the standard deviation from the mean. Statistical significance was determined
via two-way ANOVA with Sidak’s multiple comparison’s test.

Figure 3.2 Modification of sphingosine into a form undetectable by SphR by the
sphBCD operon (A) The predicted pathway of sphingosine metabolism via the enzymes
encoded by the sphBCD operon. (B) WT P. aeruginosa modifies sphingosine into a form
undetectable by SphR, which is shown in the significant decrease in sphingosine signal in
the supernatant and a decrease that is approaching significance in the cell lysate (pellet)
samples as compared to the sphingosine control (supernatant: **p-value=0.0199, pellet:
*p-value=0.1936). This modification is dependent on the presence of sphBCD, as
evidenced by a significant decrease in sphingosine signal remaining in the supernatant
and a decreased level of sphingosine that is approaching significance in the cell lysate
samples of an ∆sphBCD strain rescued by sphBCD complementation (supernatant: **p108

value=0.0193, pellet: *p-value=0.1646). All values represent the averages of three
independent experiments; error bars represent the standard deviation from the mean.
Statistical significance was determined via two-way ANOVA with Sidak’s multiple
comparison’s test.

Figure 3.3 Growth of P. aeruginosa in the presence of sphingosine is dependent on
sphBCD (A) ∆sphBCD reaches stationary phase at a significantly lower optical density in
the presence of sphingosine as compared to the ∆sphBCD:sphBCD complemented strain
(*p-value=0.0127) while there is no significant difference between the growth of WT P.
aeruginosa and complemented strains. Statistical significance was determined via twoway ANOVA and Sidak’s multiple comparison’s test. (B) The rate of ∆sphBCD growth
is impacted by the presence of sphingosine while WT and complement strains are
unaffected, as evidenced by the significantly longer doubling time of ∆sphBCD in the
presence of 200µM sphingosine as compared to the same strain in 0µM sphingosine
(**p-value=0.0030). Statistical significance was determined via two-way ANOVA and
Sidak’s multiple comparison’s test. (C) There is a visible decrease in total respiration as
measured by reduction of tetrazolium violet (TV) in cultures of ∆sphBCD in the presence
of 200 µM sphingosine. The lower amount of accumulated TV precipitate is consistent
with the lower level of cell growth at the end point of 16 hours and there is not a
significant defect in cellular respiration (Abs550/OD600) in any of the cultures.
Statistical significance was determined via two-way ANOVA and Sidak’s multiple
comparison’s test. (D) A significantly higher respiration rate, defined here as the amount
of TV reduction (Abs550 units) per cell (OD600 units) is observed in the presence of 200
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µM sphingosine in WT cells (**p-value= 0.0014) at the 4 hour time point, the entry into
log phase, as compared to ∆sphBCD and complement strains. The burst of WT
respiration is not observed at 4 hours in the 0µM sphingosine condition. Statistical
significance was determined via two-way ANOVA and Tukey’s multiple comparison’s
test. All values represent the averages of three independent experiments; error bars
represent the standard deviation from the mean.

Figure 3.4 Growth of P. aeruginosa in the presence of biologically relevant
sphingosine analogs is dependent on sphBCD (A) Deletion of the sphBCD operon
results in significantly lower growth of P. aeruginosa in the presence of
phytosphingosine (**p-value<0.00983). Phytosphingosine is another potent antimicrobial
detectable by SphR that P. aeruginosa is intrinsically resistant to. sphBCD’s contribution
to P. aeruginosa growth in the presence of phytosphingosine as well as sphingosine
demonstrates the versatility of the SphR-inducible metabolic system in managing
Pseudomonas’s response to multiple host-derived antimicrobial sphingolipids. (B) A
similar attenuation in the growth of ∆sphBCD is seen in the presence of sphinganine, a
naturally occurring analog of sphingosine (*p-value= 0.0398). Wild type growth in the
presence of sphinganine is not significantly altered and complementation with sphBCD
recovers the wild type phenotype. All values represent the averages of three independent
experiments; error bars represent the standard deviation from the mean. Statistical
significance was determined via two-way ANOVA with Sidak’s multiple comparison’s
test.
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Figure 3.5 Involvement of the members of the sphBCD operon in modification of
and P. aeruginosa growth in the presence of sphingosine (A) Mutant strains ∆sphA
and ∆sphD were able to modify sphingosine and decrease the sphingosine signal to the
same level as WT, but ∆sphC retained a significantly higher sphingosine signal in culture
as compared to WT (**p-value= 0.0094). (B) ∆sphC’s sphingosine modification defect is
recovered with sphC complementation. This indicates that sphC is an essential member
of the sphBCD operon to sphingosine modification. (C) In the presence of 200µM
sphingosine, the full sphBCD operon complemented strain (PAO1 ∆sphBCD : sphBCD)
grows to 100% of its growth in 0 µM sphingosine, while the un-complemented, sphC,
and sphCD complemented strains only reach approximately 20%, 26%, and 29% of their
maximal growth respectively, which is significantly less than the growth accomplished
by the sphBCD complemented strain (EV **p-value=0.0078, sphC *p-value=0.0179,
sphCD *p-value=0.0129). The sphBC-complemented strain grew to ~76% of its maximal
growth, and did not show a significant decrease in growth in the presence of sphingosine
as compared to the full sphBCD complement. Statistical significance was determined via
one-way ANOVA and Dunnett’s post-test. All values represent the averages of three
independent experiments; error bars represent the standard deviation from the mean.

Figure 3.6 Evidence suggesting the metabolism of sphingosine by the enzymatic
members of the sphBCD operon Amine-containing lipids whose Rf are consistent with
the sphingosine control (°) including a potential oxidized sphingosine intermediate (*) are
present in the ∆sphC culture indicating that SphC is necessary for further metabolism of
sphingosine. No amine-containing lipids are found to migrate at the Rf of sphingosine or
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an oxidized intermediate in the WT, ∆sphD, or complemented samples, indicating that
metabolism of sphingosine is accomplished in these cultures. The approximate Rf of
sphingosine in a chloroform: methanol: solvent system is 0.28. Sample overloading may
result in altered migration.

Figure 3.7 Distribution of SphC homologs among bacterial species. Pathogenic
species are highlighted in red. An oxidoreductase of S. cerevisiae was used as the outgroup for tree rooting.

Figure S3.1 Binding of sphingosine by the functional domains of AraC-type
transcriptional regulator SphR. The conserved regions of AraC-type transcriptional
regulators include a DNA-binding C-terminal domain (CTD) and an N-terminal domain
(NTD) that is thought to be responsible for ligand binding. The ligand (3-H3-sphingosine)
binding ability of the CTD and NTD of the AraC-type transcriptional regulator SphR was
tested. The CTD of SphR and an unrelated transcriptional regulator control, CdhR,
showed significant decreases in ligand binding ability (*p-value=0.0362 and **pvalue=0.0041, respectively), indicating that the NTD of SphR is responsible for
sphingosine binding. CPM= counts per minute. Significance calculated by ordinary oneway ANOVA with Dunnett’s test for multiple comparisons.
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3.7 Chapter 3 Tables
Table 3.1 Strains and plasmids used in this study
Table 3.2 Primers used in this study
Table 3.3 Protein sequences of SphC orthologs
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Figure 3.1 SphR-dependent transcriptional induction of the sphBCD operon by
sphingosine analogs.
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Table 3.1 Strains and plasmids used in this study
Designation
LAH80
LAH113
LAH82
LAH83
LAH288
LAH289
LAH118
LAH122
LAH30
LAH63
LAH152
LAH96
LAH121
LAH302
LAH301
LAH236

Genotype or Description
E. coli S17λpir
E. coli S17λpir
PAO1 ∆sphBCD WTR
PAO1 ∆sphBCD
PA14 ∆sphBCD
PA14 ∆sphBCD
PA14 ∆sphBCD sphB'-lacZYA-'sphD
PA14 ∆sphRsphBCD sphB'-lacZYA-'sphD
E. coli T7
E. coli T7
E. coli T7
PAO1 ∆sphBCD
PAO1 ∆sphBCD
PAO1 ∆sphBCD
PAO1 ∆sphBCD
PAO1 ∆sphBCD

Strains and Plasmids
Plasmid
pMQ30: sphBCDKO
pMQ30: sphB'-lacZYA-'sphD
none
none
pMQ80
pMQ80::sphBCD
none
none
pMALc2x::MBP-SphR-Full
pMALc2x::MBP-SphR-NTD

pMALc2x::MBP-SphR-CTD
pMQ80::sphBCD
pMQ80
pMQ80::sphBCvsvG
pMQ80::sphCD
pMQ80::sphC

Primers Used in Construction
2080, 2081, 2082, 2083
2082, 2286, 2287, 2288
2080-2083
2080-2083
N/A
572, 573
2080-2083 and 2082, 2286, 2287, 2288
2080-2083 and 2082, 2286, 2287, 2288
1001-1002
1001-1950
1002-2342
572, 573
N/A
572, 2514
2511, 573
2511, 2512

Table 3.2 Primers used in this study
Primer Number
2080
2081
2082
2083

Primer Name
PAsphBCD_KO_F1_KpnI
PAsphBCD_KO_F2_SOE_SmaI
PAsphBCD_KO_R2_HindIII
PAsphBCD_KO_R1_SOE_SmaI

Primer Number Primer Name
572
573
2511
2512
2514

sphB-D-MQ80-F
sphB-D-MQ80-R
sphC-exp-F EcoRI
sphC-exp-R-untagged-HindIII
sphC-exp-R-VSVG-HindIII

Primer Number Primer Name
1001
1002
2342
1950

5324 F pMALEcoRI
5324 R pMALBamHI
SphRCTD_F_EcoRI
SphR_Nterm_Rvs_KpnIXhoI

Primer Number Primer Name
874 5325 prom F
988 5325 promoter probe R biotin

∆sphBCD triple deletion
Primer Sequence
agggtaccatggaaaaccacgacaccgactat
cccgggatgctcaagccgagccactacgacctggcg
aggaagcttgctggctctgtcgctcgttcgcat
cggcttgagcatcccgggggtgttcctctctcgttg
sphBCD operon complement constructs
Primer Sequence
ACAGAAgaattcGCAACGAGAGAGGAACACCA
TATACTaagcttACCATTCCGTTCGAACTCTG
CAAGgaattcCCGCAGCGCAGGACCGATAGGGGA
CAGAaagcttCTAGGTCACGCCCAGGATGGAAGA
CAGAaagcttCTACTTGCCCAGGCGGTTCATCTCGATGTCGGTGTAGGTCACGCCCAGGATGGAAGA
MBP-SphR constructs

Primer Sequence
GAATTCATGCACAACAATGCCGCCGA
GGATCCGCGTCGCGCGGCCAGCGTG
AAGAATTCGAGCAGGAAAGCACCCAGGTG
accagactcgagggtaccgacCACCTGGGTGCTTTCCTGCTC
sphA-biotin EMSA probe

Primer Sequence
TTGTTGTGCATGGGCGAAATCCTG

5'/Biosg/GCGGGCTCTTATTATTGTTGG
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Table 3.3 Protein sequences of SphC orthologs
Organism
Saccharomyces cerevisiae S288C
Pseudomonas aeruginosa PA14
Pseudomonas aeruginosa PAO1
Mycobacterium tuberculosis H37Ra
Acinetobacter haemolyticus
Novosphingobium acidiophilum
alpha proteobacterium Mf 1.05b.01
Variovorax paradoxus EPS
Bacillus anthracis sp. Sterne
Bacillus cytotoxicus
Bacillus cereus
Aquabacterium sp. NJ1
Sphingopyxis sp. MC1
Ruegeria pomeroyi
Silicibacter lacuscaerulensis
Ahrensia sp. 13GOM1096m
Pseudomonas fluorescens
Pseudomonas protegens
Pseudomonas nitroreducens

Accession
NP_013624.1
EOT07925.1
AGY68358.1
WP_003408749.1
WP_005084451.1
WP_028641249.1
WP_029641806.1
WP_013541909.1
WP_000948923.1
WP_011983675.1
WP_076872097.1
KGM42138.1
ENY80568.1
WP_011241805.1
WP_005977476.1
WP_051540864.1
WP_011333914.1
WP_011061984.1
WP_017518543.1
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CHAPTER 4: Characterization of Stenotrophomonas maltophilia K279a’s response
to mucin
4.1 Abstract
Multidrug resistance among nosocomial pathogens is a growing health concern
worldwide. Intrinsic resistance to available therapeutics along with advantageous
biophysical characteristics enables less virulent opportunistic pathogens, such as
Stenotrophomonas maltophilia, to establish and maintain successful lung infections in
individuals who are incapacitated or immunocompromised, such as individuals with
cystic fibrosis (CF). Cystic fibrosis is a genetic lung condition that is characterized by
aberrant ion transport and mucus overproduction. S. maltophilia, while not overtly
virulent, possesses the ability to metabolize nutrient-rich host-derived mucins, which are
the heavily glycosylated glycoproteins that comprise mucus. The ability to access the vast
nutrients locked in mucins’ recalcitrant structure could provide a significant growth
advantage to a pathogen within the lung. Here we characterize, through genetic and
transcriptomic approaches, S. maltophilia’s interaction with mucin, observing mucininduced phenotypic and transcriptomic changes, and identifying genes involved in S.
maltophilia’s response to and metabolism of mucin. This study contributes to our
knowledge of how Gram-negative bacteria interact with host-derived compounds and
provides a foundation for future study into how these interactions impact the
polymicrobial infections often observed in the CF lung.
4.2 Introduction
Multi-drug resistant (MDR) bacteria pose a significant threat to patients in
healthcare settings, causing an estimated 2.8 million infections annually in the United
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States and an estimated 35,000 deaths [1], [2], [3]. Over the past decade, cases of MDR
infections have continued to climb and several bacterial species have emerged as
problematic opportunistic pathogens, including Stenotrophomonas maltophilia. S.
maltophilia is a Gram-negative nosocomial pathogen whose MDR profile has garnered
the attention of the World Health Organization, which includes S. maltophilia on its list
of MDR bacterial pathogens that pose the highest risk to public health [4], [5]. S.
maltophilia readily infects individuals in the hospital setting, targeting patients in
intensive care units and those on assisted ventilation [6], [7].
Among S. maltophilia infections, respiratory tract infections are the most common
[7], [8], [9]

. Severe and chronic S. maltophilia pulmonary infections lead to disease

exacerbation and negative outcomes in individuals with chronic obstructive pulmonary
disorder (COPD) and cystic fibrosis (CF), making the recent increase in S. maltophilia
infections in these populations especially concerning [6], [10], [11]. While respiratory
infections involving S. maltophilia have been the focus of many studies, S. maltophilia is
also responsible for causing bacteremia, carrying a relatively high mortality rate of
approximately 66%, as well as meningitis and soft tissue infections, which are associated
with long hospital stays, increased antibiotic use, and in some cases death [11], [12], [13], [14],
[15], [16]

.
Primarily isolated from environmental reservoirs including water systems, soils,

and plant roots, S. maltophilia is not a highly virulent organism, but can attribute its
success as an opportunistic pathogen to several biophysical characteristics and its
intrinsic MDR [11], [17]. In addition to low outer membrane permeability, S. maltophilia’s
genome encodes for multiple antimicrobial resistance genes, including broad-spectrum β132

lactamases, aminoglycoside aminotransferases, and multidrug efflux pumps, that together
provide protection against the majority of the currently available antimicrobial
therapeutics [11], [18], [19], [20]. An additional adaptive barrier to antimicrobial attack is the
robust biofilm structure S. maltophilia forms on a variety of surfaces. The ability of the
opportunistic pathogen to adhere to medical device materials and many of the surfaces
that populate hospital settings, as well as its frequent presence in plumbing systems,
provides S. maltophilia with a gateway to a susceptible host population [11], [21], [22].
Within susceptible hosts, S. maltophilia infections are frequently polymicrobial
[23], [24], [25], [26], [27], [28], [29]

. Resistance to many of the available therapeutics has created

niches for S. maltophilia survival that were previously occupied by more virulent
opportunistic pathogens such as Pseudomonas aeruginosa and Burkholderia cenocepacia
[30], [31]

. The CF lung environment is a specific infective niche where polymicrobial

infections commonly occur. Polymicrobial infections can be difficult to treat and can also
lead to worsened outcomes due to the complex interactions between microbes. For
example, the involvement of S. maltophilia alone in infection is associated with
decreased forced expiratory volume (FEV), increased morbidity, and a three-fold increase
in the likelihood of patient death or lung transplant, but co-infection with P. aeruginosa is
observed to significantly increase S. maltophilia cell counts within the lung, ultimately
resulting in increased patient mortality [23], [29].
The synergy between S. maltophilia and the prevalent CF pathogen P. aeruginosa
is one example of how opportunistic pathogens of varying virulence work together to
increase the severity of an infection. Another phenomenon of pathogen cooperation is
cross-feeding, or cooperative metabolism of a complex nutrient source by several
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populations of bacteria with different metabolic capabilities. In the instance of crossfeeding, single or multiple species of bacteria liberate simple compounds from complex
nutrient sources, feeding other species of bacteria that would not have the ability to
metabolize the complex substrate on their own [32], [33], [34], [35]. Polymicrobial crossfeeding during infection has the potential to negatively impact patient outcomes, as
priming of the infective niche by less virulent bacteria promotes the proliferation of more
virulent pathogens with the ability to exacerbate infection [32], [33], [34], [36]. Bacterial crossfeeding within the pulmonary environment may be an important strategy for utilization of
complex substrates such as mucin.
Mucins are the heavily glycosylated glycoproteins that make up a substantial
portion of the mucus secreted at mucosal barriers throughout the body. The human
genome has 21 known MUC genes that encode mucin-like glycoproteins [37]. These
glycoproteins include membrane bound and secreted varieties, and O-glycosylation
among each mucin type varies widely depending on the tissue type and the biological
function of the mucin at the specific site [37], [38], [39]. Pulmonary mucus is comprised
predominately of secreted mucins MUC5AC and MUC5B, and the cell-tethered mucins
MUC1, MUC4, MUC16, and MUC20 [37]. In healthy lungs, pulmonary mucins play a
critical role in clearing invading pathogens from the airways in combination with ciliary
action. In the lungs of individuals with COPD or CF, mucus overproduction and/or
aberrant ion transport transforms pulmonary mucus from a protective barrier into a static
nutrient reservoir for bacterial proliferation. The majority of bacteria cannot efficiently
utilize the complex structure of mucin, as the many O-linked glycans, cross-linked by
disulfide bridges, must be metabolized before the proteinaceous backbone can be
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accessed, but the ability to metabolize such a rich nutrient source would provide an
invading pathogen with a significant growth advantage. In this manuscript we
characterize the ability of the opportunistic pathogen S. maltophilia to utilize mucin and
identify the processes involved in S. maltophilia’s response to this host-derived
compound.

4.3 Materials and Methods
4.3.1 Strains and Growth Conditions
Stenotrophomonas maltophilia strains K279a (ATCC BAA-2423), and two
clinical CF isolates AU30115 (GW273) and AU32848 (GW275) were grown at 37°C
shaking (170 rpm) in lysogeny broth (LB), Lennox formulation, M63 media[40]
supplemented with 40 mM sodium lactate, 10 mM D-glucose, and 500 µM Lmethionine[41], or LB broth diluted 20x in M63 media (growth levels in supplemented
M63 media and 1/20 LB/M63 media were comparable). Mucin growth screens were
conducted in M63 salts media supplemented with 1% (w/v) mucin +/- 250 µM Lmethionine. Strains used in this study can be found in Table 4.1.

4.3.2 Pig Gastric Mucin (PGM) Media Preparation
M63 1% mucin media used PGM (Millipore-Sigma) as the mucin component.
M63 1% mucin was prepared as follows; 40 g PGM was dissolved into 600 ml dH2O
with mixing overnight at 4°C. The PGM solution was transferred to dialysis tubing and
dialyzed against dH2O for 8 hours with water changes every 2 hours. Dialyzed mucin was
brought up to 4 L in M63 media +/- nitrogen (ammonium sulfate) amended with 10 g
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agar per 1 L media for solid media. A clarification step, with centrifugation at 10,000 rpm
for 20 minutes, was added when preparing media for the transposon mutant screens.
Media for subsequent growth assays was not clarified, as there were no significant
differences in levels of bacterial growth in clarified versus un-clarified mucin media.

4.3.3 Mucin growth assays
S. maltophilia strains K279a, AU30115, and AU32848, were grown in M63
media supplemented with 40 mM sodium lactate, 10 mM D-glucose, and 500 µM Lmethionine overnight at 37°C. Cells were collected by centrifugation and added at a final
OD600 of 0.05 to M63 media amended with 1% mucin or amended with 40 mM sodium
lactate, 5 mM D-glucose, and 500 µM L-methionine and grown for 18 hours at 37°C
shaking. S. maltophilia growth was evaluated via CFU plating with CFU output counts
normalized to input counts.

4.3.4 Mucin-induced biofilm assays
S. maltophilia strains K279a, AU30115, and AU32848, were grown in 1/20
LB/M63 media overnight at 37°C shaking at 170 rpm. Cells were then adjusted to a final
OD600 of 0.05 (approximately 7E5 CFU/ml) in either 1/20 LB/M63 or 1% mucin M63
media, added in 150 µl volumes in technical duplicate to wells in a flexible 96 well plate,
and placed in a humidified chamber at 37°C for an 18 hour stationary incubation. Biofilm
formation was evaluated via the crystal violet staining protocol described by O’Toole et
al. [23]. Levels of biofilm formation were reported as the fold biofilm formation (Abs550)
in the 1% mucin M63 condition over the 1/20 LB/M63 minimal media condition. Fold
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calculations were conducted within each strain, comparing each strains biofilm formation
in mucin versus its minimal media biofilm formation, or across strains, comparing the
clinical isolate biofilm formation in each condition to Sm K279a’s biofilm levels in the
minimal media condition. All experiments were conducted in biological triplicate and
technical duplicate.

4.3.5 Mucin as carbon source (liquid media screen)
Cultures were transferred from 96-well freezer stocks to M63 agar plates
supplemented with 40 mM sodium lactate, 10 mM glucose, and 500 µM L-methonine,
using a 48-pin device, or ‘frog’. Spot plates were grown overnight at 37°C. The next
morning, spotted colonies were frogged from solid media plates into 120 µl of liquid
culture in 96-well plates, containing 120 µl of either control minimal media (M63, 15
mM lactate, 5 mM glucose, 500 µM L-methionine) or 1% mucin media (M63, 1% (w/v)
mucin). 96-well plates were grown at 37°C stationary overnight (~18 hours). Liquid
growth plates were then observed for growth defects by eye and potential mucin-growth
defective transposon mutants (TnMs) were rescreened by spot plating on M63 minimal
agar plates (solid media) and inoculating 500 µl of M63 minimal, LB, and M63 1%
mucin liquid media, to rule out general liquid growth defects and to confirm mucindependent growth defect phenotypes. CFU counting was made difficult by the increased
clumping observed in the presence of mucin so growth defects were scored visually. All
validation experiments were conducted in biological triplicate and technical duplicate.
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4.3.6 Mucin as sole carbon, nitrogen, and methionine source (solid media screen)
To bypass any growth defects dependent on liquid growth (motility/swimming
defects) and to put increased pressure on S. maltophilia to utilize the proteinaceous
backbone of mucin, a second more stringent screen was conducted. This screen used M63
minimal and M63 (no nitrogen) 1% mucin agar plates for screening of mucin as a sole
source of carbon and nitrogen. Freezer stocks of TnMs were frogged into media
containing 180 µl 1/20 LB/M63 media (tested and showed similar growth as M63
minimal media used previously and supported growth out of freezer) and grown
overnight at 37°C stationary. The next day 5 µl of liquid cultures were spot plated onto
M63 (no nitrogen) 1% mucin agar plates and incubated overnight, stationary, at 37°C.
TnMs with visible growth defects compared to wild type spots were considered potential
hits and validated through further screening. To validate potential hits, the TnMs were
grown overnight in 1/20 LB/M63 on the roller wheel at 37°C. Cultures were adjusted to
OD600 of 1.0 in 1/20 LB/M63 and 5 µl of OD600 1.0 culture was added to 495 µl of 1/20
LB/M63 and M63 (no nitrogen) 1% mucin. Cultures were incubated stationary at 37°C
for 24 hrs and CFU plated on PIA plates at times 0, 6, and 24 hours. All validation
experiments were conducted in technical duplicate and biological triplicate. Cultures
were pipetted vigorously before plating to break up clumps.

4.3.7 CTAB Genomic DNA purification
To identify transposon insertions in S. maltophilia K279a’s genome, CTAB
genomic DNA purifications were performed on all TnMs with aberrant mucin growth.
Cells were grown overnight in 1.5 ml of LB, collected via centrifugation and resuspended
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in 567 µl of Tris EDTA buffer (pH=8). 15 µl of 20% SDS was added to samples and
samples were vortexed to mix. After addition of 3 µl of Proteinase K (20 U/µl) and
mixing via pipette samples were incubated for 20 minutes at room temperature before
addition of 100 µl of 5 M NaCl. Afger mixing 80 µl of CTAB was added and samples
were incubated for 15 minutes at 42°C. After incubation a volume of chloroform/isoamyl
alcohol (24:1) equal to the sample volume (~765 µl) was added and samples were
centrifuged for 5 minutes at 20,000 x g to extract the aqueous layer. A second extraction
was performed via addition of an equal volume of phenol: chloroform: isoamyl alcohol
(25:24:1) with centrifugation at 20,000 x g for 5 minutes. Purified DNA present in the
aqueous layer was then precipitated using 0.6 volumes of isopropanol. The vortexed
mixture was then incubated at -80°C for 5 minutes. After precipitation the DNA was
collected via centrifugation and the DNA pellet was washed 2x with 70% EtOH. The
pellet was then air dried overnight and resuspended in 100 µl of molecular grade water.
gDNA samples were then RNase treated by adding 100 µl of 2x RNase buffer (20 mM
Tris HCl (pH=8), 600 mM NaCl, 1 mM EDTA) and 4 µl of RNase A/T1 and incubating
for 1 hour at 37°C. RNase treated samples were isopropanol precipitated again, washed,
and resolubilized before quantification via nanodrop.

4.3.8 Identification of Transposon Insertion Sites through Arbitrary-Primed PCR
(AP-PCR)
Amplification of transposon insertion sites from TnM gDNA was conducted using
a transposon specific primer (specific for the transposon pBT20) and arbitrary reverse
primers. Several rounds of Arbitrary PCR were run to clarify specific bands. Primers 895
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and 898 were used for the first round of PCR amplification and primers 900 and 901 were
used for the second round. Amplified fragments were then excised from the gel and
purified using Fisher’s GeneJET Gel Extraction and DNA Clean Up Kit (ThermoFisher
Scientific, Waltham, MA). Purified DNA was sent to Vermont Genetics Network (VGN)
core at the University of Vermont for sequencing.
The sequences surrounding the transposon insertion sites were run through
NCBI’s BLAST algorithm against the S. maltophilia K279a genome to identify the
location of gene disruptions. Primers used to amplify regions surrounding transposon
insertion sites can be found in Table 4.2.

4.3.9 Growth conditions and RNA purification for microarray analysis
S. maltophilia strain K279a was grown O/N from freezer stocks in M63
supplemented with 15 mM sodium lactate, 5 mM glucose, and 500 µM L-methionine,
conditions that are consistent with previous S. maltophilia gene expression studies
conducted by the lab [41]. Overnight cultures (4 ml) were grown shaking (170 rpm) for 20
hrs at 37°C, then collected by centrifugation at 13,000 rpm. Collected cells were washed
and re-suspended in 1 ml M63 media and adjusted to an OD600 of 0.3. 500 µl of OD600
0.3 cells were collected by centrifugation and re-suspended in pre-warmed 500 µl of
control media (M63, 4mM sodium lactate, 250µM L-methionine) or experimental
induction media (M63, 1% mucin). Samples were loaded into a 48-well plate in technical
duplicate and incubated for 4 h shaking at 170rpm at 37°C. After the induction period of
4 h cells were again collected by centrifugation and immediately re-suspended in 800 µl
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of hot RNAzol. These samples were then stored at -80°C for RNA extraction and
purification. Samples were run in biological triplicate.
RNA was extracted from samples frozen at -80°C in RNAzol buffer
(SigmaAldrich) using the RNeasy Mini Extraction Kit (Qiagen) as per the manufacturers
instructions and further purified via a DNaseI treatment and a subsequent RNeasy
purification.

4.3.10 Microarray methodology
The UVM Advanced Genome Technology Core completed the microarray
analysis, which consisted of hybridization of experimental S. maltophilia K279a DNA
probes, generated by the NuGen Pico system, to a custom Affymetrix chip containing
probes specific to the genomes of Klebsiella pneumoniae MGH 78578,
Stenotrophomonas maltophilia K279a, Burkholderia thailandensis E264, and
Pseudomonas aeruginosa PA14. S. maltophilia K279a RNA used for probe generation
and hybridization was a equal-ratio pooled mixture of RNA samples collected from three
biological experiments performed on different days. Probe intensity was determined
using the Expression Console and Transcriptome Analysis Console software package
version 2.0 (Affymetrix). Transcript changes were identified as those displaying a ≥2.5fold change in signal between the experimental and control conditions. The statistical
significance of changes in transcripts between conditions was unable to be evaluated
because the limited availability of chips only allowed for one pooled run using S.
maltophilia K279a mucin-induced RNA. To support the validity of certain changed
mucin transcripts, transcript lists were compared between the S. maltophilia K279a
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mucin microarray and a previously conducted S. maltophilia K279a synthetic sputum
(SCFM2) microarray, which was run in biological triplicate [41]. SCFM2 contains high
levels of mucin and this was reflected in the high amount of shared changed transcripts
between the mucin and SCFM2 microarrays.

4.3.11 Transcript functional annotation
Functional annotation of transcripts was completed manually. Sequences were run
through NCBIs BLAST algorithm and functional annotation was assigned after
consideration of BLAST results, conserved domains in the putative proteins, homologous
genes/proteins with known functions in other bacteria, and genomic synteny. Transcripts
with no predicted function or similarity to genes of known function were assigned to the
Hypothetical Protein category.

4.3.12 Evaluation of mucin-associated gene conservation
Conservation of mucin-associated genes across a cohort of 44 sequenced S.
maltophilia strains was evaluated by running the nucleotide sequences of S. maltophilia
K279a’s mucin-associated genes through the BLAST algorithm (BLASTn megablast)
against the non-redundant nucleotide collection of the Stenotrophomonas maltophilia
group (taxid:40324). A strain was considered to possess an ortholog of a specific gene if
the coverage and identity over the genomic region was greater than 85%. The
conservation of genes across the 44 S. maltophilia strains was recorded as the percentage
of strains possessing convincing homologs. To assess the conservation of mucinassociated genes between CF isolates AU30115 and AU32848 and environmental/plant
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associated isolates BurA1 and RR-10, BLASTn megablast was run using K279a gene
sequences against the genomes of the respective isolate. The whole-genome sequence of
CF isolates AU30115 and AU32848 were accessed via BioProjectID: 483996. The
whole-genome sequence of environmental isolate BurA1 was accessed via BioProjectID:
307423, and the genome of rice root isolate RR-10 via the non-redundant nucleotide
collection of Stenotrophomonas maltophilia RR-10 taxid: 1095923. The percent of
coverage and identity of each mucin-associated gene within the genome of each strain
was recorded and genes with lower than 85% coverage or identity were highlighted in
darker shades of the respective column color to indicate which K279a genes were not
well conserved in a specific strain.
4.4 Results
4.4.1 S. maltophilia K279a and S. maltophilia CF isolates quickly adapt to utilization
of mucin as a carbon and nitrogen source while strain PAO1 of co-infecting CF
pathogen P. aeruginosa is unable to utilize mucin
The highly glycosylated proteinaceous structure of mucin is a potentially rich
source of carbon and nitrogen, but accessing these nutrients can be difficult without the
proper metabolic machinery. To assess whether S. maltophilia lab strain and CF clinical
isolates were able to efficiently metabolize mucin, S. maltophilia strain K279a, a
bacteremia isolate and model lab strain of S. maltophilia K279a and two CF clinical
isolates of S. maltophilia were grown with mucin supplied as the sole source of carbon,
nitrogen, and methionine. The opportunistic pathogen Pseudomonas aeruginosa, strain
PAO1, was also included in the mucin growth assays as a representative of the more
virulent pathogens that commonly participate in co-infections with S. maltophilia within
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the lung. We observed that S. maltophilia K279a is able to utilize mucin as a source of
carbon and nitrogen to a significantly higher degree, approximately 6-fold higher,
compared to co-infecting CF-associated microbe Pseudomonas aeruginosa (***pvalue=0.0009) (Figure 4.1A). Both clinical CF isolates of S. maltophilia, AU30115 and
AU32848 are also able to utilize mucin to a higher degree as compared to P. aeruginosa
strain PAO1, approximately 6-fold and 5-fold respectively (AU30115: ***pvalue=0.0007, AU32848: **p-value=0.0039) (Figure 4.1A). Metabolism of mucin by S.
maltophilia strains may provide metabolic assistance to the poor mucin-metabolizer P.
aeruginosa within the infection niche, allowing for the increased growth of the more
virulent opportunistic pathogen. All experiments were conducted in technical duplicate
and biological triplicate and statistical significance was determined via One-Way
ANOVA with Tukey’s multiple comparisons test. Error bars represent the standard
deviation from the mean.
To gain a more in-depth picture into the kinetics of the switch to mucin
metabolism in S. maltophilia, seeing as the microbe is often introduced into the host lung
from environmental reservoirs where mucin-metabolic machinery may not be as
important, we observed the effects of pre-growth conditions on S. maltophilia isolates
ability to efficiently metabolize mucin. S. maltophilia isolates are able to switch to
efficient utilization of mucin as a sole source of carbon and nitrogen after ~18 h of
growth on mucin. After overnight growth of S. maltophilia isolates on 1% mucin M63
media, all isolates subsequently grown on 1% mucin media surpassed their growth on
M63 minimal media after 18 hours of incubation (Figure 4.1B). Clinical CF isolate
AU30115 grew to a significantly higher density on mucin, as compared to its growth on
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M63 minimal media, when pre-grown on mucin media (**p-value=0.0053). When
isolates were pre-grown on M63 media without mucin, subsequent growth on 1% mucin
didn’t surpass their growth on minimal media (Figure 4.1B). This suggests that S.
maltophilia isolates previously occupying a mucin-rich niche can more rapidly dominant
a subsequent niche where mucin is a significant nutrient source. All experiments were
conducted in technical duplicate and biological triplicate. Statistical significance was
determined via two-way ANOVA with Sidak’s multiple comparisons test. Error bars
represent the standard deviation from the mean.
4.4.2 Biofilm formation in S. maltophilia K279a is induced in the presence of mucin
while CF isolates display lower biofilm formation regardless of presence of mucin
Biofilm formation is a successful strategy to promote bacterial-survival within a
host environment and the formation of a protective biofilm structure is an integral part of
many opportunistic pathogens’ response to the host environment. After incubation with
1% mucin, S. maltophilia strain K279a formed a more robust surface-attached biofilm as
compared to the same strain in media lacking mucin (*p-value=0.013) (Figure 4.2A4.2B). Surface-attached biofilm formation in CF isolates AU30115 and AU32848 was
unaffected by the presence of mucin (Figure 4.2A). Significantly lower surface-attached
biofilm formation was observed in both clinical CF isolates in both the 1% mucin M63
media condition and the M63 minimal media condition as compared to K279a in the
corresponding conditions (Figure 4.2C). The lack of surface-attached biofilm formation
in the S. maltophilia clinical isolates must be considered with the caveat that we did not
evaluate other potential biofilm-formation behaviors. It is known that S. maltophilia
K279a and clinical isolates dispay an increased clumping phenotype ] in the presence of
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synthetic sputum media, which contains mucin. The clinical isolates may display
increased clumping in the presence of mucin, or increased mucin-attached biofilm
formation, which our assay was unable to detect. We also only evaluated surface-attached
biofilm formation at one time point and in one oxygen condition, so we cannot rule out
different time or oxygen concentration-dependent factors on biofilm formation kinetics.
However, the increase in surface-attached biofilm formation in S. maltophilia K279a
suggests that biofilm formation is triggered in response to mucin in an S. maltophilia
strain that is not well adapted to the lung environment. This also suggests that surfaceattached biofilm formation may be an important initial response to the lung in order to
establish infection, but becomes dispensable as S. maltophilia adapts to the lung
environment. All experiments were conducted in technical duplicate and biological
triplicate. Statistical significance was determined by two-way ANOVA with Tukey’s test
for multiple comparisons. Error bars represent the standard deviation from the mean.
4.4.3 Genes involved in cell growth and morphology, sugar modification, ion
transport and gene regulation are nessecary for S. maltophilia growth on mucin
To identify genes potentially involved in S. maltophilia’s metabolism of mucin, a
mucin-growth screen was conducted using a transposon mutant library of S. maltophilia
K279a. Transposon mutants with insertions in three genes involved in the production of
structural cell membrane component, lipopolysaccharide (LPS), showed aberrant growth,
including lower cell density and/or increased clumping, in 1% mucin liquid media, which
provides mucin as the sole source of carbon. These LPS-associated transposon-disrupted
genes included smlt0702, encoding a putative glycosyltransferase family 2 protein,
rmlD/rfbD, encoding a putative dTDP-4-dehydrorhamnose reductase, and rmlB/rfbB,
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encoding a putative dTDP-glucose 4,6-dehydratase (Figure 4.3A). All three of these
genes encode putative proteins that are involved in sugar modification, specifically
modifications that are involved in the pathway essential for LPS production (Figure
4.3B). Further study is needed to determine whether the sugar-modification functions of
these putative proteins can also be applicable towards the utilization of abnormal sugar
sources such as the O-glycans associated with mucin.
It is unclear whether these sugar-associated genes are specifically nessecary for
growth on mucin sugars or whether they are important for general growth due to their
function in LPS formation. In order to uncover additional mucin-specific genes that may
have gone undetected in the mucin carbon-source screen, we conducted a similar growth
screen with more stringent growth conditions. This more stringent screen involved solid
media that provided mucin as the sole source of carbon, nitrogen, and methionine. This
screen revealed four more genes necessary for maximal S. maltophilia growth on mucin.
Disruption of smlt4208/bfmK, which encodes a HAMP domain-containing histidine
kinase response regulator, caused significantly attenuated growth of S. maltophilia K279a
on mucin (***p-value=0.0002). Disruption of smlt4171, encoding a putative CDPglycerol glycerophosphotransferase family protein, resulted in a ~63% reduction in
growth on mucin (**p-value=0.0019). Disruption of putative rod-shape determining
protein Smlt4058 resulted in a significant lack of growth on mucin (***p-value=0.0003),
and disruption of smlt0517, which encodes a putative metal efflux transporter resulted in
a 92.5% decrease in growth on mucin (****p-value<0.0001) (Figure 4.3C). The
predicted functions of the genes necessary for growth on mucin show that regulatory,
structural, transport, and sugar modification processes are all involved in S. maltophilia
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K279a’s utilization of mucin (Figure 4.3D). All growth assays were conducted in
technical duplicate and biological triplicate. One-way ANOVA was used to determine
statistical significance with Dunnett’s test for multiple comparisons. Error bars represent
the standard deviation from the mean.
4.4.4 The top three characterized transcript classes involved in S. maltophilia’s
response to mucin include primary metabolism genes, phage related/DNA transfer
genes, and protease/peptidase genes
Our transposon mutant screens identified multiple genes necessary for S.
maltophilia growth on mucin, but did not identify any of the protease or peptidase genes
predicted to be needed for degradation of the peptide backbone of mucin. We can assume
that S. maltophilia K279 is degrading the peptide backbone of mucin because K279a is
auxotrophic for methionine, an amino acid that was only present in the media as part of
mucin’s peptide backbone. Because we did not identify any putative protease or
peptidase enzymes in our growth screens, it is likely that peptidase and/or protease
actions are functionally redundant and render a transposon mutant screen, which
presumably only disrupts one gene at a time, an insufficient method for identification.
To gain a broader picture of the genes involved in mucin-metabolism in S.
maltophilia, and to potentially identify the proteases and/or peptidases involved in mucin
degradation, we exposed S. maltophilia to 1% mucin and a control media containing no
mucin and identified differentially expressed genes via microarray. There are 45 genes
that are expressed greater than 2.5-fold higher in the presence of mucin over the control
condition in S. maltophilia K279a (Table 4.3). Of these genes, the majority encode for
hypothetical proteins with unknown function (Figure 4.4A). Among the transcripts with
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predicted functions, the first most abundant is comprised of genes that are phage related
or involved in DNA transfer. The second most abundant functional transcript class
includes genes involved in primary metabolism, and the third most abundant is comprised
of predicted protease and peptidase genes (Figure 4.4A).
Although it is the third most abundant functional transcript class, 4 of the 5 genes
belonging to the protease/peptidase transcript class are among the most highly induced
genes in response to mucin. Putative auto-transporter smlt1350 is the most highly induced
predicted protease, followed by smlt1001, then smlt4145, then smlt4395, and lastly
smlt3895 (Figure 4.4B). Only two genes, smlt4397 and smlt4396, surpass the putative
protease/peptidases in expression levels in the presence of mucin. The two most highly
induced transcripts in response to mucin include smlt4397, which transcribes a putative
thioredoxin-fold containing SCO1/SenC family protein most likely involved in
cytochrome c oxidase assembly and smlt4396, which transcribes an exported protein of
unknown function and is located immediately downstream of protease smlt4395.
4.4.5 The majority of S. maltophilia K279a’s mucin-associated genes are conserved
across metabolizing CF isolates AU30115 and AU32848
All three of our tested S. maltophila isolates are able to sufficiently metabolize
mucin. After gaining a more detailed picture of the genes necessary for and involved in
mucin metabolism in S. maltophilia K279a, we investigated whether these genes were
conserved among sequenced S. maltophilia isolates. The degree of conservation of all
mucin-associated genes between different strains of S. maltophilia was assessed using
NCBI’s BLAST algorithm against a collection of 44 sequenced S. maltophilia strains. A
gene was considered to be conserved in a given strain if the strain possessed a homolog
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with coverage and identity of greater than 85%. Of all 12 mucin-associated genes
analyzed, the majority were conserved in 98-100% of the S. maltophilia strains analyzed.
Four genes were only present in 45-86% of S. maltophilia strains, including putative
auto-transporter and potential protease encoding gene smlt1001, putative extracellular
serine protease encoding gene smlt4145, histidine kinase response regulator encoding
gene smlt4028, and putative rod-shape determining and scaffolding protein encoding
gene smlt4058 (Figure 4.5A).
We were specifically interested in the degree of conservation of the mucinassociated genes in the CF clinical isolates of S. maltophilia. The clinical CF isolates
AU30115 and AU32848 showed strong conservation of mucin-associated genes with two
exceptions. Strain AU30115 lacks a homolog of the Co(II)/Zn(II) efflux transporter
encoded by smlt0517 (dmeF). Strain AU32848 possesses a putative extracellular serine
protease with homology to the putative extracellular serine protease encoded by
smlt4145, but it has low coverage and identity, lower than the ≥85% criteria (Figure
4.5B). As both CF isolates are equally as effective at utilizing mucin, loss of these genes
may not be sufficient to disrupt growth on mucin, or there may be redundant mechanisms
in the accessory genomes of these strains. We were also interested in whether more
human-associated strains of S. maltophilia held higher conservation of mucin-associated
genes as compared to environmental isolates. To evaluate this, we compared the
conservation of mucin-associated genes between our clinical isolates and several
environmental and plant-associated isolates. Our comparisons showed that the two
environmental isolates, soil-associated strain BurA1 and rice root-associated strain RR-
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10, displayed lower conservation of mucin-associated genes, with only 66.67% of genes
conserved in BurA1 and even less, 33.33% conserved in RR-10 (Figure 4.5B).
4.5 Discussion
4.5.1 Mucin utilization in S. maltophilia K279a as a carbon and nitrogen source is a
complex and redundant process
The heavily glycosylated glycoprotein structure of mucin is extremely nutrient
rich, providing a source of carbon, nitrogen, and methionine to the methionine
auxotrophic Gram-negative opportunistic pathogen S. maltophilia K279a. The ability to
utilize mucin is not shared among all Gram-negatives and has the potential to provide S.
maltophilia with a growth advantage in infective niches where mucin is present in high
quantities, like within the CF lung. Aberrant ion transport and overproduction of mucus
are part of the pathology of CF, leading to a high concentration of mucin within the
airways. Although mucin is an abundant potential source of nutrients in CF sputum, not
all bacteria are able to metabolize it due to its complex structure, consisting of O-linked
glycans and disulfide cross-linked sugars, which shield the proteinaceous core from
degradation.
Throughout this study we identified multiple genes that are necessary and/or
involved in S. maltophilia’s response to and utilization of mucin. Our results suggest that
metabolism of mucin by S. maltophilia involves redundant processes. For example, none
of the genes that were highly induced in the presence of mucin, including proteases and
peptidases, were hit in our phenotypic screens. This may indicate that these
proteases/peptidases are redundant in function and can compensate for the loss of one or
more of the other proteases. The two most highly induced putative proteases, smlt1350
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and smlt1001, have high sequence similarity and may be compensatory for each other. If
S. maltophilia K279a possess multiple proteases that can achieve the same mucin
degradative function, disruption of a singular protease/peptidase in the phenotypic screen
would not have significantly impacted the ability of S. maltophilia to grow on mucin.
Another indication of the complexity of S. maltophilia’s response to mucin is the
necessity of the histidine kinase response regulator protein smlt4208/bfmK in utilization
of mucin. smlt4208 has been partially characterized by Zheng and colleagues, who
confirmed its role in biofilm formation in S. maltophilia, renaming it bfmK [42]. bfmK is
part of a two-component signaling system with bfmA (smlt4209), a signaling system that
is predicted to be involved in multiple different cellular processes that have yet to be
characterized.
4.5.2 S. maltophilia K279a’s response to mucin includes expression of processes and
putative proteins predicted to be involved in virulence
The majority of genes involved in the degradation of mucin are strongly
conserved between infection-causing clinical isolates of S. maltophilia, such as clinical
CF isolates AU30115 and AU32848 which possess orthologs for 11 of the 12 identified
S. maltophilia K279a mucin-associated genes. In comparison, two examples of S.
maltophilia strains with low conservation of mucin-associated genes are the soil-isolate
BurA1 and rice-root isolate RR-10. While there are other environmental isolates such as
R551-3 and JV3 that share the majority of mucin-associated genes, BurA1 and RR-10 are
good examples of how few mucin-associated genes are necessary for S. maltophilia
survival in the environmental niche. BurA possesses homologs for 8 of the 12 mucinassociated genes and the rice-root isolate RR-10 possesses only four. The decrease in the
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strength of conservation of mucin-associated genes as S. maltophilia strains are isolated
further from the human niche suggests that genes involved in the degradation of mucin
are important during interactions with the host and become less necessary as S.
maltophilia adapts to different environments such as the soil or plant roots. Many of the
genes induced in the presence of mucin are also induced in the presence of synthetic CF
sputum media (SCFM2), indicating that S. maltophilia’s response to mucin is a large
component of S. maltophilia’s overall response to the CF lung environment [41]. SCFM2
has also been observed to induce other virulence-associated phenotypes such as increased
resistance to oxidative stress in S. maltophilia K279a, AU30115, and AU32848, and
increased biofilm formation in K279a. Because of the parallels in gene expression and
induced biofilm phenotype between the mucin and SCFM2 response, it is possible that S.
maltophilia’s response to mucin may induce similar virulence-associated pathways such
as oxidative stress resistance.
There are several mucin-associated genes with the potential to be involved in S.
maltophilia K279a virulence in response to host-derived mucin. The putative
autotransporters smlt1001 and smlt1350 are highly transcribed in response to mucin and
are predicted to be displayed on the outer membrane due to the autotransporter β-barrel
conserved domain in their C-terminal. Smlt1001 possesses a predicted ClpP/crotonase
domain in its N-terminal, supporting the hypothesis that it is an extracellular secreted
protease involved in degradation of mucin peptides (Figure 4.6A) [43]. Putative
autotransporter Smlt1350 does not possess any conserved domains in the N-terminal
region but 3D modeling of the N-terminal alone produces a structure most similar to a
ClpP protease subunit [44]. Despite the similar predicted fold to protease ClpP, Smlt1350
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only retains two of the three predicted catalytic triad members present in ClpP’s
sequence, raising the question of whether Smlt1350 is an active extracellular protease, or
whether it is a non-catalytic paralog of Smlt1001 with a different evolved function
(Figure 4.6B). Many autotransporter proteins act in bacterial virulence via catalytic
protease, esterase, or lipase activity, or through non-enzymatic mechanisms including
biofilm formation and adhesion to host cells (the many roles of autotransporter passenger
domains are outlined by Henderson and Nataro[45]). The predicted extracellular secretion
of Smlt1001 and Smlt1350, putative protease-like domains, and predicted protease-like
secondary structure, suggest that these autotransporters are involved in S. maltophilia
virulence, either through degradation of mucin components or adhesion, in the case of the
potentially non-catalytic Smlt1350.
Another extracellular protease with the potential to bind and degrade
glycoproteins like mucin is the putative autotransporter serine protease Smlt4145.
Sequence analysis of the putative protein Smlt4145 reveals a conserved S8/S53 serine
protease domain characteristic of endo and exopeptidases, an autotransporter β-barrel
domain, and a fibronectin-binding domain (Figure 4.6C)[46]. Fibronectin is a
glycoprotein component present in the extracellular matrix of eukaryotic cells that
pathogenic bacteria like Salmonella enterica bind during pathogenesis, using
extracellular fibronectin-binding proteins like S. enterica’s ShdA [47]. The presence of a
glycoprotein-binding domain in the extracellular protease Smlt4145 suggests that it may
be instrumental in the binding and degradation of mucin during host infection.
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4.5.3 Liberation of nutrients from a complex and abundant substrate like mucin by
S. maltophilia may impact the dynamics of polymicrobial lung infection
Overproduction of mucus causes multiple issues with host immune defense
against bacterial pathogens. Physically, mucus overproduction and aberrant ion transport
in cases of CF and COPD result in thick mucus that prevents productive mucociliary
clearance. Mucus overproduction can also lead to issues with the host complement
system by affecting the antimicrobial function of properin, or Factor P [48], [49], [50]. Apart
from these adverse affects, mucus has the potential to provide abundant nutrients to
infecting bacterial pathogens. Although mucin is a potential source of nutrients, it is not
utilized effectively by many of the opportunistic pathogens you usually find in the CF
lung, including many strains of Pseudomonas aeruginosa, which in the presence of
healthy mucus down-regulates virulence associated genes including those involved in
siderophore production, quorum sensing, and type three secretion

[51]

.

Non-mucin metabolizing pathogens still survive in the lung environment, but
experience significant boosts in growth when cross-fed the byproducts of mucus
metabolism by mucin-degraders [32]. Flynn and colleagues determined that addition of
mucin-fermenting oral anaerobes to a P. aeruginosa PA14 culture containing mucin
enabled PA14 to grow to a significantly higher density in the presence of mucin as
compared to when PA14 was grown alone on mucin [32]. Flynn et al. also found that the
major byproducts of mucin fermentation, propionate and acetate, were being metabolized
by P. aeruginosa, enabling its increased growth [32]. Other CF pathogens including
Achromobacter xylosoxidans, Burkholderia cenocepecia, Stenotrophomonas maltophilia
and Staphylococcus aureus were tested for their ability to grow on the byproducts of
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mucin fermentation, and all pathogens experienced a significant increase in growth in the
presence of mucin fermenters [32]. The increase in growth of other CF pathogens when
cross-fed by mucin-degrading bacteria is an example of how niche priming by less
pathogenic bacteria (oral microbes) can promote the growth of more pathogenic bacterial
species such as S. aureus. An increase in pathogenic species fed by mucus-fermenters
negatively impacts the host, starting a cycle of increased inflammation and epithelial
damage, which increases the nutrient pool, fueling sustained pathogen growth.
While S. maltophilia is a non-fermentative microbe, it is still able to degrade
mucin and may provide metabolic products other than, or in addition to, propionate and
acetate to co-infecting pathogens [10]. We can hypothesize that the many secreted
proteases up-regulated in the presence of mucin help to liberate amino acids for bacterial
utilization and that S. maltophilia imports the sugars derived from cleavage of O-linked
glycans into the cell for reduction via aerobic respiration as the SCO1/SenC family
cytochrome c oxidase assembly protein Smlt4397 is the highest up-regulated putative
protein in the presence of mucin [52], [53], [54], [55].
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4.6 Chapter 4 Figures
Figure 4.1 S. maltophilia more efficiently utilizes mucin as a sole source of nutrients
when given time to adjust to mucin as the primary nutrient substrate. (A) S.
maltophilia K279a and S. maltophilia CF isolates AU30115 and AU32848 grow
approximately 5.5 fold higher than the maximum growth of CF pathogen P. aeruginosa
on M63 supplemented with 1% mucin as the sole carbon and nitrogen source. All S.
maltophilia isolates grow significantly higher on 1% mucin compared to P. aeruginosa,
suggesting the presence of mucin-specific metabolic machinery in S. maltophilia isolates
(K279a ***p-value=0.0009, AU30115 ***p-value=0.0007, AU32848 **pvalue=0.0039). (B) The ability of S. maltophilia isolates to efficiently utilize 1% mucin
as a sole carbon and nitrogen source is influenced by pre-growth conditions. Overnight
growth of strains on 1% mucin media causes higher subsequent growth of S. maltophilia
isolates on fresh 1% mucin media (between 3 fold and 5 fold) after adjustment to a
uniform OD600. While all isolates showed higher subsequent growth on 1% mucin media
after overnight growth in the presence of mucin, clinical CF isolate AU30115 achieves a
significantly higher fold growth as compared to its growth on M63 minimal media (**pvalue=0.0053). Overnight growth of S. maltophilia isolates on M63 minimal media does
not induce the processes necessary for efficient mucin utilization, as M63 minimal media
pre-grown cultures do not show significantly higher growth when subsequently grown on
1% mucin media as compared to M63 minimal media.
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Figure 4.2 Stenotrophomonas maltophilia isolates displaying varying degrees of
biofilm formation under different conditions (A) Mucin induced significantly higher
biofilm formation (~2 fold increase) in S. maltophilia K279a as compared to its biofilm
formation in 1/20 LB/M63 media (*p-value=0.013). Clinical CF isolates AU30115 and
AU32848 showed no significant changes in biofilm formation in the presence of mucin.
(B) Crystal violet staining demonstrates the robust mucin-dependent biofilm formation in
S. maltophilia K279a. (C) After incubation in either 1/20 LB/M63 media or M63 1%
mucin media S. maltophilia strain K279a displays significantly higher biofilm formation
as compared to clinical CF isolates AU30115 and AU32848. Respective p-values: 1/20
LB/M63 AU30115 **p-value=0.0027, 1/20 LB/M63 AU32848 **p-value=0.0017, 1%
mucin M63 AU30115 ***p-value=0.0005, 1% mucin M63 ***p-value=0.0004.

Figure 4.3 Liquid and solid media screens of a S. maltophilia K279a transposon
mutant (TnM) library identified several genes involved in wild type S. maltophilia
growth on mucin as a sole source of carbon and nitrogen. (A) TnMs displaying
aberrant growth in liquid 1% mucin media, including increased clumping and decreased
cell density, had disruptions in genes involved in the synthesis of cell structural
component lipopolysaccharide (LPS). (B) A gene-association map predicted using the
STRING database, which takes factors such as experimental evidence, genomic
proximity, co-expression, and co-occurrence of certain genes into account, shows the
likely involvement of all liquid screen hits in the process of LPS production, including O158

antigen synthesis. (C) Four TnMs with aberrant mucin growth were identified in the solid
media screen (smlt4208: ***p-value=0.0002, smlt0517: ***p-value=0.0003, smlt4171:
**p-value=0.0019, smlt4058: ****p-value<0.0001). (D) Disruptions in genes involved in
cell growth and morphology, sugar modification, ion transport, and gene regulation
resulted in some degree of aberrant mucin growth in S. maltophilia K279a.

Figure 4.4 Microarray analysis identified transcripts of genes with more than a 2.5fold increase in expression in S. maltophilia K279a in the presence of 1% mucin. (A)
Analysis of the predicted functions of the up-regulated genes showed that the largest
transcript class consisted of genes of unknown function. Of the up-regulated genes with
predicted functions, genes involved in primary metabolism, phage/DNA transfer, and
protease/peptidase production were among the top three most abundant transcript classes.
(B) Protease and peptidase genes were among the most highly up-regulated genes, with
predicted autotransproters smlt1001 and smlt1350 displaying over 10-fold increases in
expression in mucin over the control condition.

Figure 4.5 Mucin-associated genes are highly conserved among S. maltophilia strains
with a few exceptions. (A) Conservation of mucin-associated genes among 44 sequenced
strains of S. maltophilia shows that 66.67% are highly conserved (defined as 85% or
higher coverage and identity). Genes with lower conservation across the 44 strains are
highlighted in purple and include the sensor-histidine kinase response regulator smlt4208
(bfmK), predicted rod-shape determining protein smlt4058 (mreC), putative
autotransporter smlt1001, and putative autotransporter-containing peptidase smlt4145.
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(B) Among the strains studied, including bacteremia isolate K279a and CF isolates
AU30115 and AU32848, the majority of mucin-associated genes are conserved, with
gene coverage and identity between 98-100%. Clinical isolate AU30115 lacks a homolog
for smlt0517, the predicted CDF family Co(II)/Zn(II) efflux transporter. Clinical isolate
AU32848 possesses a potential homolog for predicted peptidase smlt4145 but with low
coverage and identity. The conservation of mucin-associated genes is weaker in two
environmental isolates, BurA1 and RR-10. Genes with coverage lower than 85% are
highlighted in a darker shade of the column color. 66.67% of mucin-associated genes
were highly conserved in BurA1 while only 33.33% were conserved in the rice-root
isolate RR-10. A 16S rRNA control gene that is highly conserved among S. maltophilia
strains and is not associated with the response to mucin, rsmD, was also analyzed for
conservation across strains and was highly conserved in all four.

Figure 4.6 Several highly expressed autotransporters have characteristics that may
contribute to S. maltophilia virulence (A) Smlt1001 possesses a ClpP/crotonase-like
domain in the N-terminus predicted to be involved in protein degradation. (B) Although
lacking a conserved proteolytic domain, the predicted secondary structure of Smlt1350
most closely resembles a ClpP protease subunit, but the absence of the third member of
ClpP’s catalytic triad (boxed in red) may indicate a lack of catalytic activity. (C)
Smlt4145 has the most probable protease domain, belonging to the S8/S53 superfamily of
serine proteases, with several catalytic residues present. The fibronectin- binding domain
between the protease and autotransporter domains suggests that Smlt4145 binds
glycoproteins for subsequent cleavage via the serine protease domain.
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4.7 Chapter 4 Tables
Table 4.1 Strains used in this study
Table 4.2 Primers used in the study
Table 4.3 Transcript changes in S. maltophilia K279a in response to mucin
(cut-off fold change ≥ 2.5)
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Figure 4.5 Mucin-associated genes are highly conserved among S. maltophilia strains
with a few exceptions.
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Table 4.1 Strains used in this study.

Strains
Strain
K279a
AU30115
AU32848
K279a
K279a
K279a
K279a
K279a
K279a
K279a

Description
bacteremia isolate/lab strain
CF clinical isolate
CF clinical isolate
bacteremia isolate/lab strain
bacteremia isolate/lab strain
bacteremia isolate/lab strain
bacteremia isolate/lab strain
bacteremia isolate/lab strain
bacteremia isolate/lab strain
bacteremia isolate/lab strain

Genotype
Wild Type
Wild Type
Wild Type
TnM_6:C12 (smlt0702)
TnM_18:G6 (rmlD/rfbD)
TnM_25:D6 (rmlB/rfbB)
TnM_1:5A (mreC)
TnM_2:3B (smlt0517)
TnM_39:2E (smlt4171)
TnM_47:11G (bfmK)

Table 4.2 Primers used in this study.
Primer Number
895
898
900
901

Identification of Tn Insertion Sites
Primer Name
Primer Sequence
Rnd1 TnM20 (for pBT20) TATAATGTGTGGAATTGTGAGCGG
Rnd1 PA Arb primer 3
GGCCACGCGTCGACTAGTACNNNNNNNNNNGATAT
Rnd2 TnM20 (for pBT20) ACAGGAAACAGGACTCTAGAGG
Rnd2 Arb primer
GGCCACGCGTCGACTAGTAC
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Table 4.3 Transcript changes in S. maltophilia K279a in response to mucin
(cut-off fold change ≥ 2.5)
Target Description
putative SCO1/SenC family protein
conserved hypothetical exported protein
putative autotransporter
putative outer membrane autotransporter
putative extracellular serine protease precursor
putative serine protease
putative formate dehydrogenase, iron-sulfur subunit
putative transmembrane protein
putative propionate--CoA ligase
putative formate dehydrogenase-o, major subunit
putative formate dehydrogenase, cytochrome b556 (FDN) subunit
putative head-tail preconnector protein
putative methyl-accepting chemotaxis protein
putative proline dipeptidase
putative Major Facilitator Superfamily transmembrane transport protein
putative ArsR family regulatory protein
conserved hypothetical protein
putative phage-related protein
conserved hypothetical protein
putative phage-related protein
putative universal stress family protein
putative TonB dependent receptor protein
putative copper resistance protein
conserved hypothetical protein
putative sulphite reductase flavodoxin containing alpha subunit
putative oxidoreductase
conserved hypothetical protein
putative D-lactate dehydrogenase
conserved hypothetical protein
conserved hypothetical protein
putative 4-hydroxyphenylpyruvate dioxygenase
putative xylose isomerase/endonuclease family protein
conserved hypothetical protein
putative nucleoside H+ symport transporter permease protein
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical exported protein
putative oxidoreductase
putative lipocalin-like protein
putative two-component regulatory system family, response regulator protein
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Chromosomal Location
Smlt4397
Smlt4396
Smlt1001
Smlt1350
Smlt4145
Smlt4395
Smlt3845
Smlt3996
Smlt0947
Smlt3843
Smlt3846
Smlt1868
Smlt2762
Smlt3861
Smlt4621
Smlt2148
Smlt1867
Smlt1892
Smlt1891
Smlt1866
Smlt2137
Smlt1175
Smlt2442
Smlt1871
Smlt2763
Smlt1189
Smlt1863
Smlt1351
Smlt1893
Smlt1864
Smlt4330
Smlt1196
Smlt0111
Smlt1195
Smlt1890
Smlt3897
Smlt1894
Smlt1865
Smlt1191
Smlt1194
Smlt4353
Smlt2645

Fold Change (linear)
(mucin vs. pyruvate)
25.98
23.68
16.42
13.76
11.89
7.86
6.12
5.77
5.19
4.8
4.75
4.23
3.94
3.92
3.68
3.66
3.61
3.6
3.52
3.42
3.36
3.07
3.03
3.02
3.02
2.99
2.92
2.9
2.89
2.88
2.88
2.86
2.85
2.81
2.81
2.8
2.67
2.64
2.63
2.62
2.53
2.51
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CHAPTER 5: Dissertation Summary
Opportunistic pathogens such as Pseudomonas aeruginosa and Stenotrophomonas
maltophilia pose a large threat to human health and the growing incidence of multi-drug
resistant infections caused by these nosocomial pathogens is a public health concern[1], [2],
[3], [4]

. Even related bacteria that are generally considered nonpathogenic, such as

Pseudomonas putida, are able to exploit host-derived nutrients and, on rare occasions,
cause infection in immunocompromised individuals[5]. The ability of these pathogens to
transition from the environment to a human host is in large part predicted to be due to
transcription of specific regulators that detect host-derived compounds and initiate the
transcription of genes involved in the exploitation of these compounds, promoting
pathogen growth and virulence[6].
The rapid increase in multidrug resistance among Gram-negative bacteria and the
emergence of new opportunistic pathogens highlight the necessity for the development of
new strategies for treatment of opportunistic infections. The goal of the research outlined
in this dissertation is to gain a better understanding of how Gram-negative bacteria of
varying degrees of virulence detect, respond to, and exploit host-derived nutrients, and
how these responses impact the host-pathogen interaction.
5.1 Chapter 2 Summary
In Chapter 2 of this dissertation, a creatine-responsive system regulating creatine
metabolism was identified in the environmental Gram-negative bacteria P. putida.
Creatine is a physiologically important and bioactive polyamine compound, playing vital
roles in the cycling and transport of high-energy molecules throughout the blood and
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tissues of the body[7]. Given the phylogenetic distribution of homologs of P. putida’s
creatine-responsive genes primary in non-pathogenic bacteria, it appears that this creatine
metabolic system evolved as a mechanism for exploitation of a nitrogen-rich compound
encountered in soils during mammalian tissue degradation and waste excretion. The
appearance of orthologs of P. putida’s creatine-responsive transcriptional regulator
PP_3665 and the creatinase PP_3667 in several pathogenic species including
Acinetobacter and Burkholderia species, calls into question whether metabolism of
creatine aids infection by allowing for exploitation of a nutrient-rich compound that is
abundant in mammalian tissues and serum.
In addition to furthering our understanding of the potential role of creatine in
bacterial pathogenesis, characterization of the creatine-responsive transcriptional
regulator can also aid in our understanding of regulators belonging to the same family.
PP_3665 is a class-I glutamine amidotransferase domain-containing AraC-family
transcriptional regulator (GATR), a type of transcriptional regulator that has been
associated with the detection of multiple N-methylated amine and polyamine compounds
that are important to bacterial metabolism and stress resistance. Identifying the cognate
ligand for GATR PP_3665 establishes the function of a previously uncharacterized
GATR, an important contribution to the field of bacterial regulation and polyamine
metabolism.
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5.2 Remaining Questions regarding the role of creatine metabolism
5.2.1 Does creatine metabolism contribute to bacterial virulence and does horizontal
gene transfer of creatine metabolic genes to pathogenic bacteria increase survival
within certain infection niches?
As discussed in Chapter 2, P. putida rarely causes infections in humans. The
likely use for the creatine responsive and metabolic genes transcribed by P. putida is for
degradation of animal excretions or decaying tissues present in the soil, P. putida’s
primary niche. The appearance of creatinase PP_3667 orthologs on plasmids carried by
more pathogenic bacteria such as Acinetobacter species (Figure 2.6) raises the question
as to whether P. putida’s creatine-degrading genes have the potential to support tissue
damage in the context of a tissue-invasive bacterial infection. Certain isolates of
Pseudomonas aeruginosa associated with the presentation of Shanghai fever, which is an
enteric illness with symptoms including necrotizing enteritis, sepsis, and echythema
gangrenosum, possess orthologs of the creatine-responsive creatinase in P. putida[8]. It is
possible that the presence of creatine-metabolism genes promotes P. aeruginosa growth
in the context of a necrotizing tissue-damaging infection like Shanghai fever.
The ability of pathogens possessing creatinase PP_3667 and transcriptional
regulator PP_3665 homologs to grow on creatine, including P. aeruginosa Shanghai
fever and Acinetobacter isolates, could be tested via creatine growth assays like those
conducted in Chapter 2. The role of the creatinase-responsive system in growth on
creatine in these isolates could be evaluated through targeted gene deletions and
assessment of the mutants’ abilities to grow on creatine. Measuring levels of tissue
damage caused by and/or levels of serum survival of strains possessing or lacking the
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creatine metabolic genes would allow us to determine if creatine metabolism contributes
to virulence.
If we observed any increase in virulence of strains possessing homologs to P.
putida’s creatine metabolism genes, it would also be interesting to evaluate whether P.
putida’s creatine-responsive and metabolic genes can directly transfer the ability to
degrade creatine to other Gram-negative bacteria. The cross-species activity of P.
putida’s creatine metabolic system could be evaluated by expressing the creatine
metabolic genes of P. putida along with the creatine-responsive transcriptional regulator
PP_3665 on a plasmid and/or via chromosomal integration in a species of interest, such
as Pseudomonas aeruginosa, that does not efficiently metabolize creatine. Seeing as
transposons containing creatinase orthologs are retained on plasmids in pathogenic
Acinetobacter, it is reasonable to hypothesize that creatine metabolism genes are
susceptible to gene transfer and that they may be useful during infection (Figure 2.6).
5.3 Chapter 3 Summary
In Chapter 3 of this dissertation, a sphingosine-responsive metabolic operon of the
Gram-negative opportunistic pathogen P. aeruginosa was characterized. This metabolic
operon, containing a putative mono-heme cytochrome c SphB, putative oxidoreductase
enzyme SphC, and putative aldolase enzyme SphD, was evaluated for its ability to
modify sphingosine and its biological relevance in the context of P. aeruginosa growth in
the presence of sphingosine. Sphingosine is an amphipathic host-derived lipid that is
primary generated by metabolism of the host membrane components sphingomyelin and
ceramide. Sphingosine is an effective antimicrobial against many Gram-positive and
Gram-negative bacteria and acts as a first line of innate-immune defense on the skin and
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at mucosal barriers throughout the body [9], [10]. Gram-positive bacteria generally succumb
to lower concentrations of sphingosine, while certain Gram negatives like P. aeruginosa
can withstand extremely high sphingosine concentrations [11].
Chapter 3 of this dissertation validated the role of sphBCD in aiding P.
aeruingosa growth in the presence of high concentrations of sphingosine. The necessity
of sphB and sphC for metabolism of sphingosine by P. aeruginosa was also observed.
The sphBCD operon was transcribed in response to multiple biologically-relevant
sphingosine analogs, and was necessary for the maximal growth of P. aeruginosa in the
presence of several antimicrobial sphingosine analogs. This research begins the
characterization of a bacterial system used to neutralize the negative effects of a hostderived antimicrobial on bacterial growth. It also validates the existence and activity of
genes involved in metabolism of a host-derived compound that in its bioactive form,
sphingosine-1-phosphate (S1P), plays a critical role in immune cell signaling (S-1-P
immune signaling review[12]). As a whole, this research adds to the fields of hostpathogen interactions and bacterial sphingolipid metabolism and providing a foundation
for future studies into how P. aeruingosa sphingosine metabolism effects the progression
of opportunistic infections.
5.4 Research In Progress: P. aeruginosa sphingosine metabolism
5.4.1 Identification of sphingosine metabolic products produced by Pseudomonas
aeruginosa
Chapter 3 of this dissertation provided evidence of the role of metabolic operon
sphBCD in sphingosine modification by P. aeruginosa. The hypothesized metabolic
pathway beginning with reduction by putative oxidoreductase SphC, followed by
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cleavage by putative aldoase SphD, was also validated in Chapter 3, as loss of SphC
alone is enough to prevent modification of sphingosine into a form that is no longer
detectable by SphR (Figure 3.5A). Although we have experimental evidence suggesting
that sphBCD acts on sphingosine, we have yet to confirm the identities of the metabolic
products of sphingosine metabolism. In order to achieve this goal, constructs expressing
tagged versions of enzymes SphC and SphD have been built. A vsvG-tagged version of
SphC has been tested for its ability to complement wild type P. aeruginosa growth in the
presence of sphingosine and its ability to modify sphingosine when expressed in a PAO1
∆sphC background (Figure 5.1A, 5.1B). Currently no phenotypic defect has been
observed in PAO1 ∆sphD mutants potentially due to redundant aldolase enzymes in P.
aeruginosa, so the activity of a tagged-SphD enzyme will be tested in an in-vitro
enzymatic assay, which is under development. The necessity of sphB for maximal sphC
activity is also noted in Chapter 3, therefore all three sphBCD products will be expressed
and purified for the sphingosine metabolism assays. The products of SphBCD
metabolism of sphingosine will be determined via mass spectrometry.
5.5 Remaining questions regarding the biological role of sphBCD
5.5.1 At what stage of P. aeruginosa lung infection is sphBCD most important?
Lacking functional sphR, which is the transcriptional regulator necessary for
transcription of the sphBCD operon, significantly decreases the survival of P. aeruginosa
within the murine lung, though curiously, lacking sphC does not significantly impact P.
aeruginosa survival within the murine lung [13]. Despite the lack of an in vivo survival
defect when genes in the sphBCD operon are deleted, all operon members are highly
induced in response to lung surfactant, suggesting that sphBCD plays a role in P..
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aeruginosa’s interaction with the lung [13]. The two potential hypotheses given this
information is that P. aeruginosa uses sphingosine as a nutrient source or that sphBCD is
needed to detoxify antimicrobial sphingosine from the extracellular environment. Given
that sphingosine isn’t efficiently used by P. aeruginosa as a source of nutrients, the more
likely hypothesis is that of detoxification. If the function of sphBCD is detoxification, a
survival defect would be expected in the ∆sphC strain, but curiously there is none
observed using a short-term (24 h) murine lung infection model. This discrepancy, taken
with the in vitro observation that lack of sphC causes a significant P. aeruginosa growth
defect in the presence of high levels of sphingosine, raises the question of when sphBCD
is most important during the course of infection. P. aeruginosa is endogenously very
resistant to sphingosine, therefore only high levels of sphingosine will result in a decrease
in P. aeruginosa growth due to sphingosine’s antimicrobial effects. It is possible that
sphBCD becomes important in vivo only after there has been sufficient cerN-dependent
sphingosine generation. It is also possible that the necessity of sphBCD would only be
seen during infection of the lungs of CFTR deficient mice, which accumulate high levels
of ceramide in their lungs prior to infection [14], [15]. An increase in ceramide and other
sphingolipid species due to alterations in de novo sphingolipid synthesis and recycling
pathways has also been observed in human epithelial cells from individuals with low
functional CFTR expression or the ∆F508CFTR mutation [16]. The increased levels of
ceramide in CFTR deficient lungs would cause higher localized concentrations of
sphingosine after cerN-mediated ceramide hydrolysis, making sphBCD necessary for
detoxification. The impact of sphBCD operon members on P. aeruingosa survival during
CF lung infection could be evaluated in vitro by measuring survival of P. aeruginosa
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wild type and sphBCD operon mutants in the presence of synthetic sputum media
(SCFM), which has a high ceramide concentration, and in vivo using an infection model
of gut-corrected CFTR-deficient mice [15], [17].
There is also evidence that sphingosine-responsive SphR-dependent genes
become less essential as an infection transitions into a chronic one. Lars Jelsbak’s group
at the Technical University of Demark discovered multiple intergenic regions in P.
aeruginosa’s genome that are prone to mutation during chronic lung infection [18]. One of
the mutated regions is the promoter region of the sphingosine-responsive cerN gene.
Three unique mutations in SphR’s binding site are present in the P. aeruginosa chronic
infection clinical isolates studied by Jelbak and colleagues (Figure 5.2A). The mutated
promoter regions of cerN were tested for their ability to be recognized by SphR and
induce sphingosine-responsive gene transcription. Two of the three mutated promoter
regions were no longer recognized by SphR, resulting in a lack of cerN transcription in
the presence of sphingosine (Figure 5.2A, 5.2B). This evolved loss of cerN production
calls into question the necessity of sphBCD during chronic infection. If cerN is not
contributing to the extracellular sphingosine pool, sphBCD may become obsolete as P.
aeruingosa infection progresses and strains with mutation in both cerN and sphBCD
promoter regions may be selected for. A mutation resulting in lack of sphBCD
transcription could help to reduce inflammation by lowering the accumulation of
hexadecenal, a putative metabolic product of sphingosine metabolism that causes
apoptosis in several mammalian cell types [19]. Alternatively the promoter region of
sphBCD may be unaffected and expressed during chronic infection to metabolize
extracellular sphingosine generated by host-derived ceramidases. It would be interesting
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to determine whether the promoter region of sphBCD is also mutated in the P.
aeruginosa chronic infection isolates that have mutated cerN promoter regions and to test
any mutated sphBCD promoters for SphR-dependent transcriptional activity. If sphBCD’s
promoter region is maintained in its sphingosine-responsive state during strain evolution
in chronic infection, it would support the hypothesis that sphBCD is still essential for
detoxification of host-generated sphingosine even in the absence of cerN sphingosine
generation, and/or suggest that sphingosine metabolism has other biological roles during
chronic infection, such as modulating the host-immune response via metabolism of
bioactive sphingolipids. The biological role of SphR-dependent genes cerN and sphBCD
in chronic lung infections could be tested via the use of murine lung infection models that
mimic chronic infection [20].
5.5.2 What is the biological function of the sphBCD operon in other infection niches?
There are several body sites abundant in sphingosine, sphingosine analogs, and
sphingosine precursors, where P. aeruginosa infects or colonizes. Two body sites of
particular interest are the skin, where conditions including psoriasis and atopic dermatitis
render individuals prone to bacterial infection, and the gallbladder, from which P.
aeruginosa is one of several bacteria isolated in cases of gallstone disease [21], [22], [23], [24],
[25]

.

5.5.3 Is sphBCD important in P. aeruginosa’s interaction with dermal sphingolipids?
The skin produces various ceramide and sphingosine species, including all of the
sphingosine analogs tested for induction of SphR-dependent genes in Chapter 3 of this
dissertation. The functions of these sphingolipids are to maintain proper skin barrier
function, primary through signaling, antibacterial activity, and prevention of trans183

epidermal water loss [22]. Certain sphingolipids, such as phytoceramide (phytoCer), which
is a type of ceramide consisting of a fatty acid and phytosphingosine, comprise ~32% of
epidermal sphingolipids and are the most essential for effective barrier function. A
reduction in phytoCer is correlated with most skin diseases, including psoriasis; a skin
disease characterized by hyper-proliferation of keratinocytes and increased inflammation
effecting 1-3% of the population, and atopic dermatitis, an inflammatory skin disorder
[22]

. Considering the high induction of sphBCD in response to phytosphingosine, the

sphingolipid component of phytoCer, it can be hypothesized that sphBCD plays a role in
P. aeruginosa survival on the skin (Figure 5.3). It is also reasonable to hypothesize that
infection involving P. aeruginosa on the skin of individuals prone to psoriasis or atopic
dermatitis may exacerbate the condition, as P. aeruginosa possesses the metabolic
machinery to fully degrade phytoCer and other barrier-maintaining sphingolipids.
There is evidence of the involvement of P. aeruginosa in psoriatic lesion
infection, as P. aeruginosa was one of 18 genera of bacteria that have been cultured from
psoriatic lesional skin [22]. P. aeruginosa has also been cultured from individuals with
eczema, specifically from the leg and trunk regions. It is interesting to note that
Staphylococcus aureus is the most commonly dominating bacteria on psoriatic skin, most
likely due to the low levels of sphingolipids, which are highly antimicrobial to S. aureus
[11], [22]

. It is likely that sphBCD aids in the survival of P. aeruginosa on the skin, as the

operon is highly induced in the presence of sphingolipids found on the skin. The role of
sphBCD in P. aeruginosa skin infection is an important area requiring study, as P.
aeruginosa has the potential to exacerbate skin conditions characterized by insufficient
sphingolipid composition such as psoriasis and atopic dermatitis, and/or to create a
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sphingolipid-deficient environment on otherwise healthy skin allowing for the
proliferation of other pathogenic sphingosine-sensitive bacteria such as S. aureus.
sphBCD’s role in modification of hair-sheath barrier lipids like phytosphingosine and
how degradation of sphingolipids at hair follicles impacts the pathogenesis of P.
aeruginosa folliculitis would also be an interesting topic to investigate.
5.5.4 Do P. aeruginosa’s sphingosine-responsive genes play a role in gallstone
disease?
The biliary tract contains high levels of lipids, predominantly cholesterol and
phosphatidylcholine (PC) [25]. Microbes have been isolated from the biliary tract,
specifically the gallbladder, in cases of symptomatic gallstone disease, where bile
components within the gallbladder crystalize forming stones [25]. The second most
common microbe isolated from the gallbladders of individuals with gallstone disease is
P. aeruginosa [24]. The presence of P. aeruginosa in the gallbladders of individuals with
gallstones is interesting, as a study by Lee et al found that mice with higher levels of
ceramide in their bile due to dietary regiments had a higher incidence of gallstone
formation [25]. It would be interesting to investigate whether P. aeruginosa’s ability to
metabolize sphingomyelin, which is found in abundance in the outer leaflet of cells, into
ceramide contributes to the formation of gallstones. The role of sphBCD in the
gallbladder and whether the further metabolism of ceramide to inflammatory sphingosine
contributes to the pathology of gallstone disease is also a topic of interest. It is reasonable
to hypothesize that sphBCD is important in P. aeruingosa’s ability to metabolize host
sphingolipids within the gallbladder due to the high levels of precursors sphingomyelin
and ceramide present in the biliary tract, but it would be interesting to evaluate the extent
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to which P. aeruginosa’s sphingolipid-responsive system contributes to gallstone disease
pathology via mouse gallstone disease models infected with PAO1 wild type and
∆sphBCD strains [26], [27].
5.6 Chapter 4 Summary
S. maltophilia is an opportunistic pathogen that infects the lungs of
immunocompromised individuals such as those with CF or COPD. Chapter 4 of this
dissertation evaluates S. maltophilia’s capacity to metabolize mucin as a sole source of
carbon, nitrogen, and methionine, and identifies genes involved in S. maltophilia’s
response to and metabolism of mucin. Mucins are the heavily glycosylated glycoproteins
that comprise mucus, which is found in abundance in CF sputum and is a nutrient rich
substrate for the bacteria that are able to metabolize it. Although mucin fermentation,
which is carried out by many oral anaerobic bacteria, has been characterized, the
processes involved in aerobic mucin metabolism by the non-fermenter S. maltophilia
have not been elucidated. The mucin-associated genes identified in Chapter 4 include
those involved in sugar modification, cell growth and morphology, transcriptional
regulation, and peptide degradation. This research adds to our knowledge of how
opportunistic pathogens utilize recalcitrant host-derived nutrients and provides the
foundation for future research regarding the potential for nutritional synergy between
opportunistic pathogens during infection.
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5.7 Research in Progress: S. maltophilia mucin metabolism
5.7.1 Potential protease redundancy and phenotypic defects due to selective pressure
Chapter 4 of this dissertation identified genes that are necessary for the metabolism
of, or involved in the response to mucin as a carbon and nitrogen source for the
opportunistic pathogen Stenotrophomonas maltophilia. The genes identified must be
validated through deletion and complementation of the genes from the genome of S.
maltophilia, and subsequent testing of deletion and complement strains for aberrant
growth on mucin. S. maltophilia K279a deletion strains have been created for the top four
highly-induced putative proteases, including single deletions of auto-transporter
smlt1001, extracellular protease smlt4145, and serine protease smlt4395, and a double
deletion of both auto-transporters smlt1001 and smlt1350. Growth assays using M63 1%
mucin media as the sole carbon, nitrogen, and methionine source showed no significant
defects in growth between wild type K279a and deletion strains (Figure 5.4). This
supports the hypothesis that the mucin-responsive proteases are redundant in their
capacity to metabolize mucin and that singular deletions of proteases involved in mucin
degradation may not be sufficient to produce defective mucin growth.
While testing mutants in auto-transporters smlt1001 and smlt1350 for mucin-related
phenotypes, a significant surface-attached biofilm defect was observed compared to wild
type (Figure 5.5A, 5.5B). It was not surprising to observe a biofilm formation defect in
K279a after deletion of mucin-associated genes, as part of S. maltophilia’s phenotypic
response to mucin involves robust biofilm formation (Figure 4.2).
The lack of characterized homologs in other species and the absence of predicted
conserved domains, aside from the auto-transporter beta-barrel domains in Smlt1350 and
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Smlt1001, and crotonase-like domain in Smlt1001, make it hard to predict the exact
function of these auto-transporters. While Smlt1001 has a putative catalytic domain,
Smlt1350 does not, therefore the function of these outer membrane proteins may be in
adhesion rather than protein degradation. Unfortunately, biofilm assays conducted with
wild type revertants of K279a ∆smlt1001 and ∆smlt1001smlt1350 strains also displayed
varying degrees of aberrant biofilm formation, indicating that the reduced ability to form
a biofilm in the presence of mucin was an artifact of the selection pressures applied
during the allelic exchange protocol.
Wild type revertant colonies are colonies that have passed through the selective
pressure applied during the allelic exchange protocol but recombined to lose the deletion
construct, and regenerate the wild type locus. These revertants are expected to phenocopy
the wild type strain as, hypothetically, there are no genetic differences between wild type
revertants and the original wild type strain. The aberrant biofilm defects observed in a
handful of wild type revertant colonie,s as well the mutant strains, indicated that offtarget mutations were most likely accumulating during allelic exchange. It is important to
note that both smlt1001 and smlt1350 have a tRNA present in their direct upstream or
downstream genomic regions. tRNAs frequently recombine as they are very similar in
sequence and there may be stress-induced chromosomal rearrangement of larger genomic
areas around smlt1001 and smlt1350 during the process of allelic exchange, which could
be responsible for more systemic and varied phenotypes in ‘wild type revertants’ that
have scrambled off-site regions of the genome due to random tRNA recombination.
Many Gram-negative bacteria are known to invert large areas of their genome in response
to stress, creating small colony variants with phenotypes very similar to our allelic
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exchange mutants and wild type reverts (Figure 5.3C) [28], [29], [30], [31], [32], [33]. By placing
intense selection pressure on S. maltophilia during the allelic exchange protocol we may
have triggered large-scale genomic inversions or rearrangements. We are currently
purifying genomic DNA from and sequencing a selection of K279a colonies with varying
degrees of phenotypic defects in order to determine the regions of S. maltophilia’s
genome that are most conducive to rearrangement under antibiotic stress. This could
provide some insight into which regions of the genome are involved in the transition to
small colony variants during chronic infection where pathogens are continuously exposed
to antibiotic stress.
5.7.2 Validation of the necessity of mucin-associated genes in S. maltophilia growth
on mucin
Given the nonspecific phenotypic defects discovered in mutants and wild type
revertants alike, a different protocol of mutant generation must be developed before the
genes identified in the phenotypic screens and microarray can be evaluated for their role
in growth on mucin. Strategies involving the CRISPR Cas9 system and single step
recombination using chromosomally integrated antibiotic resistance cassettes are in the
process of development and optimization. The tendency towards large-scale genomic
rearrangement may also be strain specific; therefore we will use the previously created
mucin-associated gene deletion constructs and attempt allelic exchange in the genetically
tractable clinical isolates AU30115 and AU32848.
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5.8 Remaining questions regarding mucin metabolism in S. maltophilia and
potential roles in virulence
5.8.1 Are there extracellular sialidases and glycosylases involved in S. maltophilia’s
response to mucin?
There are many different types of mucin glycoproteins expressed throughout the
human body. The studies conducted in Chapter 4 of this dissertation used pig gastric
mucin (PGM) as a substrate from S. maltophilia growth. There are many similarities
between PGM and human derived mucins, such as the presence of O-linked glycans,
terminal carboxyl and sulfate groups, and cysteine, serine and threonine rich regions, but
the specific structures and biophysical properties of different mucin polymers are
heterogeneous [34], [35], [36]. Although PGM was used for the microarray experiments
conducted in Chapter 4 of this dissertation, microarrays conducted using purified bovine
submaxillary mucins, which are very similar to human-derived mucins, garnered very
similar results, with the majority of the mucin-associated genes that were up-regulated in
the PGM microarray also being highly expressed in the bovine submaxillary mucincontaining microarray [37]. The similarity in genes expressed after exposure to two
different types of mucin suggests that S. maltophilia’s response to mucin is not specific to
a certain mucin type.
Although S. maltophilia’s transcriptional responses to PGM and bovine submaxillary
mucins were similar, there are certain enzymes whose expression was expected that were
not up regulated in the mucin microarrays. The absence of highly transcribed
extracellular glycosylases and sialidases in the mucin microarray could be due to the time
point at which the microarray samples were taken. The fact that proteases/peptidases
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were the most highly transcribed genes indicates that S. maltophilia was degrading the
proteinaceous backbone of mucin at the time of RNA isolation, and in order to access this
backbone mucin must be stripped of its O-linked glycans. In order to identify the
glycosylases and sialidases potentially involved in lysing the disulfide crosslinks between
mucin glycans and hydrolyzing the O-linkages between the mucin peptide backbone and
its attached glycans, RNA must be collected at earlier time points then the 4 hour time
point already analyzed.
Although no putative extracellular glycosylases were highly transcribed in response
to mucin in K279a, several genes involved in sugar modification were hit in the
phenotypic screens. Although the majority of these sugar-modifying enzymes have
connections to LPS production, there is a possibility that these enzymes can moonlight as
sugar metabolism enzymes when certain sugars are present in excess. In addition to
testing the sugar-metabolism capacity of the LPS-associated enzymes, through
construction of gene deletions and completion of growth assays to compare mutant
growth on different glycans, it would be interesting to investigate whether S. maltophilia
can incorporate irregular sugars into its LPS when supplied predominantly with a certain
type of glycan. Glycan content could be evaluated using glycan-identifying microarray
strategies or SDS PAGE electrophoresis with glycan-specific antibodies [38], [39]. If the
composition of respiratory mucins shifts the composition of S. maltophilia surface and
LPS-incorporated sugars in favor of specific mucin-associated glycans, the composition
of S. maltophilia LPS could be used as an indicator of adaptation to the lung.
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5.8.2 What role do the mucin-associated genes bfmK/smlt4208 and smlt4145 play in
S. maltophilia virulence?
There are two genes whose role in S. maltophilia’s response to mucin is of
particular interest. The first is the histidine kinase response regulator bfmK (smlt4208).
Although bfmK has been partially characterized, and its role in biofilm formation and cell
motility has been confirmed, construction of a clean gene deletion for use in determining
which genes are part of bfmK’s regulatory network during exposure to mucin (via RNA
seq), would provide important information regarding the extent of bfmK’s role in S.
maltophilia virulence [40]. As mucin is a signal triggering the transcription of virulenceassociated genes in other bacteria such as Acinetobacter, it is important to determine
whether bfmK contributes to S. maltophilia virulence in a similar way, by triggering a
multi-gene response to mucin [41], [42]. The second gene that may play a role in S.
maltophilia mucin-mediated virulence is the putative extracellular protease smlt4145.
Protein sequence analysis of Smlt4145 shows that in addition to a serine protease and
autotransporter domain, Smlt4145 possesses a region between the protease and
autotransporter domains with a predicted fibronectin-binding domain (Figure 4.6C). The
fibronectin-binding domain identified in Smlt4145 is modeled off of the host colonization
protein ShdA of Salmonella enterica [43], [44]. Although ShdA and Smlt4145 share low
sequence similarity, Salmonella sp. 3DZ2-4SM possesses a putative autotransporter
serine protease containing a fibronectin-binding domain with 76.69% identity over the
133 amino acid region. The similarity between the two whole protein sequences was
slightly lower at 54.92%. Fibronectin is a glycoprotein that is bound by many pathogenic
bacteria to assist with colonization. The presence of a putative glycoprotein-binding
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domain and protease domain makes Smlt4145 a good candidate protein for involvement
in mucin binding and degradation. Although the already constructed K279a ∆smlt4145
strain does not show aberrant growth on mucin (Figure 5.4), a new deletion mutant must
be made using a system that does not result in non-specific biofilm defects so that the
contribution of smlt4145 to mucin binding by S. maltophilia can be reliably evaluated. It
is also possible that any of the other mucin-responsive putative proteases may be able to
compensate for a lack of smlt4145, resulting in no measurable mucin growth defect in the
single ∆smlt4145 mutant strain.
5.8.3 What is the role of S. maltophilia mucin metabolism during polymicrobial
infection?
Mucin is not easily metabolized by many opportunistic pathogens associated with
the CF lung. The contribution of mucin-fermentative oral anaerobes to the growth of CF
pathogens via cross-feeding with mucin fermentation products has been studied [45]. S.
maltophilia is non-fermentative and most likely does not metabolize mucin in the same
way as oral anaerobes, therefore the effects of S. maltophilia mucin metabolism on the
growth of non-mucin metabolizing organisms during polymicrobial lung infection has yet
to be evaluated. The first step in evaluating S. maltophilia’s ability to cross-feed coinfecting lung pathogens like P. aeruginosa would be to conduct trans-well experiments
where P. aeruginosa is supplied with the byproducts of S. maltophilia mucin metabolism
as the primary nutrient source. If P. aeruginosa, a microbe that is unable to utilize mucin
efficiently, grows well in the presence of the products of S. maltophilia mucin
metabolism, it can be hypothesized that the presence of S. maltophilia within a mucinrich environment like the CF lung will improve the growth of P. aeruginosa during poly193

microbial infection. Further characterization of any nutritional synergy between P.
aeruginosa and S. maltophilia could be achieved by identification of the specific products
of S. maltophilia mucin metabolism via mass spectrometry and subsequent evaluation of
P. aeruginosa growth on the identified mucin metabolic products.
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5.9 Material and Methods
5.9.1 Strains and Growth Conditions
Pseudomonas aeruginosa PAO1 wild type and ∆sphR strains carrying cerN
transcriptional reporter plasmids (Table 5.1) were grown in 1xMOPS media
supplemented with 25 mM pyruvate, 5 mM glucose, and 20 µg/ml gentamicin +/- 20 µM
sphingosine for transcriptional induction assays. Stenotrophomonas maltophilia K279a
knockout strains were grown in 1/20 LB/M63 media or M63 1% mucin media to test
mutants’ ability to utilize mucin as a sole source of carbon, nitrogen, and methionine.
5.9.2 P. aeruginosa cerN promoter mutant transcriptional induction assays
P. aeruginosa PAO1 wild type and ∆sphR strains carrying cerN promoter mutant
reporter plasmids (Table 5.1) were grown overnight in 1xMOPS media supplemented
with 25 mM pyruvate, 5 mM glucose, and 20 µg/ml gentamicin at 37°C shaking at 170
rpm. Strains were washed with 1xMOPs and added to a final OD600 of 0.05 to glass tubes
containing 1xMOPS supplemented with 25 mM pyruvate, 5 mM glucose, 20 µg/ml
gentamicin and +/- 20 µM sphingosine. Sphingosine was added to 20 µM from a 5 mM
stock solution in ethanol. Ethanol was evaporated off before addition of media and cells.
The cultures were incubated for 4 hours, shaking, at 37°C. Levels of growth (optical
density at 600 nm) and β-galactosidase activity (absorbance at 420 nm) were measured
using the Synergy II plate reader (BioTek). Transcriptional activity was calculated via
Miller’s protocol[46] and reported as a percentage of the wild type cerN promoter
transcriptional activity.
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5.9.3 P. aeruginosa sphBCvsvG sphingosine growth assays and assessment of SphCvsvG’s sphingosine modification ability via thin layer chromatography
P. aeruginosa sphingosine growth assays were conducted as previously described
in Chapter 3 of this dissertation. The sphBCvsvG complement construct was tested for the
ability of a tagged version of SphC to recover wild type growth in the presence of
sphingosine. vsvG-tagged SphC’s ability to modify sphingosine was also evaluated via
sphingosine modification assays run with P. aeruginosa ∆sphC complemented with
tagged and untagged sphC. Breifly, P. aeruingosa ∆sphC:sphC complement strains were
incubated for 18 hours at 37°C with 50 µM sphingosine, followed by the separation of
the cultures into the organic and aqueous phases. Visualization of sphingosine remaining
in the organic phase of each culture was achieved via separation by thin layer
chromatography and staining with ninhydrin spray. The sphingosine modification assay
protocol is described in detail in Chapter 3 of this dissertation.
5.9.4 Deletion of mucin-associated genes in S. maltophilia K279a via homologous
recombination
Deletion constructs for mucin-associated genes smlt4145, smlt4395, smlt1350,
and smlt1001, were built using sequence-specific primers as outlined in Table 5.2.
Deletion constructs were created via amplification, restriction digestion, and sequential
ligation of gene-of-interest flanking regions into the similarly cut S. maltophiliacompatible suicide plasmid pGW67, which possesses the gentamicin and tetracycline
antibiotic resistance cassettes, for selection of single cross-over mutants, and the sacB
gene for counter-selection of double-crossover mutants. Homologous recombination was
preformed as follows: E. coli S17λpir strains carrying the deletion constructs were mated
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with S. maltophilia K279a at 1:1 and 1:10 concentrations and plated on LB agar plates
supplemented with 40 µg/ml tetracycline, 20 µg/ml gentamicin, and 100 µg/ml
kanamycin (LB +Abx), for the first round of selection. Single-crossover mutants were restreaked on LB + Abx plates once more to ensure that there is no carry over of antibiotic
sensitive colonies. Confirmed single-crossover mutants were grown for 4 hours in LB to
allow for the second crossover to occur. 1:100 and 1:1000 dilutions were plated on LB no
salt agar plates amended with 10% sucrose to select for deletion mutants or wild type
revertants. Strains were screened for gene deletion or wild type reversion using the
screening (scrn) primers outlined in Table 5.2.
5.9.5 S. maltophilia K279a mucin growth assays
Mucin growth assays were carried out as previously described in Chapter 4 of this
dissertation using S. maltophilia K279a ∆smlt4145, ∆smlt4395, ∆smlt1001, and
∆smlt1001smlt1350 deletion strains. ∆smlt4145, ∆smlt4395, and ∆smlt1001 are deletion
mutants of single putative proteases, while ∆smlt1001smlt1350 is a double deletion of
potential paralogs smlt1001 and smlt1350.
5.9.6 S. maltophilia K279a mucin biofilm assays
Biofilm assays +/- 1% mucin were conducted as previously described in Chapter
4 of this dissertation. Coverslip-attached biofilm assays were also conducted by
incubating coverslips vertically in S. maltophilia cultures grown on M63 media 1%
mucin or 1/20 LB/M63 media, followed by washing of the coverslip and crystal violet
staining to visualize bacterial clumping and the surface attached biofilm structure using a
light microscope.
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5.9 Chapter 5 Figures
Figure 5.1 Modification of sphingosine is dependent on the presence of SphC (A)
vsvG-tagged SphC complements wild type (WT) growth in the presence of 200µM
sphingosine. There is no statistical difference between WT : EV and ∆sphBCD :
sphBCvsvG strain growth but the un-complemented strain, ∆sphBCD : EV grows to a
significantly lower OD600 (*p-value=0.0399). Statistical significance was determined via
2wayANOVA and Tukey’s test for multiple comparisons. (B) vsvG-tagged SphC
complements untagged SphC’s ability to metabolize sphingosine, presented as the
disappearance of the ninhydrin stained sphingosine spot separated via thin layer
chromatography (TLC) after sphingosine was incubated with complemented or uncomplemented PAO1 ∆sphC strains of P. aeruginosa. The organic phase of each sample
was isolated and run on the TLC plate along with a sphingosine control sample. The
retention factor (Rf) of sphingosine is approximately 0.83 in the solvent system used
(chloroform: methanol: water (65:25:4)).
Figure 5.2 P. aeruginosa isolates from chronic CF lung infections acquire mutations
in the cerN promoter region (A) A multiple sequence alignment of cerN wild type and
mutant promoters shows mutations in or around SphR’s binding half site (highlighted in
yellow). (B) Only mutations within the SphR half site sequence cause ablation of SphRdependent induction of cerN (****p-value<0.0001). All transcriptional induction
experiments were conducted in biological triplicate and technical duplicate. Statistical
significance was determined via One Way ANOVA using Dunnett’s multiple
comparisons test.
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Figure 5.3 Phytosphingosine, the sphingolipid component of phytoceramide, causes
high SphR-dependent induction of the sphBCD operon (****p-value<0.0001). All
transcriptional induction experiments were run in biological triplicate and technical
duplicate. Statistical significance was determined using 2way ANOVA and Sidak’s
multiple comparisons test.
Figure 5.4 Single deletions of mucin-induced proteases in S. maltophilia K279a don’t
impact growth on mucin. S. maltophilia K279a gene deletions of mucin-associated
putative proteases show no significant deficiencies in growth on 1% mucin as a sole
source of carbon, nitrogen, and methionine as compared to wild type S. maltophilia
K279a.
Figure 5.5 Deletion of smlt1350 via allelic exchange resulted S. maltophilia K279a
clones with phenotypic defects (A) S. maltophilia K279a ∆smlt1350 has a biofilm
defect when compared to wild type in the presence of 1% mucin (*p-value=0.0261) but
there was no statistically significant difference between wild type and ∆smlt1350 surfaceattached biofilm formation in minimal media or diluted LB media. (B) Although the
difference in biofilm formation between S. maltophilia K279a wild type and ∆smlt1350
in diluted LB media is not statistically significant, there is a visible decrease in
∆smlt1350’s biofilm formation in 1% mucin and diluted LB media’s. (C) There is also a
visible difference in cell size and clumping in the presence of 1% mucin, with smaller
cells and less clumping in ∆smlt1350 as compared to wild type. Biofilm assays were
conducted in biological triplicate and technical duplicate with Sidak’s multiple
comparison’s test.
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5.10 Chapter 5 Tables
Table 5.1 Strains and plasmids used in this study
Table 5.2 Primers used in this study
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Table 5.1 Strains and plasmids used in this study.
Strains and Plasmids
cerN promoter mutants
Designation Genotype or Description Plasmid
LAH135
PAO1 WT
pMW5:cerN promoter mutant 206.3
LAH136
PAO1 ∆sphR
pMW5:cerN promoter mutant 206.3
LAH137
PAO1 WT
pMW5:cerN promoter mutant 222.2
LAH138
PAO1 ∆sphR
pMW5:cerN promoter mutant 222.2
LAH141
PAO1 WT
pMW5:cerN promoter mutant 243.5
LAH142
PAO1 ∆sphR
pMW5:cerN promoter mutant 243.5
pMW5:cerN WT promoter
LAH147
PAO1 WT
S. maltophilia K279a gene deletions
Designation Genotype or Description Plasmid
LAH158
E. coli S17λpir
pGW67:smlt4145KO
LAH199
K279a ∆smlt4145
none
LAH178
E. coli S17λpir
pGW67:smlt4395KO
LAH196
K279a ∆smlt4395
none
LAH169
E. coli S17λpir
pGW67:smlt1350KO
LAH193
K279a ∆smlt1350
none
LAH179
E. coli S17λpir
pGW67:smlt1001KO
LAH213
K279a ∆smlt1001smlt1350 none
K279a ∆smlt1001
LAH192
none
sphC complement constructs
Designation Genotype or Description Plasmid
LAH206
PAO1 ∆sphC
pMQ80:sphCvsvG
LAH212
PAO1 ∆sphC
pMQ80
PAO1 ∆sphC
pMQ80:sphC
LAH209
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Primers Used in Construction
574, 1807
574, 1807
574, 1807
574, 1807
574, 1807
574, 1807
574, 1807
Primers Used in Construction
2448, 2449, 2450, 2451
N/A
2476, 2477, 2478, 2479
N/A
2444, 2445, 2446, 2447
N/A
2615, 2616, 2617, 2618
N/A
N/A
Primers Used in Construction
2511, 2514
N/A
2511, 2512

Table 5.2 Primers used in this study.

Primer Number
2448
2449
2450
2451
2494
2495
Primer Number
2444
2445
2446
2447
2456
2457
Primer Number
2476
2477
2478
2479
2480
2481
Primer Number
2615
2616
2617
2618
2619
2620

smlt4145 deletion construct
Primer Name
Primer Sequence
Smlt4145_F1_HindIII AAAAAGCTTGACGAAGAAACGACGCACTC
Smlt4145_R1_XbaI AAATCTAGAGGGCTCACCAGGCTTATCAA
Smlt4145_F2_XbaI AAATCTAGACGTAGGCTTCCTTGGCTCC
Smlt4145_R2_EcoRI AAAGAATTCGCCGCACACAGACAGATTCA
smlt4145_F1scrn
TCGTTTCCGGTGACATCCAG
smlt4145_Rscrn
GTTGTCCAGGTAGGGGAAGC
smlt1350 deletion construct
Primer Name
Primer Sequence
Smlt1350_F1_HindIII AAAAAGCTTTTGACATGGGCAGGGTCTTC
Smlt1350_R1_XbaI AAATCTAGAATACGTTCTCTCTCTCCACCCGCAA
Smlt1350_F2_XbaI AAATCTAGACGGTATGGTCGGCATGGCATT
Smlt1350_R2_EcoRI AAAGAATTCGCGGATCACTGCATGGGTAT
Smlt1350_F_scrn
TATGAAGTCGTGCAGCCCAA
Smlt1350_R_scrn
TGGCGGTGACATTCAACGTA
smlt4395 deletion construct
Primer Name
Primer Sequence
Smlt4395_F1_HindIII AAAAAGCTTTCGGTGCGCAGATGCAGCGT
Smlt4395_R1_XbaI AAATCTAGAATACACGAATCCTTCTGT
Smlt4395_F2_XbaI AAATCTAGATGATGAAGACCACCAT
Smlt4395_R2_EcoRI AAAGAATTCCTGTTCGCGCCGTACGGCATG
smlt4395_scrn_F
TCAACGTCATCACCGTAGGC
smlt4395_scrn_R
TTCTGGCGGTTGGTGTTCTT
smlt1001 deletion construct
Primer Name
Primer Sequence
smlt1001_F1_HindIII AAGCTTGCTCGCTGTCACCGTAGTAG
smlt1001_R2_XbaI TCTAGAGTTCTGAGCACACGCCATTC
smlt1001_F2_XbaI
TCTAGACTCTCCAGACCGCTAACGC
smlt1001_R2_EcoRI GAATTCGATCACTGTCGAAGACGGCA
smlt1001_scrn_F
GGATTGAGGTCTCCGCTCAC
smlt1001_scrn_R
ATGAACTGACCCAGCAGTCG
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